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Previous research has demonstrated that the successful management of type 2
diabetes is dependent on the patients' social environment, in particular, the role
of significant others. Therefore, the focus of this research was to explore the
illness beliefs of patients with type 2 diabetes and their partners in a
prospective study. The theoretical framework for the research was guided by
the self-regulatory model of illness behaviour (Leventhal et al, 1984) which
asserts that individuals conceptualise illness around 5 'core' dimensions
regarding the control, consequences, course, identity and cause of their condition.
These 'illness representations' describe the underlying differences on which
individuals differ with regard to their illness.
In particular, the extent that patients and partners share representations of
diabetes was explored in relation to the patients' adaptation and self-
management of the condition. A total of 164 patient-partner dyads were
recruited and followed-up at 12 months later. The illness representations of
patients and their partners were assessed with diabetes-specific measures.
Patients' self-management behaviours were assessed by self-report measures of
adherence with diet, physical activity and medication at both time-points and
objectively with a single measure of glucose control (HbAlc) at 12 months. In
addition, marital satisfaction and psychological morbidity were assessed at both
time-points. It was found that patient-partner dyads, generally, held similar
representations of diabetes. In addition, logistic regression analyses
demonstrated that partners' diabetes representations were influential in the
extent of patients self-management behaviours, and levels of psychological
morbidity after the influence of patients' representations, past behaviour, and
demographic and clinical variables.
The findings are discussed in the context of previous research examining illness
representations in chronic disease, the implications for the self-regulatory
model of illness behaviour and future behavioural interventions to improve the
self-management behaviours of patients with type 2 diabetes.
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CHAPTER 1: THE SOCIAL CONTEXT AND THE
MANAGEMENT OF DIABETES
1.1. Introduction
The present thesis aims to explore the role of significant others in the health
behaviours of patients with type 2 diabetes. Before introducing the theoretical
framework used to facilitate this enquiry, the extent and nature of how a
diabetic patients' social environment impacts on disease management is
examined. Therefore, this introductory chapter focuses on the importance of
the social context in relation to patients' efforts to manage diabetes with regard
to their health behaviours and control of blood glucose. In particular, the
chapter will focus on the construct of social support and its relationship with
adherence to treatment recommendations in patients with diabetes
A critique of social support and its measurement precedes the review of
empirical studies examining the construct. There are also a number of points
and issues regarding treatment adherence that are addressed before reviewing
the empirical literature examining the role of social support and diabetes.
These include; the prevalence and consequences of non-adherence in chronic
disease, the distinction between intentional and non-intentional adherence, and
the measurement of adherence. Finally, the ongoing debate regarding the
terminology used to describe patients' fulfilment of treatment
recommendations is also addressed.
IA/hat is type 2 diabetes?
Type 2 diabetes (non-insulin dependent) presents as a spectrum of metabolic
abnormalities characterised by prominent insulin resistance and relative insulin
deficiency. It accounts for about 90% of all cases of diabetes, tending to emerge
in mid to late adulthood. The major risk factors for diabetes include a family
history of diabetes, obesity (BMI> =27 kg per m 2) age (>= 45 years),
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hypertension, and high cholesterol levels. There is a progressive increase in the
world-wide prevalence of type 2 diabetes. This increase is primarily the result
of lifestyle changes, and in particular the steady rise in the prevalence of obesity
(Amos et al, 1997, WHO, 1997). Finally, the prevalence of type 2 diabetes is
projected to double by 2010 and is also accelerating in the younger population
(ibid).
Consequences of lijpe 2 diabetes
The longer the duration of diabetes the greater the likelihood of developing
symptoms and signs of degenerative complications. The consequences of poor
management of type 2 diabetes can be severe. Complications related to
diabetes include blindness, amputations, and diseases of the kidneys, heart and
central nervous system (Kaplan & Hartwell, 1987). The treatment of diabetes
and its complications also constitutes a huge financial burden accounting for
around 5% of the UK National Health Service budget (Leese, 1991).
Management of type 2 diabetes
Apart from being a serious chronic illness and social problem, the patient with
type 2 diabetes has the principal responsibility for the management of their
illness. In particular, the daily management of diabetes involves eating regular
healthy meals, taking physical exercise, self-testing blood glucose levels and, for
many patients, taking medicine. The goal of this combination of tasks is to
maintain glucose levels within a target range - by achieving tight blood glucose
control the rate of complications decreases (DCCT, 1993; UKPDS, 1998). Self-
management not only involves completing such activities but considering the
inter-relationships among these tasks and implementing appropriate changes in
the daily plan when necessary. However, rates of non-adherence with these
behaviours are high, ranging from 30-75% (Paes et al., 1998) and often result in
poor disease outcomes (Nicolucci et al., 1996). Indeed, Nicolucci et al speculate
that the risk of diabetic complications could be reduced by up to one third, if
18
such 'avoidable' factors could be removed. Therefore, a major concern in the
management of type 2 diabetes is how to encourage adherence with prescribed
regimens.
The role of diet
Following a healthy diet is the primary treatment for type 2 diabetes. The goal
of dietary intervention is to maintain near-normal glucose and lipid levels;
maintain a reasonable body weight; prevent, delay or treat nutrition related risk
factors and complications and improve overall health (Franz et al, 1994).
However, dietary advice (along with physical exercise) is the most difficult
aspect of the treatment regimen for patients to adhere with (Glasgow et al,
1997). An analysis of adherence to diet therapy among patients with diabetes
showed that only 20-50% of patients followed dietary recommendations
(Savage & Knowler, 1984; Skender et al., 1996). Moreover, Hixenbaugh and
Winkley (2001) demonstrated that many patients have difficulty in eating the
right type of food (59%), the right amount of food (49%) eating at regular
intervals (36%) and maintaining an ideal weight (37%).
The current dietary recommendations for patients with type 2 diabetes are the
same as for the general population. It is, therefore, the recommendation of
Diabetes UK (formerly British Diabetic Association) to eat regular meals that
are;
• low in fat (esp. saturated fat)
• high in fibre
• eat carbohydrates high in starch
• low in sugar
and to:
• eat five portions of fruit and vegetables a day
• reduce salt
• moderate alcohol consumption
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In addition, patients are encouraged to achieve /maintain a desirable body
mass index (BMI). All newly diagnosed patients with diabetes should receive
dietary advice from a State Registered Dietitian and receive additional support
from a trained member of their Primary Health Care Team (Avon Health
Diabetic Care Manual, 1996).
1.2. Prevalence and consequences of non-adherence
Patient non-adherence with a treatment regimen may seriously undermine the
effectiveness of medical care, and may, in turn give rise to poorer clinical
outcomes (Haynes et al., 1996). Therefore, adherence with medical regimens is
widely recognised as one of the principal challenges in healthcare. Non-
adherence amongst patients is more prevalent when the illness is chronic and
the treatment recommendations are largely prophylactic (Haynes et al., 1979;
Meichenbaum & Turk, 1987). Approximations of the scale of the problem vary
considerably, although average estimates of adherence in chronic illness
converge at about 50% (Evans et al. 2001; Hulka et al. 1976; Wright, 1993).
A specific consequence of non-adherence is an increase in diagnostic and
therapeutic procedures, with subsequent increased health-care expenditure. It
has been speculated that the risk of diabetic complications could be reduced by
up to one-third if adherence with health behaviours could be improved
(Nicolucci et al, 1996). The far-reaching financial and human costs of non-
adherence (Lowe et al, 1995) have led to many investigations to seek to identify
the determinants of adherence. This work has identified a number of socio-
demographic (e.g., age, gender, ethnicity, social class, disease status:
Hawthorne et al, 1993; Koskinen et al, 1996; Nicolucci, et al., 1996; Dunbar-Jacob
et al. 1995) and psychosocial correlates (e.g., social support, locus of control,
health beliefs, psychological morbidity: Fukunishi et al, 1998; Schoenberg et al,
1998; Schwartz et al, 1991), and has led to the development of interventions
designed to promote adherence (Epstein & Cluss, 1993, Lustman et al, 1998).
However, results indicate that many of these interventions have failed to
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generate significant improvements in adherence and treatment outcomes
(Haynes et al., 1998). Thus, the understanding of the factors which may
influence medication adherence remains inadequate.
It is also acknowledged that many other factors influence adherence to
treatment regimens such as the perceived efficacy of the treatment, cost-benefits
of adherent behaviour, complexity of the regimen, side effects of medication,
psychological morbidity and socio-economic status which have been explored
elsewhere in the literature. In addition, issues such as the quality of the
practitioner-patient relationship, satisfaction with care, understanding of the
condition may also impact on adherence as described in the seminal work of
Ley (1982,1988).
Intentional and non-intentional adherence
It is suggested that non-adherence behaviours fall into two broad categories
(Home, 1997). First, 'unintentional' non-adherence occurs when the patients'
intentions to take the medication are impeded by barriers such as forgetting,
and inability to follow the treatment instructions because of poor
understanding, memory or physical problems such as poor eyesight or
impaired manual dexterity. Second, 'intentional' non-adherence is when an
individual chooses not to follow some or all of prescribed treatment
recommendations or when an individual has learned to manipulate or deviate
from treatment recommendations that suits his or her lifestyle. Intentional non-
adherence is sometimes referred to as "intelligent non-compliance" in
acknowledgement of the fact that, from the patient's perspective, it may be




Multiple methods of assessment are used in research examining adherence to
treatment recommendations including self-report questionnaires and diaries,
biological markers, and clinical outcomes. However, there are important issues
regarding the measurement of adherence with treatment regimens. Each
method reveals somewhat different information about the patient's behaviour
with regard to their regimen as well as different reports of adherence.
Therefore, the selection of a strategy to measure adherence requires careful
attention to the limitations of each method and a well-specified definition of
adherence. Indeed, there is a danger that self-report measures of adherence
may permit patient over-reporting due to failure of memory or understanding
or deliberate omission of the truth to bias findings. Taking medication
adherence as an example, when validated against objective measures such as
pill counts or biochemical methods, self-report is highly variable in terms of
accuracy (Francis et al, 1969). This has been observed across a range of
therapies for chronic conditions including medications for hypertension (Rudd
et al., 1989) and RA medications (Dunbar-Jacob, 1993). In addition, studies that
rely on clinical outcome measures (e.g., blood pressure, HbAlc) may also be
unreliable as a patients' condition may improve or deteriorate for reasons
unrelated to adherence such as stress (Surwit & Schneider, 1993).
The 'adherence' versus 'compliance 'debate
Finally, there is considerable debate regarding the most appropriate
terminology to use when describing patients' fulfilment of recommended health
behaviours. Indeed, terms such as 'adherence', 'compliance' and 'concordance'
are often used interchangeably in the literature. Some investigators argue that
differences between these terms extend beyond semantics. Indeed, Trostle,
(1988) asserts that the term 'compliance' is an expression of practitioner's
medical authority over patients who are expected to obey without question.
Others, such as Eisenthal et al., (1979) argue that 'adherence' is a confirmation
of the active, participative role of patients in the management of their care.
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Adherence has been defined as..... . 'the extent to which the patient's behaviour (in
terms of taking medications, following diets or other lifr style changes) coincides with
medical or health advice' (Haynes, 1979). More recently, 'concordance' has
emerged as a term to describe an agreement reached between a patient and a
practitioner that respects the beliefs and wishes of the patient determining
whether, when and how medicines are to be taken. Although reciprocal, this is
an alliance in which health care professionals recognise the primacy of the
patient's decisions about taking the recommended medications. While
acknowledging such differences in terminology, the term 'adherence' is used in
the present thesis and is intended to encompass the definition given by Haynes
(1979).
1.3. Social support: An introduction
Much research effort has been invested in the purported beneficial effects of
social support on health and well-being. Indeed, empirical evidence suggests
that social support is associated with greater adherence with treatment
regimens (Levy, 1986). Before examining this work two general models that
explain how social support may impact on treatment adherence in chronic
disease are introduced. First, the 'main effects' model of social support is
considered to be a positive and useful resource such that the benefits are great
even when people are not exposed to stressful situations such as chronic illness
(Cohen & Syme, 1985). The second model known as the 'buffering' model,
suggests that social support may serve as a source of protection (as a buffer)
against adverse effects resulting from the presence of a stressor (Cohen &
McKay, 1984). Indeed, it is likely that social support may enhance adherence,
either directly (through encouragement, reassurance, reinforcement, systematic
cues, bolstering of competence, and motivation) or indirectly (by buffering the
effect of factors that may impede adherence, e.g., life stress, anxiety and
depression). However, this section primarily addresses the literature
examining the 'main effects' model of social support in studies with diabetes
patients and the role of the spouse in particular. First, however, issues
surrounding the measurement of social support are addressed.
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Measurement of Social Support
The measurement of social support has been approached in two main ways.
One approach conceives of social support in terms of the structure of an
individual's interpersonal relationships or social network, the other in terms of
the frnctions that these relationships or networks serve for an individual. The
measurement of social support is based on tools assessing an individual's
perception of either the availability of others who provide these functions or the
actual receipt of these support functions (Stroebe & Stroebe, 1995). Therefore,
'structural' measures assess the existence or quantity of social relationships (i.e.,
availability of family and friends), whereas 'functional' measures of social
support assess whether interpersonal relations serve particular functions (types
of resources). Turner (1992) asserted that the effective measurement of
perceived support provides the best lever by which to estimate the relative
significance of potentially modifiable social factors for health and well-being.
Furthermore, conceptions of available social support are both dispositional and
cognitive, whereas conceptions of perceived support are situational and
behavioural, involving interaction between individuals (Dunkel-Schetter et al.
1992).
With regard to 'functional' measures, it has been proposed that social support
consists of multiple components. Indeed, Schaefer et al. (1981) studied the
relationship between social network size and three types of social support; 1.
'tangible' (or 'instrumental'), 2. 'emotional' and 3. 'informational'. The three
types of support were examined in relation to stressful life events,
psychological symptoms, morale and physical health status, hence
recommending the need to study these components separately. 'Instrumental'
support consists of behaviours that directly help the person in need (i.e.,
practical help with work etc). 'Emotional' support involves providing empathy,
care, love and trust. Finally, 'informational' support involves providing people
with information that they can use in coping with their problems. However,
24
House and Kahn (1985) also include 'appraisal assistance' which is closely
related to 'informational support'. It also involves the transmission of
information relevant for an individual's self-evaluation. Finally, Cutrona (1990)
added a fifth component, 'social integration', which combines structural and
fr nctional characteristics of support.
A problem with only measuring recipient perceptions of social support instead
of the actual support that is given is that such perceptions are not always
accurate. Such perceptions are not only based on what the recipient felt was
needed versus what was actually given, but what the provider(s) perceived was
needed by the recipient. In addition, provider and recipient perceptions do not
correlate well. For example, providers may feel that they are giving more than
what recipients feel they are receiving (Sarason et al., 1990). Recipients may
also be dissatisfied and consider it negative support if the provider encourages
behaviours that the recipient does not want to display (Tilden, 1985).
When evaluating social support it is also necessary to consider cause and effect.
For example, it may be difficult to determine whether a lack of social support
contributed to a problem occurring (e.g., depression) or if the problem was pre-
existing in the individual and thus influenced the lack of adequate social
support. Researchers have tended to ignore this phenomenon and assume that
social support always results in positive outcomes. Also, researchers tend not
to examine social support and changes in social network over extended periods
of time (Kahn, 1994). Furthermore, support may vary throughout one's life, or
even through the course of a stressful life event such as chronic illness. As a
result it is difficult to evaluate this cause-effect phenomenon.
Support from significant others
A supportive family environment has been identified as a particularly
important source of social support for chronically ill individuals (Moos & Moos,
1986). Furthermore, an early study demonstrated that support provided by the
spouse may determine adherence to long-term medical regimens (Doherty et
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al.,1983). The authors examined the influence of social support on adherence
with hypertensive treatment from the perspective of the participant, the spouse
and medical staff members. The authors reported that hypertensive men who
had highly supportive spouses were more likely to adhere to their medication
regimen than men with less supportive spouses. The health beliefs of the
spouse were also related to levels of support provided. Indeed, wives who
believed more strongly in the benefits of the therapeutic regimen were more
likely to offer higher support to their husbands. This seminal study
demonstrated the importance of spousal health beliefs, provision of support
and the implications for adherent behaviour.
1.4. Social support and diabetes management
With regard to the topic of the thesis, studies examining the role of social
support and marital satisfaction in the management and control of diabetes are
reviewed in the following section. These studies are also summarised in Table
2.1.
A search was conducted to locate empirical studies examining the role of the
social context in the management and control of diabetes. In particular, the
search focused on finding literature examining the 'social support' in the
context of treatment adherence in adult diabetic patients. Quantitative studies
published in the English language were located through undertaking electronic
database searches on 'Psychlnfo', 'BIDS', 'Web of Science' and 'Medline'.
Further literature was found by hand searching journals and reference lists
from relevant journal articles.
Family support in type 2 diabetes
MacLean and Lo (1998) examined expected success in adherence with exercise
and diet regimes in 95 patients with type 2 diabetes. The aim was to determine
if family support was associated with adherence and intentions to continue to
adhere. Family support was assessed with the Perceived Social Support from
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Family Scale (Famsup: Procidano & Heller, 1983). The General Health
Questionnaire (Goldberg, 1978) was used to assess transient and chronic stress.
In addition, variables pertaining to intention, self-efficacy and self-esteem (Self-
Esteem Inventory; Rosenberg, 1995) were also evaluated. The results from
regression analyses demonstrated that adherence was a function of the capacity
to utilise family support, positive attitudes, high self-esteem, absence of stress
and acceptance of the challenges of the illness. The importance of good family
support, absence of stress, and capacity to take up the challenges of the disease
was replicated by Lo (1999) with regard to successful adherence in 146 diabetes
patients dependent on insulin.
Overall, the findings of these studies indicate that patients with diabetes who
have access to good social support and experience less stress are more likely to
engage in adherent behaviours. However, as these were cross-sectional studies
it is not permissible to make causal predictions, it is possible that good
intentions to adhere attract higher levels of support from the patient's family. It
is also reiterated that actual adherence was not measured, instead a measure of
the patient's efficacy and intention to comply with the regimen was utilised.
Furthermore, no distinction was made between diet, exercise and blood-glucose
testing, therefore it cannot be assumed that patients' intend or are able to
adhere equally to these management requirements. It is also uncertain to what
extent such findings can be viewed as indicators of patients' actual behaviours
regarding the successful management of diabetes. It is well documented from
previous research that intentions to perform a health behaviour do not
necessarily translate into an action been taken. Indeed, it may be that further
cognitive activity is required to ensure that intentions are translated into actions
(Norman & Conner, 1996).
In a study of 213 insulin-treated patients with diabetes Toljamo and Hentinen
(2001) examined the role of social support and adherence to self-care regimens.
Social support was assessed with an instrument developed for the study based
on the definition of social support provided by House (1981). It consisted of 13
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items relating to 'emotional', 'instrumental', 'informational' and 'peer' support
from other patients. Adherence to aspects of the diabetic regimen were
measured with a 20-item scale covering insulin treatment, diet, exercise and
blood-glucose monitoring. Metabolic control was measured with levels of
HbAlc taken from patient records. Measures of HbAlc reflects patients' mean
metabolic control over the 6-12 weeks preceding measurement and is part of the
routine management of patients with diabetes and widely accepted as reliable
and valid index of metabolic control (Nathan et al., 1984).
Factor analysis of the adherence to self-care scale revealed two distinct factors:
'flexible self-care' and 'regimen adherent self-care'. These factors were then
dichotomised at their median value to give the following four adherence
categories: 1) 'regimen-adherent self-care', 2) 'no regimen-adherent self-care', 3)
'flexible self-care' and 4) 'no flexible self-care'. The factor structure of social
support was also examined. The items regarding 'emotional' and
'instrumental' support loaded highly on the same factor, and were combined to
form a single variable labelled 'emotional and instrumental' support. The
remaining variables of 'informational', 'peer', 'negative' and 'financial' support
remained intact. Logistic regression analyses were employed to determine
predictors of neglect of self-care. Patients who adhered to self-care either
flexibly or with strict adherence to the regimen received more social support
from family and friends than those who neglected self-care. There were no
statistically significant relationships between other types of social support and
adherence to self-care. Surprisingly, those who perceived more peer support
from other patients with diabetes had worse blood-glucose levels. Getting no
'emotional and instrumental' support was related to neglect of self-care. The
authors concluded that adherence to self-care was associated with support from
family and friends. In particular, those with 'emotional and instrumental'
support from their friends and family adhered better to self-care.
For efficiency in the operationalisation of social support in this study, the type
and source of support were combined. However, in so doing, some
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information may have been lost; therefore social support may be best assessed
with separate measures to capture more accurately the nature of support. A
further limitation, is that participants were regular attenders at a diabetes clinic
and thus must be considered as having a more responsible approach to
managing their disease and may not be 'typical' diabetes patients.
Glasgow and Toobert (1988) prospectively, examined the influence of the social
environment in relation to health outcomes in 127 patients with type 2 diabetes.
The social environment was assessed with the Diabetes-Family Behaviour
Checklist (DFBC), a self-report measure specifically developed to assess social
support received from family members for the performance of self-care
activities in patients with type 1 diabetes (Schafer et al., 1986). The scale was
modified (DFBC-II) for use in a population with type 2 diabetes. Two versions
of the DFBC-II were administered; one for the subject and another for the
partner or 'significant other'. Four different aspects of the diabetes regimen
were assessed (glucose testing, medication taking, diet and exercise). Dietary
adherence was also measured with a 3-day food record and subjects were
trained to estimate portion sizes and asked to weigh servings of meats and
cheeses. Adherence to medication, physical activity, and glucose testing was
assessed with a version of the Summary of Diabetes Self-Care Activities scale.
It was demonstrated that measures of family support were the strongest and
most consistent predictors of a composite measure of adherence in patients with
type 2 diabetes. However, the results of this study are tempered by relying
solely on self-reports of family interaction. In addition, the process of self-
monitoring family interactions may have altered patterns of self-care over the
period of study.
The role of social support and self-efficacy (belief in the ability to perform a
given behaviour) in the self-care behaviours of 94 patients was assessed in
patients with type 1 or type 2 diabetes (Williams & Bond, 2002). The ability to
perform behaviours in four regimen areas; blood glucose testing, exercise,
eating habits and medication were assessed with a 29-item questionnaire. The
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frequency of both supportive and unsupportive family behaviours was assessed
with the DFBC (Schafer et al, 1986). Items of the scale addressed blood-glucose
testing, diet, exercise, medication, and general regimen adherence. Participants
nominated their closest supporter (e.g., wife, husband, daughter) and indicated
how often that person assisted in the performance of a given self-care
behaviour. Response options ranged from 'never' to 'at least once a day'. Self-
care behaviour was assessed with the Summary of Diabetes Self-Care activities
scale (Toobert &t Glasgow, 1984). The family member nominated as providing
the most help with diabetes management was the spouse or partner (n=75, 83%
of those with family support). It was demonstrated that self-efficacy was
associated with social support and positive diet-related family interactions. In
addition, a mediation effect was found for self-efficacy with positive diet self-
care support and positive exercise self-care support. However, when the effects
of self-efficacy were controlled, social support was no longer a significant
independent predictor of self-care. The authors argue that the results support
Bandura's (1977) claim that social support is a source of efficacy information but
does not affect behaviour directly, thus social support could be an important
source of efficacy information among diabetes patients. Although this study
showed that the receipt of social support was a predictor of dietary and exercise
behaviour, no such relationship was found for medication adherence. This may
be a function of using a composite measure of regimen adherence such as the
Summary of Diabetes Self-care Scale which may not have been able to
differentiate among different aspects of behaviour. Alternatively, if this finding
truly reflects the relationship between social support and medication adherence
it affirms the view that 'it should not be assumed that because a family member
is supportive of a patient's adherence to one aspect of the regimen......that he
or she will be supportive of other diabetes activities' (Glasgow & Toobert, 1988,
p.384)
Social support and gender
It has been observed that social support has differential effects for men and
women in relation to health (Antonucci, 1985; Kessler et al., 1985). These effects
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have also been demonstrated in type 2 diabetes. In a small and simple study
(n= 37), Heitzmann & Kaplan (1984) examined the role of support in relation to
blood-glucose control. The patients' social support network was measured by
the Social Support Questionnaire (Sarason et al., 1983). The SSQ provides
separate scores for network size and satisfaction with available support.
A single measure of HbAlc was used to assess the extent of control of diabetes
The measurement of HbAlc provides a measure of blood glucose control such
that higher levels indicate poorer control of diabetes. Groups of high and low
recipients of social support were formed by median split and analysis of
variance was conducted to determine the effects of gender and social support
on levels of HbAlc. It was demonstrated that women were in better control of
type 2 diabetes when they were more satisfied with their social support
network. In contrast, men were in poorer control when they had high
satisfaction with social support scores. However, the social support network
scores were not significantly related to glucose control for men and women.
These results were replicated in a prospective study Kaplan and Hartwell (1987)
using the Social Support Questionnaire (Sarason et al., 1983). Regimen
adherence was assessed via levels of HbAlc. Male patients expressing greater
satisfaction with perceived social support exhibited poorer glyceamic control at
18-months follow-up. In addition, women selected spouses as supports only
half as often as men did. This study highlighted the complexity of the
relationship between satisfaction with social support, network size and gender
with the control of type 2 diabetes.
Together, these studies suggest that social support, network size and
satisfaction have different functions for men and women with type 2 diabetes.
One explanation is that social support serves as a more important buffer of
stress for women than it does for men. According to the buffering hypotheses,
social support should have greater effects under higher levels of stress. In this
study women reported greater worry than men relating to their diabetes and, in
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turn, may have a more positive response to high levels of social support.
However, it is unclear why diabetes should be correlated with low worry for
men but not for women. It is possible that men have a more casual disposition
toward their illness and that they receive support for this stance. Alternatively,
it could be that a satisfactory support system directly affects behaviours that
result in good or poor control of diabetes. For example, networks found
satisfactory to women may support behaviours that lead to good control. In
contrast, networks satisfactory to men may reinforce lifestyle patterns that are
not in the patients' best interests.
Social Support and family functioning
It has been proposed that the family system has a role in the initiation, selection
of symptoms, clinical course, use of clinical facilities and adherence to medical
treatment in chronic disease (Anderson & Auslander, 1980, Hansen &
Hengeller, 1984). The 'family functioning' concept refers to a set of patterns or
interactions among members of a family (Epstein et al., 1978). During the
course of a chronic disease such as diabetes, adverse interactions may impose
an excessive load on the capability for adaptation of the family. Thus, it is
suggested that under such circumstances, family functioning may change to
'rigid' control, which may threaten family stability.
Garay-Sevilla et al (1995) examined the role of social support in adherence to
diet and medication in patients with type 2 diabetes. Support was assessed in
200 patients with a modified diabetes-specific questionnaire (Ruggiero et al.,
1990). Family functioning was evaluated with the modified McMaster model
(Epstein et al., 1978). Adherence to treatment was assessed with a seven-item
self-report measure concerning daily intake of food, acceptance and adherence
to prescribed diet and the patient's interest in keeping an appropriate weight.
In addition, medication adherence was assessed with three questions about
continuity of intake (e.g., self decided changes of doses). Regression analyses
demonstrated that adherence to diet was predicted positively by social support
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and disease duration. Social support was also the main determinant of
medication adherence. In addition, adherence to medication was lower in
patients from families with 'rigid control' (if permissions for members of the
family were seldom given) than those with 'laissez-faire' (if permissions were
almost always granted) type of control or 'flexible' control (if permissions were
frequently obtained).
A rigid control of behaviour within a family may imply decreased adaptation to
change, in particular to deleterious changes such as chronic disease in one of its
members. In turn, this may favour denial of the disease. It may also enhance
the development of conflict with the authority, increasing the denial of the
disease resulting in a decrease in adherence. Finally, the results are
compromised by a response rate of just 20%. Therefore it is possible that those
consenting to participate were naturally more concerned about their condition
and consequently exhibited greater adherence.
The marital relationship and blood-glucose control
Trief et al, (2001) examined the relationship between marital adjustment, blood-
glucose control and psychosocial adaptation to diabetes. A mixed sample of 78
married patients aged 18-55 years with insulin-treated type 1 or type 2 diabetes
(^ lyear) participated in the study. Marital quality was measured with the DAS
(Spanier, 1976). Functional health status was measured with the MOS-SF36
(Ware & Sherbourne, 1992). Diabetes-specific emotional distress was assessed
with the Problem Areas in Diabetes Scale (PAID; Polonsky et al, 1995). Finally,
glucose control was assessed with a single measure of HbAlc.
Higher levels of marital satisfaction predicted lower scores on the PAID.
Marital quality did not predict levels of HbAlc when treated as a continous
variable. Thus subjects were divided into three groups; good glyceamic control
was defined as ^ 7.4%, acceptable control was defined as a value between 7.5-
8.4%, and poor glyceamic control was defined as HbAlc value of> 8.4%. These
figures were based on the findings of the Diabetes Control and Complications
Trial which demonstrated that the risk of significant microvascular
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complications dramatically increases when HbAlc levels exceed 8.4% (DCCT
Research Group, 1988). Due to small numbers 'acceptable' and 'poor
controlled' patients were combined for analysis and dichotomised into two
groups; HbAlc <7.4 and ^ 7.4%. Stepwise regression analyses demonstrated a
trend for marital satisfaction measures with the DAS to be predictive of
glyceamic control, although the effect just missed statistical significance
(p=.O56). The authors concluded that marital quality does relate to an
individual's adaptation to diabetes with regard to levels of emotional distress.
Although a significant relationship was not found for marital satisfaction and
HbAlc it is suggested that the marital relationship may be more powerful than
general family support in terms of its impact on glyceamic control. Finally, the
cross-sectional design prohibits enquiry into causality as it cannot be
determined if a poor relationship leads to poor illness adaptation and glucose
control or that poor control/adaptation leads to a more problematic marital
relationship. Finally, by including patients with both type 1 and type 2 diabetes
it is difficult to delineate how support and marital satisfaction differ for these
medically defined sub-groups. Indeed, regular insulin administration by
patients with type 1 diabetes may pose unique challenges compared with type 2
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1.5. Summary of social support in diabetes
In general, the findings of the studies examining the role of social support in
treatment adherence and control of diabetes demonstrate that higher levels of
social support favour better management of the condition. More favourable
indicators of the role of social support were evident in the prediction of self-
management behaviours such as exercise, dietary and medication adherence.
Indeed, the studies of Glasgow and Toobert (1988); Toljamo and Hentinen
(2001) and Williams & Bond (2002) found that social support was predictive of
adherent behaviour, whereas Lo (1999) and MacLean and Lo (1998) found that
social support was predictive of intentions to adhere to self-management
behaviours. However, with regard to blood-glucose control social support
appears to serve different functions according to the gender of the patient. A
surprising finding is that men were in poorer control when satisfied with the
level of support they received whereas women were in better control
(Heitzmann and Kaplan, 1984; Kaplan & Hartwell, 1987). In addition, patients
receiving support from other patients with diabetes were also likely to exhibit
poorer control (Toljamo and Hentinen, 2001) while Trief et al (2001) did not find
a significant relationship between marital quality and HbAlc. Such mixed
findings make it unclear how the social environment influences the control of
diabetes measured through blood-glucose assays.
1.6. Discussion
This chapter examined selected literature examining the social context in the
management of diabetes. The concept of 'social support' has been shown to be
consistent in demonstrating positive relationships with the selected outcomes in
diabetic patients. In particular, these favourable results were observed in
relation to good self-management behaviours. The often inadequate and
inconsistent conceptualisation of social support and the instruments used to
measure the construct may in part, explain the equivocal results. It is also likely
that the patients used in studies are at differing stages of disease progression or
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Previous research has demonstrated that the successful management of type 2
diabetes is dependent on the patients' social environment, in particular, the role
of significant others. Therefore, the focus of this research was to explore the
illness beliefs of patients with type 2 diabetes and their partners in a
prospective study. The theoretical framework for the research was guided by
the self-regulatory model of illness behaviour (Leventhal et al, 1984) which
asserts that individuals conceptualise illness around 5 'core' dimensions
regarding the control, consequences, course, identhy and cause of their condition.
These 'illness representations' describe the underlying differences on which
individuals differ with regard to their illness.
In particular, the extent that patients and partners share representations of
diabetes was explored in relation to the patients' adaptation and self-
management of the condition. A total of 164 patient-partner dyads were
recruited and followed-up at 12 months later. The illness representations of
patients and their partners were assessed with diabetes-specific measures.
Patients' self-management behaviours were assessed by self-report measures of
adherence with diet, physical activity and medication at both time-points and
objectively with a single measure of glucose control (HbAlc) at 12 months. In
addition, marital satisfaction and psychological morbidity were assessed at both
time-points. It was found that patient-partner dyads, generally, held similar
representations of diabetes. In addition, logistic regression analyses
demonstrated that partners' diabetes representations were influential in the
extent of patients self-management behaviours, and levels of psychological
morbidity after the influence of patients' representations, past behaviour, and
demographic and clinical variables.
The findings are discussed in the context of previous research examining illness
representations in chronic disease, the implications for the self-regulatory
model of illness behaviour and future behavioural interventions to improve the
self-management behaviours of patients with type 2 diabetes.
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CHAPTER 1: THE SOCIAL CONTEXT AND THE
MANAGEMENT OF DIABETES
1.1. Introduction
The present thesis aims to explore the role of significant others in the health
behaviours of patients with type 2 diabetes. Before introducing the theoretical
framework used to facilitate this enquiry, the extent and nature of how a
diabetic patients' social environment impacts on disease management is
examined. Therefore, this introductory chapter focuses on the importance of
the social context in relation to patients' efforts to manage diabetes with regard
to their health behaviours and control of blood glucose. In particular, the
chapter will focus on the construct of social support and its relationship with
adherence to treatment recommendations in patients with diabetes
A critique of social support and its measurement precedes the review of
empirical studies examining the construct. There are also a number of points
and issues regarding treatment adherence that are addressed before reviewing
the empirical literature examining the role of social support and diabetes.
These include; the prevalence and consequences of non-adherence in chronic
disease, the distinction between intentional and non-intentional adherence, and
the measurement of adherence. Finally, the ongoing debate regarding the
terminology used to describe patients' fulfilment of treatment
recommendations is also addressed.
What is type 2 diabetes?
Type 2 diabetes (non-insulin dependent) presents as a spectrum of metabolic
abnormalities characterised by prominent insulin resistance and relative insulin
deficiency. It accounts for about 90% of all cases of diabetes, tending to emerge
in mid to late adulthood. The major risk factors for diabetes include a family
history of diabetes, obesity (BMI> =27 kg per m 2) age (>= 45 years),
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hypertension, and high cholesterol levels. There is a progressive increase in the
world-wide prevalence of type 2 diabetes. This increase is primarily the result
of lifestyle changes, and in particular the steady rise in the prevalence of obesity
(Amos et al, 1997, WHO, 1997). Finally, the prevalence of type 2 diabetes is
projected to double by 2010 and is also accelerating in the younger population
(ibid).
Consequences of type 2 diabetes
The longer the duration of diabetes the greater the likelihood of developing
symptoms and signs of degenerative complications. The consequences of poor
management of type 2 diabetes can be severe. Complications related to
diabetes include blindness, amputations, and diseases of the kidneys, heart and
central nervous system (Kaplan & Hartwell, 1987). The treatment of diabetes
and its complications also constitutes a huge financial burden accounting for
around 5% of the UK National Health Service budget (Leese, 1991).
Management of type 2 diabetes
Apart from being a serious chronic illness and social problem, the patient with
type 2 diabetes has the principal responsibility for the management of their
illness. In particular, the daily management of diabetes involves eating regular
healthy meals, taking physical exercise, sell-testing blood glucose levels and, for
many patients, taking medicine. The goal of this combination of tasks is to
maintain glucose levels within a target range - by achieving tight blood glucose
control the rate of complications decreases (DCCT, 1993; UKPDS, 1998). Self-
management not only involves completing such activities but considering the
inter-relationships among these tasks and implementing appropriate changes in
the daily plan when necessary. However, rates of non-adherence with these
behaviours are high, ranging from 30-75°c (Paes et al., 1998) and often result in
poor disease outcomes Nicolucci et aL, 1996). Indeed, Nicolucci et al speculate
that the risk of diabetic complications could be reduced by up to one third, if
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such 'avoidable' factors could be removed. Therefore, a major concern in the
management of type 2 diabetes is how to encourage adherence with prescribed
regimens.
The role of diet
Following a healthy diet is the primary treatment for type 2 diabetes. The goal
of dietary intervention is to maintain near-normal glucose and lipid levels;
maintain a reasonable body weight; prevent, delay or treat nutrition related risk
factors and complications and improve overall health (Franz et al, 1994).
However, dietary advice (along with physical exercise) is the most difficult
aspect of the treatment regimen for patients to adhere with (Glasgow et al,
1997). An analysis of adherence to diet therapy among patients with diabetes
showed that only 20-50% of patients followed dietary recommendations
(Savage & Knowler, 1984; Skender et al., 1996). Moreover, Hixenbaugh and
Winkley (2001) demonstrated that many patients have difficulty in eating the
right type of food (59%), the right amount of food (49%) eating at regular
intervals (36%) and maintaining an ideal weight (37%).
The current dietary recommendations for patients with type 2 diabetes are the
same as for the general population. It is, therefore, the recommendation of
Diabetes UK (formerly British Diabetic Association) to eat regular meals that
are;
• low in fat (esp. saturated fat)
• high in fibre
• eat carbohydrates high in starch
• lowinsugar
and to:
• eat five portions of fruit and vegetables a day
• reduce salt
• moderate alcohol consumption
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In addition, patients are encouraged to achieve /maintain a desirable body
mass index (BMI). All newly diagnosed patients with diabetes should receive
dietary advice from a State Registered Dietitian and receive additional support
from a trained member of their Primary Health Care Team (Avon Health
Diabetic Care Manual, 1996).
1.2. Prevalence and consequences of non-adherence
Patient non-adherence with a treatment regimen may seriously undermine the
effectiveness of medical care, and may, in turn give rise to poorer clinical
outcomes (Haynes et al., 1996). Therefore, adherence with medical regimens is
widely recognised as one of the principal challenges in healthcare. Non-
adherence amongst patients is more prevalent when the illness is chronic and
the treatment recommendations are largely prophylactic (Haynes et al., 1979;
Meichenbaum & Turk, 1987). Approximations of the scale of the problem vary
considerably, although average estimates of adherence in chronic illness
converge at about 50% (Evans et al. 2001; Hulka et al. 1976; Wright, 1993).
A specific consequence of non-adherence is an increase in diagnostic and
therapeutic procedures, with subsequent increased health-care expenditure. It
has been speculated that the risk of diabetic complications could be reduced by
up to one-third if adherence with health behaviours could be improved
(Nicolucci et al, 1996). The far-reaching financial and human costs of non-
adherence (Lowe et al, 1995) have led to many investigations to seek to identify
the determinants of adherence. This work has identified a number of socio-
demographic (e.g., age, gender, ethnicity, social class, disease status:
Hawthorne et al, 1993; Koskinen et al, 1996; Nicolucci, et al., 1996; Dunbar-Jacob
et al. 1995) and psychosocial correlates (e.g., social support, locus of control,
health beliefs, psychological morbidity: Fukunishi et al, 1998; Schoenberg et al,
1998; Schwartz et al, 1991), and has led to the development of interventions
designed to promote adherence (Epstein & Cluss, 1993, Lustman et al, 1998).
However, results indicate that many of these interventions have failed to
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generate significant improvements in adherence and treatment outcomes
(Haynes et al., 1998). Thus, the understanding of the factors which may
influence medication adherence remains inadequate.
It is also acknowledged that many other factors influence adherence to
treatment regimens such as the perceived efficacy of the treatment, cost-benefits
of adherent behaviour, complexity of the regimen, side effects of medication,
psychological morbidity and socio-economic status which have been explored
elsewhere in the literature. In addition, issues such as the quality of the
practitioner-patient relationship, satisfaction with care, understanding of the
condition may also impact on adherence as described in the seminal work of
Ley (1982,1988).
Intentional and non-intentional adherence
It is suggested that non-adherence behaviours fall into two broad categories
(Home, 1997). First, 'unintentional' non-adherence occurs when the patients'
intentions to take the medication are impeded by barriers such as forgetting,
and inability to follow the treatment instructions because of poor
understanding, memory or physical problems such as poor eyesight or
impaired manual dexterity. Second, 'intentional' non-adherence is when an
individual chooses not to follow some or all of prescribed treatment
recommendations or when an individual has learned to manipulate or deviate
from treatment recommendations that suits his or her lifestyle. Intentional non-
adherence is sometimes referred to as "intelligent non-compliance" in
acknowledgement of the fact that, from the patient's perspective, it may be




Multiple methods of assessment are used in research examining adherence to
treatment recommendations including self-report questionnaires and diaries,
biological markers, and clinical outcomes. However, there are important issues
regarding the measurement of adherence with treatment regimens. Each
method reveals somewhat different information about the patient's behaviour
with regard to their regimen as well as different reports of adherence.
Therefore, the selection of a strategy to measure adherence requires careful
attention to the limitations of each method and a well-specified definition of
adherence. Indeed, there is a danger that self-report measures of adherence
may permit patient over-reporting due to failure of memory or understanding
or deliberate omission of the truth to bias findings. Taking medication
adherence as an example, when validated against objective measures such as
pill counts or biochemical methods, self-report is highly variable in terms of
accuracy (Francis et al, 1969). This has been observed across a range of
therapies for chronic conditions including medications for hypertension (Rudd
et al., 1989) and RA medications (Dunbar-Jacob, 1993). In addition, studies that
rely on clinical outcome measures (e.g., blood pressure, HbAlc) may also be
unreliable as a patients' condition may improve or deteriorate for reasons
unrelated to adherence such as stress (Surwit & Schneider, 1993).
The 'adherence' versus 'compliance 'debate
Finally, there is considerable debate regarding the most appropriate
terminology to use when describing patients' fulfilment of recommended health
behaviours. Indeed, terms such as 'adherence', 'compliance' and 'concordance'
are often used interchangeably in the literature. Some investigators argue that
differences between these terms extend beyond semantics. Indeed, Trostle,
(1988) asserts that the term 'compliance' is an expression of practitioner's
medical authority over patients who are expected to obey without question.
Others, such as Eisenthal et al., (1979) argue that 'adherence' is a confirmation
of the active, participative role of patients in the management of their care.
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Adherence has been defined as..... . 'the extent to which the patient's behaviour (in
terms of taking medications, following diets or other life style changes.) coincides with
medical or health advice' (Haynes, 1979). More recently, 'concordance' has
emerged as a term to describe an agreement reached between a patient and a
practitioner that respects the beliefs and wishes of the patient determining
whether, when and how medicines are to be taken. Although reciprocal, this is
an alliance in which health care professionals recognise the primacy of the
patient's decisions about taking the recommended medications. While
acknowledging such differences in terminology, the term 'adherence' is used in
the present thesis and is intended to encompass the definition given by Haynes
(1979).
1.3. Social support: An introduction
Much research effort has been invested in the purported beneficial effects of
social support on health and well-being. Indeed, empirical evidence suggests
that social support is associated with greater adherence with treatment
regimens (Levy, 1986). Before examining this work two general models that
explain how social support may impact on treatment adherence in chronic
disease are introduced. First, the 'main effects' model of social support is
considered to be a positive and useful resource such that the benefits are great
even when people are not exposed to stressful situations such as chronic illness
(Cohen St Syme, 1985). The second model known as the 'buffering' model,
suggests that social support may serve as a source of protection (as a buffer)
against adverse effects resulting from the presence of a stressor (Cohen &
McKay, 1984). Indeed, it is likely that social support may enhance adherence,
either directly (through encouragement, reassurance, reinforcement, systematic
cues, bolstering of competence, and motivation) or indirectly (by buffering the
effect of factors that may impede adherence, e.g., life stress, anxiety and
depression). However, this section primarily addresses the literature
examining the 'main effects' model of social support in studies with diabetes
patients and the role of the spouse in particular. First, however, issues
surrounding the measurement of social support are addressed.
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Measurement of Social Support
The measurement of social support has been approached in two main ways.
One approach conceives of social support in terms of the structure of an
individual's interpersonal relationships or social network, the other in terms of
the functions that these relationships or networks serve for an individual. The
measurement of social support is based on tools assessing an individual's
perception of either the availability of others who provide these functions or the
actual receipt of these support functions (Stroebe & Stroebe, 1995). Therefore,
'structural' measures assess the existence or quantity of social relationships (i.e.,
availability of family and friends), whereas 'functional' measures of social
support assess whether interpersonal relations serve particular functions (types
of resources). Turner (1992) asserted that the effective measurement of
perceived support provides the best lever by which to estimate the relative
significance of potentially modifiable social factors for health and well-being.
Furthermore, conceptions of available social support are both dispositional and
cognitive, whereas conceptions of perceived support are situational and
behavioural, involving interaction between individuals (Dunkel-Schetter et al.
1992).
With regard to 'functional' measures, it has been proposed that social support
consists of multiple components. Indeed, Schaefer et al. (1981) studied the
relationship between social network size and three types of social support; 1.
'tangible' (or 'instrumental'), 2. 'emotional' and 3. 'informational'. The three
types of support were examined in relation to stressful life events,
psychological symptoms, morale and physical health status, hence
recommending the need to study these components separately. 'Instrumental'
support consists of behaviours that directly help the person in need (i.e.,
practical help with work etc). 'Emotional' support involves providing empathy,
care, love and trust. Finally, 'informational' support involves providing people
with information that they can use in coping with their problems. However,
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House and Kahn (1985) also include 'appraisal assistance' which is closely
related to 'informational support'. It also involves the transmission of
information relevant for an individual's self-evaluation. Finally, Cutrona (1990)
added a fifth component, 'social integration', which combines structural and
ft nctional characteristics of support.
A problem with only measuring recipient perceptions of social support instead
of the actual support that is given is that such perceptions are not always
accurate. Such perceptions are not only based on what the recipient felt was
needed versus what was actually given, but what the provider(s) perceived was
needed by the recipient. In addition, provider and recipient perceptions do not
correlate well. For example, providers may feel that they are giving more than
what recipients feel they are receiving (Sarason et al., 1990). Recipients may
also be dissatisfied and consider it negative support if the provider encourages
behaviours that the recipient does not want to display (Tilden, 1985).
When evaluating social support it is also necessary to consider cause and effect.
For example, it may be difficult to determine whether a lack of social support
contributed to a problem occurring (e.g., depression) or if the problem was pre-
existing in the individual and thus influenced the lack of adequate social
support. Researchers have tended to ignore this phenomenon and assume that
social support always results in positive outcomes. Also, researchers tend not
to examine social support and changes in social network over extended periods
of time (Kahn, 1994). Furthermore, support may vary throughout one's life, or
even through the course of a stressful life event such as chronic illness. As a
result it is difficult to evaluate this cause-effect phenomenon.
Support from signIficant others
A supportive family environment has been identified as a particularly
important source of social support for chronically ill individuals (Moos & Moos,
1986). Furthermore, an early study demonstrated that support provided by the
spouse may determine adherence to long-term medical regimens (Doherty et
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al.,1983). The authors examined the influence of social support on adherence
with hypertensive treatment from the perspective of the participant, the spouse
and medical staff members. The authors reported that hypertensive men who
had highly supportive spouses were more likely to adhere to their medication
regimen than men with less supportive spouses. The health beliefs of the
spouse were also related to levels of support provided. Indeed, wives who
believed more strongly in the benefits of the therapeutic regimen were more
likely to offer higher support to their husbands. This seminal study
demonstrated the importance of spousal health beliefs, provision of support
and the implications for adherent behaviour.
1.4. Social support and diabetes management
With regard to the topic of the thesis, studies examining the role of social
support and marital satisfaction in the management and control of diabetes are
reviewed in the following section. These studies are also summarised in Table
2.1.
A search was conducted to locate empirical studies examining the role of the
social context in the management and control of diabetes. In particular, the
search focused on finding literature examining the 'social support' in the
context of treatment adherence in adult diabetic patients. Quantitative studies
published in the English language were located through undertaking electronic
database searches on 'Psychlnfo', 'BIDS', 'Web of Science' and 'Medline'.
Further literature was found by hand searching journals and reference lists
from relevant journal articles.
Family support in type 2 diabetes
MacLean and Lo (1998) examined expected success in adherence with exercise
and diet regimes in 95 patients with type 2 diabetes. The aim was to determine
if family support was associated with adherence and intentions to continue to
adhere. Family support was assessed with the Perceived Social Support from
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Family Scale (Famsup: Procidano & Heller, 1983). The General Health
Questionnaire (Goldberg, 1978) was used to assess transient and chronic stress.
In addition, variables pertaining to intention, self-efficacy and self-esteem (Self-
Esteem Inventory; Rosenberg, 1995) were also evaluated. The results from
regression analyses demonstrated that adherence was a function of the capacity
to utilise family support, positive attitudes, high self-esteem, absence of stress
and acceptance of the challenges of the illness. The importance of good family
support, absence of stress, and capacity to take up the challenges of the disease
was replicated by Lo (1999) with regard to successful adherence in 146 diabetes
patients dependent on insulin.
Overall, the findings of these studies indicate that patients with diabetes who
have access to good social support and experience less stress are more likely to
engage in adherent behaviours. However, as these were cross-sectional studies
it is not permissible to make causal predictions, it is possible that good
intentions to adhere attract higher levels of support from the patient's family. It
is also reiterated that actual adherence was not measured, instead a measure of
the patient's efficacy and intention to comply with the regimen was utilised.
Furthermore, no distinction was made between diet, exercise and blood-glucose
testing, therefore it cannot be assumed that patients' intend or are able to
adhere equally to these management requirements. It is also uncertain to what
extent such findings can be viewed as indicators of patients' actual behaviours
regarding the successful management of diabetes. It is well documented from
previous research that intentions to perform a health behaviour do not
necessarily translate into an action been taken. Indeed, it may be that further
cognitive activity is required to ensure that intentions are translated into actions
(Norman & Conner, 1996).
In a study of 213 insulin-treated patients with diabetes Toljamo and Hentinen
(2001) examined the role of social support and adherence to self-care regimens.
Social support was assessed with an instrument developed for the study based
on the definition of social support provided by House (1981). It consisted of 13
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items relating to 'emotional', 'instrumental', 'informational' and 'peer' support
from other patients. Adherence to aspects of the diabetic regimen were
measured with a 20-item scale covering insulin treatment, diet, exercise and
blood-glucose monitoring. Metabolic control was measured with levels of
HbAlc taken from patient records. Measures of HbAlc reflects patients' mean
metabolic control over the 6-12 weeks preceding measurement and is part of the
routine management of patients with diabetes and widely accepted as reliable
and valid index of metabolic control (Nathan et al., 1984).
Factor analysis of the adherence to self-care scale revealed two distinct factors:
'flexible self-care' and 'regimen adherent self-care'. These factors were then
dichotomised at their median value to give the following four adherence
categories: 1) 'regimen-adherent self-care', 2) 'no regimen-adherent self-care', 3)
'flexible self-care' and 4) 'no flexible self-care'. The factor structure of social
support was also examined. The items regarding 'emotional' and
'instrumental' support loaded highly on the same factor, and were combined to
form a single variable labelled 'emotional and instrumental' support. The
remaining variables of 'informational', 'peer', 'negative' and 'financial' support
remained intact. Logistic regression analyses were employed to determine
predictors of neglect of self-care. Patients who adhered to self-care either
flexibly or with strict adherence to the regimen received more social support
from family and friends than those who neglected self-care. There were no
statistically significant relationships between other types of social support and
adherence to self-care. Surprisingly, those who perceived more peer support
from other patients with diabetes had worse blood-glucose levels. Getting no
'emotional and instrumental' support was related to neglect of self-care. The
authors concluded that adherence to self-care was associated with support from
family and friends. In particular, those with 'emotional and instrumental'
support from their friends and family adhered better to self-care.
For efficiency in the operationalisation of social support in this study, the type
and source of support were combined. However, in so doing, some
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information may have been lost; therefore social support may be best assessed
with separate measures to capture more accurately the nature of support. A
further limitation, is that participants were regular attenders at a diabetes clinic
and thus must be considered as having a more responsible approach to
managing their disease and may not be 'typical' diabetes patients.
Glasgow and Toobert (1988) prospectively, examined the influence of the social
environment in relation to health outcomes in 127 patients with type 2 diabetes.
The social environment was assessed with the Diabetes-Family Behaviour
Checklist (DFBC), a self-report measure specifically developed to assess social
support received from family members for the performance of self-care
activities in patients with type 1 diabetes (Schafer et al., 1986). The scale was
modified (DFBC-II) for use in a population with type 2 diabetes. Two versions
of the DFBC-II were administered; one for the subject and another for the
partner or 'significant other'. Four different aspects of the diabetes regimen
were assessed (glucose testing, medication taking, diet and exercise). Dietary
adherence was also measured with a 3-day food record and subjects were
trained to estimate portion sizes and asked to weigh servings of meats and
cheeses. Adherence to medication, physical activity, and glucose testing was
assessed with a version of the Summary of Diabetes Self-Care Activities scale.
It was demonstrated that measures of family support were the strongest and
most consistent predictors of a composite measure of adherence in patients with
type 2 diabetes. However, the results of this study are tempered by relying
solely on self-reports of family interaction. In addition, the process of self-
monitoring family interactions may have altered patterns of self-care over the
period of study.
The role of social support and self-efficacy (belief in the ability to perform a
given behaviour) in the self-care behaviours of 94 patients was assessed in
patients with type 1 or type 2 diabetes (Williams & Bond, 2002). The ability to
perform behaviours in four regimen areas; blood glucose testing, exercise,
eating habits and medication were assessed with a 29-item questionnaire. The
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frequency of both supportive and unsupportive family behaviours was assessed
with the DFBC (Schafer et al, 1986). Items of the scale addressed blood-glucose
testing, diet, exercise, medication, and general regimen adherence. Participants
nominated their closest supporter (e.g., wife, husband, daughter) and indicated
how often that person assisted in the performance of a given self-care
behaviour. Response options ranged from 'never' to 'at least once a day'. Self-
care behaviour was assessed with the Summary of Diabetes Self-Care activities
scale (Toobert & Glasgow, 1984). The family member nominated as providing
the most help with diabetes management was the spouse or partner (n=75, 83%
of those with family support). It was demonstrated that self-efficacy was
associated with social support and positive diet-related family interactions. In
addition, a mediation effect was found for self-efficacy with positive diet self-
care support and positive exercise self-care support. However, when the effects
of self-efficacy were controlled, social support was no longer a significant
independent predictor of self-care. The authors argue that the results support
Bandura's (1977) claim that social support is a source of efficacy information but
does not affect behaviour directly, thus social support could be an important
source of efficacy information among diabetes patients. Although this study
showed that the receipt of social support was a predictor of dietary and exercise
behaviour, no such relationship was found for medication adherence. This may
be a function of using a composite measure of regimen adherence such as the
Summary of Diabetes Self-care Scale which may not have been able to
differentiate among different aspects of behaviour. Alternatively, if this finding
truly reflects the relationship between social support and medication adherence
it affirms the view that 'it should not be assumed that because a family member
is supportive of a patient's adherence to one aspect of the regimen......that he
or she will be supportive of other diabetes activities' (Glasgow & Toobert, 1988,
p.384)
Social support and gender
It has been observed that social support has differential effects for men and
women in relation to health (Antonucci, 1985; Kessler et al., 1985). These effects
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have also been demonstrated in type 2 diabetes. In a small and simple study
(n= 37), Heitzmann & Kaplan (1984) examined the role of support in relation to
blood-glucose control. The patients' social support network was measured by
the Social Support Questionnaire (Sarason et al., 1983). The SSQ provides
separate scores for network size and satisfaction with available support.
A single measure of HbAlc was used to assess the extent of control of diabetes
The measurement of HbAlc provides a measure of blood glucose control such
that higher levels indicate poorer control of diabetes. Groups of high and low
recipients of social support were formed by median split and analysis of
variance was conducted to determine the effects of gender and social support
on levels of HbAlc. It was demonstrated that women were in better control of
type 2 diabetes when they were more satisfied with their social support
network. In contrast, men were in poorer control when they had high
satisfaction with social support scores. However, the social support network
scores were not significantly related to glucose control for men and women.
These results were replicated in a prospective study Kaplan and Hartwell (1987)
using the Social Support Questionnaire (Sarason et al., 1983). Regimen
adherence was assessed via levels of HbAlc. Male patients expressing greater
satisfaction with perceived social support exhibited poorer glyceamic control at
18-months follow-up. In addition, women selected spouses as supports only
half as often as men did. This study highlighted the complexity of the
relationship between satisfaction with social support, network size and gender
with the control of type 2 diabetes.
Together, these studies suggest that social support, network size and
satisfaction have different functions for men and women with type 2 diabetes.
One explanation is that social support serves as a more important buffer of
stress for women than it does for men. According to the buffering hypotheses,
social support should have greater effects under higher levels of stress. In this
study women reported greater worry than men relating to their diabetes and, in
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turn, may have a more positive response to high levels of social support.
However, it is unclear why diabetes should be correlated with low worry for
men but not for women. It is possible that men have a more casual disposition
toward their illness and that they receive support for this stance. Alternatively,
it could be that a satisfactory support system directly affects behaviours that
result in good or poor control of diabetes. For example, networks found
satisfactory to women may support behaviours that lead to good control. In
contrast, networks satisfactory to men may reinforce lifestyle patterns that are
not in the patients' best interests.
Social Support and family functioning
It has been proposed that the family system has a role in the initiation, selection
of symptoms, clinical course, use of clinical facilities and adherence to medical
treatment in chronic disease (Anderson & Auslander, 1980, Hansen &
Hengeller, 1984). The 'family functioning' concept refers to a set of patterns or
interactions among members of a family (Epstein et al., 1978). During the
course of a chronic disease such as diabetes, adverse interactions may impose
an excessive load on the capability for adaptation of the family. Thus, it is
suggested that under such circumstances, family functioning may change to
'rigid' control, which may threaten family stability.
Garay-Sevilla et al (1995) examined the role of social support in adherence to
diet and medication in patients with type 2 diabetes. Support was assessed in
200 patients with a modified diabetes-specific questionnaire (Ruggiero et al.,
1990). Family functioning was evaluated with the modified McMaster model
(Epstein et al., 1978). Adherence to treatment was assessed with a seven-item
self-report measure concerning daily intake of food, acceptance and adherence
to prescribed diet and the patient's interest in keeping an appropriate weight.
In addition, medication adherence was assessed with three questions about
continuity of intake (e.g., self decided changes of doses). Regression analyses
demonstrated that adherence to diet was predicted positively by social support
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and disease duration. Social support was also the main determinant of
medication adherence. In addition, adherence to medication was lower in
patients from families with 'rigid control' (if permissions for members of the
family were seldom given) than those with 'laissez-faire' (if permissions were
almost always granted) type of control or 'flexible' control (if permissions were
frequently obtained).
A rigid control of behaviour within a family may imply decreased adaptation to
change, in particular to deleterious changes such as chronic disease in one of its
members. In turn, this may favour denial of the disease. It may also enhance
the development of conflict with the authority, increasing the denial of the
disease resulting in a decrease in adherence. Finally, the results are
compromised by a response rate of just 20%. Therefore it is possible that those
consenting to participate were naturally more concerned about their condition
and consequently exhibited greater adherence.
The marital relationship and blood-glucose control
Trief et al, (2001) examined the relationship between marital adjustment, blood-
glucose control and psychosocial adaptation to diabetes. A mixed sample of 78
married patients aged 18-55 years with insulin-treated type 1 or type 2 diabetes
(^ lyear) participated in the study. Marital quality was measured with the DAS
(Spanier, 1976). Functional health status was measured with the MOS-SF36
(Ware & Sherbourne, 1992). Diabetes-specific emotional distress was assessed
with the Problem Areas in Diabetes Scale (PAID; Polonsky et al, 1995). Finally,
glucose control was assessed with a single measure of HbAlc.
Higher levels of marital satisfaction predicted lower scores on the PAID.
Marital quality did not predict levels of HbAlc when treated as a continous
variable. Thus subjects were divided into three groups; good glyceamic control
was defined as ^ 7.4%, acceptable control was defined as a value between 7.5-
8.4%, and poor glyceamic control was defined as HbAlc value of> 8.4%. These
figures were based on the findings of the Diabetes Control and Complications
Trial which demonstrated that the risk of significant microvascular
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complications dramatically increases when HbAlc levels exceed 8.4% (DCCT
Research Group, 1988). Due to small numbers 'acceptable' and 'poor
controlled' patients were combined for analysis and dichotomised into two
groups; HbAlc <7.4 and ^ 7.4%. Stepwise regression analyses demonstrated a
trend for marital satisfaction measures with the DAS to be predictive of
glyceamic control, although the effect just missed statistical significance
(p=O56). The authors concluded that marital quality does relate to an
individual's adaptation to diabetes with regard to levels of emotional distress.
Although a significant relationship was not found for marital satisfaction and
HbAlc it is suggested that the marital relationship may be more powerful than
general family support in terms of its impact on glyceamic control. Finally, the
cross-sectional design prohibits enquiry into causality as it cannot be
determined if a poor relationship leads to poor illness adaptation and glucose
control or that poor control/adaptation leads to a more problematic marital
relationship. Finally, by including patients with both type 1 and type 2 diabetes
it is difficult to delineate how support and marital satisfaction differ for these
medically defined sub-groups. Indeed, regular insulin administration by
patients with type 1 diabetes may pose unique challenges compared with type 2
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1.5. Summary of social support in diabetes
In general, the findings of the studies examining the role of social support in
treatment adherence and control of diabetes demonstrate that higher levels of
social support favour better management of the condition. More favourable
indicators of the role of social support were evident in the prediction of self-
management behaviours such as exercise, dietary and medication adherence.
Indeed, the studies of Glasgow and Toobert (1988); Toijamo and Hentinen
(2001) and Williams & Bond (2002) found that social support was predictive of
adherent behaviour, whereas Lo (1999) and MacLean and Lo (1998) found that
social support was predictive of intentions to adhere to self-management
behaviours. However, with regard to blood-glucose control social support
appears to serve different functions according to the gender of the patient. A
surprising finding is that men were in poorer control when satisfied with the
level of support they received whereas women were in better control
(Heitzmann and Kaplan, 1984; Kaplan & Hartwell, 1987). In addition, patients
receiving support from other patients with diabetes were also likely to exhibit
poorer control (Toijamo and Hentinen, 2001) while Trief et al (2001) did not find
a significant relationship between marital quality and HbAlc. Such mixed
findings make it unclear how the social environment influences the control of
diabetes measured through blood-glucose assays.
1.6. Discussion
This chapter examined selected literature examining the social context in the
management of diabetes. The concept of 'social support' has been shown to be
consistent in demonstrating positive relationships with the selected outcomes in
diabetic patients. In particular, these favourable results were observed in
relation to good self-management behaviours. The often inadequate and
inconsistent conceptualisation of social support and the instruments used to
measure the construct may in part, explain the equivocal results. It is also likely
that the patients used in studies are at differing stages of disease progression or
have differing levels of severity and this may in turn influence the provision
and receipt of social support and study outcomes. For example, the experience
of a disease such as diabetes may fluctuate with regard to symptoms, therefore,
influencing levels of support from others. In turn, patients may be more (or
less) motivated to adhere to treatment when experiencing acute symptoms. The
employment of prospective designs that include assessments of
symptomatology from the patient's perspective may permit the dynamic
interaction with psychosocial variables to be delineated. With further regard to
study design, the majority of the studies reviewed are cross-sectional in design.
The findings suggest that different effects of social support exist according to
the provision of support and interaction with demographic and contextual
factors. Indeed, the findings have reinforced the assertion that social support
may not be beneficial for all individuals, and this appears to have particular
relevance for males with diabetes. Also a distinction should be made between
social support per se and support provided by the family, particularly the
spouse. Indeed, some studies (Doherty et al. 1983, Garay-Sevilla et al. 1995)
demonstrated an influence of the spouse in adherence to treatment in
conditions such as hypertension and diabetes. In addition, the cross-sectional
design of many studies prohibits causal inferences regarding social support and
adherence. It may be that high adherers tend to attract more social support
rather than low adherer's receiving less support. Again, there is a need for
well-designed prospective studies to delineate this relationship. Also, the type
of support received is clearly of importance. For example, Toljamo &
Hentinen's (2001) study showed that a mix of 'emotional' and 'instrumental'
support favoured better adherence and Garay-Sevila et al (1995) showed that
patients receiving social support in a flexible family environment exhibited
better medication adherence.
The studies reviewed have included patients with both type 1 and type 2
diabetes which to some extent prohibits the generalisation of the findings. The
management of type 1 diabetes is believed to more genetic in its aetiology than
type 2 diabetes that is believed to have a stronger behavioural component
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suggests that managing the disease may be a different experience for either
group of patients. Indeed, type 1 diabetes is primarily managed with insulin
whereas the management of type 2 diabetes requires a careful balance of diet,
exercise and medication (and insulin in more chronic cases). Adherence to such
regimens may not be associated with the same psychosocial issues. A further
point relates to the homogenous nature of the study participants across the
studies reviewed. The study populations were typically drawn from
Caucasian, middle income communities thus limiting the generalisation of
findings to the wider diabetic community.
To conclude, it is apparent that adherence is likely to be influenced in a complex
manner that involves a combination of psychological and social factors and
these may vary between a specific condition and treatment regimen.
Furthermore, what may be a determinant of one aspect of the regimen may not
necessarily be a determinant of another. For example, a diabetes patient may
adhere to prescribed medication but not exercise or dietary recommendations.
It is clear that past approaches are insufficient in predicting which individuals
are at risk of non-adherence. Finally, to conclude, the diversity of studies
examining diabetic patients' social environment demonstrates that the quality
of interactions with 'significant others' particularly the spouse or partner serves
to influence a range of health behaviours. The role of the spouse or partner of
the diabetic patient is therefore worthy of further consideration in studies
examining adherence with diabetic regimens.
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CHAPTER 2 PART 1 - ILLNESS
REPRESENTATIONS IN CHRONIC DISEASE: A
SYSTEMATIC LITERATURE REVIEW
2.1. Introduction
In Chapter 1 it was shown that the influence of the patients' social environment
is an important determinant in patients' management of type 2 diabetes. The
purpose of the present chapter is to explore the appropriateness of the proposed
theoretical framework for the thesis in predicting relevant outcomes in the
process of living with chronic disease. Indeed, it is proposed that the
employment of the self-regulatory model of ifiness behaviour (SRM; Leventhal
et al, 1984) will assist in exploring the role of patients' health beliefs in chronic
disease, Of particular pertinence to the examination of the role of significant
others in the health behaviours of patients with type 2 diabetes, the health
beliefs of partners of patients with chronic disease are considered.
The SRM has been the focus of considerable research activity within health
psychology and has resulted in a growing body of empirical studies examining
the predictive utility of the model in the context of chronic disease including
diabetes. In response to the current interest in utilising the SRM, a systematic
review of studies was conducted. This systematic review aggregates the results
of published and unpublished empirical studies that have utilised the SRM in
the context of adults with chronic disease. More specifically, the review focuses
on the extent that individual components of the illness representations
framework are associated with or predict clinical, behavioural and
psychological outcomes. An overview of the dimensions of the illness
representations framework and the different approaches employed in
measuring illness representations in empirical studies precedes the review.
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2.2. Self-regulatory model
The SRM posits that the patient is an active participant in the health care
process (Weinman & Petrie, 1997). It is also argued that an individual
experiencing illness may perceive a range of problems that are pertinent only to
that individual, while others experiencing the same condition have their own
unique experiences. In order to make sense of and respond to these problems,
patients create their own 'models' or representations of their illness which then
influence their coping and care seeking behaviour (Cameron et al, 1993). The
process is regarded as self-regulatory because the three components of the
model, interpretation, coping and appraisal have been shown to interrelate in
order to maintain the status quo. Therefore, if an individual's normal state of
health is disrupted by illness, or the threat of illness, the model proposes that
they are motivated to regain the balance (Leventhal & Diefenbach, 1991;
Leventhal et al, 1984).
It is postulated that these representations emerge as soon as patients experience
initial symptoms or are given a disease label, and may change with disease
progression, the emergence of further symptoms and responses to medical
intervention (Weinman et al, 1996). Furthermore, it is argued that not only do
illness representations give personal meaning to patients' symptoms and
experience of illness, but act as a framework for guiding and evaluating coping
efforts that are evoked to deal with the illness. Moreover, self-regulation theory
predicts that illness representations will be directly related to coping and, via
coping, to adaptive or maladaptive outcomes (Leventhal et al, 1984, Weinman
et al, 1996). In this way, the self-regulation process is considered to be dynamic,
as feedback from appraisals of coping efforts influence cognitive
representations, emotional responses and future coping efforts (Leventhal et al,
1980, 1984).
Dimensions of Illness Representations
Leventhal and colleagues identified four common themes or 'dimensions' of
how people think about their illness via extended open-ended interviews with
42
patients recently diagnosed with hypertension, cancer or diabetes (Leventhal et
al, 1980; 1984, Meyer et al, 1985). It ras posited that each patient has their own
'common sense' beliefs regarding the identity or label assigned to the illness and
knowledge of the symptoms associated with it. The time-line dimension
assesses the perceived course the illness takes; for example whether the patient
believes the illness will be acute or chronic in its duration. The perceived cause
of the illness assesses the extent that various possible causal factors are
responsible for causing the illness in question. The consequences dimension
assesses the extent that the illness impacts on an individual's life; for example,
in terms of the way other people see them. Finally, Lau and Hartman (1983)
proposed a fifth dimension - cure or control, arguing that patients' models may
also incorporate beliefs about the controllability of the condition; the extent to
which they perceive they will make a recovery or limit disease progression.
These five dimensions are regarded as the basic components of illness
representations, influencing how patients conceptualise and cope with their
condition (Leventhal et al, 1980, 1984).
Assessment of Illness Representations
The original work of Leventhal and colleagues used in-depth, semi-structured
interviews with hypertensive and cancer patients as a means of eliciting illness
representations (Leventhal et alE, 1984). The interviews focused on perceptions
regarding the identity, time-line, consequences and causes of these conditions.
However, it was not a time-efficient, economic or reliable method and resulted
in a large variation in the quality and quantity of response. Later, an attempt
was made by Turk (1986) to operationalise the 'common-sense' constructs
described by Leventhal (1980) in a questionnaire. The Implicit Models of Illness
Questionnaire (IMIQ, Schiaffino & Cea, 1995) as it is known has four
dimensions. First, curability reflects a combination of items from the cause, cure
and thne-line components of Leventhal's model. Personal responsibility includes
causes, consequences and identity components, and symptom variability captures
the cyclical time-line notion of the illness representation framework. Finally,
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serious consequences is consistent with the consequences component of the illness
representation framework.
In response to growing interest in patients' representations of illness and how
they may influence outcomes in chronic disease, the theoretically-based Illness
Perception Questionnaire (IPQ) was developed to assess illness representations
(Weinman et al, 1996). The IPQ is based on the five dimensions of illness
representation: identity, time-line, consequences, cure/control and cause and
studies utilising the IPQ have provided support for these dimensions and have
also shown links between illness representations and a range of psychological
outcomes including coping (Heijmans, 1999; 1998, Moss-Morris, 1996, Scharloo
et al, 1998) and mood (Fortune et al, 2000, Murphy et al, 1999).
Recently the IPQ has undergone further development. The Revised Illness
Perception Questionnaire (IPQ-R; Moss-Morris et al, 2002) divides the control
dimension into personal and treatment control and time-line consists of two
distinct scales acute/chronic and cijclical. In addition two new scales have been
included to measure emotional representations (emotional responses to illness)
and the extent to which patients feel they understand their condition, namely
illness coherence.
In parallel with the assessment of illness representations utilising the IPQ and
the IPQ-R, patients' representations of chronic disease have been examined
using the Personal Models of Illness framework (Hampson et al, 1990). Based
on the SRM, Hampson and colleagues broadened the definition of illness
representations to include patients' beliefs and emotions about the cause,
symptoms, course, treatment and consequences of their disease and referred to
these as 'personal models' of illness. However, in patients with diabetes
(Hampson et al, 1990) and osteoarthritis (Hampson et al, 1994), a distinction
between course (time-line) and consequences was not found thus a single
internally consistent construct described as seriousness was formed.
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Utility of illness representations
The introduction of the IPQ and IPQ-R led to a considerable increase in studies
employing the SRM framework to investigate psychological correlates and
determinants of outcome in chronic disease. Empirical studies with various
methodological designs, across a range of chronic conditions, have
demonstrated the consistency and validity of the five dimensions of patients'
representations of illness (Baumann et al, 1989, Bishop et al, 1987, Lau &
Hartman, 1983, Meyer et al, 1985). Moreover, illness representations have been
shown to be related to the decision to seek health care (Baumann et al, 1989,
Leventhal & Diefenbach, 1992, Cameron et al, 1993) and compliance with
medical advice (Leventhal et al, 1980). More recently, illness representations
have been examined in relation to patients' coping, adaptation and functioning
in chronic disease (Heijmans, 1999; 1998, Moss-Morris et al, 1996, Scharloo et al,
1998). However, to date, there has only been one attempt to systematically
review this growing body of literature. This meta-analytic review (Hagger &
Orbell, 2003) demonstrated evidence to support the construct and discriminant
validity of the consequences, con trol/cure, identity and time-line dimensions across
a variety of conditions examined in 45 studies. Hagger utilised content analysis
to classify coping and health outcomes into distinct categories and
demonstrated theoretically predictable relations between illness cognitions and
target outcomes. For example, identity was associated with the coping
strategies of avoidance and emotional expression, control beliefs were associated
with cognitive reappraissal, emotional expression and problem-focused
strategies. Chronic time-line and serious consequences were associated with
avoidance and emotional expression. With regard to health outcomes,
perceptions of control were associated with psychological well-being, social
functioning and vitality while consequences, tinieline and identity were negatively
associated with psychological well-being, role and social functioning and
vitality
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2.3. Aims and scope of the review
The present review was intended to broaden the scope of Hagger and Orbell's
meta-analytic approach in several ways. First, the current review is systematic
rather than meta-analytical in nature. This methodology was considered to be
appropriate for two main reasons:
1. The self-regulatory framework has been adopted in studies that vary
considerably in terms of the patient populations studied, their sample sizes,
methods for assessing illness representations and also the selection and
measurement of outcome measures. In the light of the heterogeneous nature of
the data being synthesised, the present author considered that a systematic
review method would be most appropriate in enabling a clear synthesis of such
a diverse body of evidence.
2. Another important feature of meta-analytical approaches is that they examine
the evidence for consistency. However, it may be inappropriate to expect
consistency in the relationship between illness representations and outcomes
across different diseases, as different illnesses place disparate demands on
individuals. Thus, the predictive validity of the different dimensions should be
expected to differ between patient groups. A systematic review method
permitted the synthesis of evidence from disparate patient groups without
having to expect such consistency.
The focus of this review is on the evidence pertaining to patients living with
chronic conditions only. Chronic conditions were defined as long-standing
illnesses (more than three months), which might be expected to have a
profound impact on the lives of sufferers. Thus studies examining the illness
representations of carers and partners were not included. The review included
studies that have utiuised any of the well-recognised scales measuring illness
representations i.e., the illness perception questionnaire (IPQ; Weinman et al,
1996), the revised illness perception questionnaire (IPQ-R; Moss-Morris et al,
2002), the implicit models of illness questionnaire (IMIQ . Schiaffino & Cea,
1995) and the personal models of diabetes interview PMDI (Hampson et al,
1990, 1995). Studies that have operationalised any of the recognised dimensions
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proposed by Leventhal et al. (1980;1984) through the use of non-validated scales
were also included.
Finally, the categorisation of outcome measures differs from that of Hagger &
Orbell. The present review examined the relationship between illness
representations and three categories of outcome: clinical and psychological and
behavioural. The clinical category encompasses both objective (e.g., blood
pressure, blood glucose and cholesterol) and self-report measures (e.g., pain,
disease severity) of the clinical status of the patient. The psychological category
encompasses self-report measures of the patient's psychological responses to
their condition (e.g., depression, adjustment, anxiety). Finally, the behavioural
category assessed coping responses (coping strategies, treatment adherence,
clinic visits). Researchers have examined the role of coping as a possible
mediator but most have focused on coping scales. However, Leventhal
originally conceptualised coping in terms of behaviours such as clinic
attendance and medication adherence. Thus the present review will first
examine the relationship between illness representations and outcomes (clinical
and psychological) and will then go on to discuss evidence for the possible
mediators of these outcomes, namely coping scales and coping behaviours. In
contrast, Hagger & Orbell focused on two categories of outcome, namely coping
and illness. Within coping they identified 7 groupings. However, all but one of
these related to self-report measures of coping strategies. The only behavioural
measure of coping considered was doctor visits. This contrasts with the present
review in which the 'behavioural' outcomes category examines 6 behavioural
measures of coping, in addition to self-report coping strategy measures.
Similarly, within their illness outcomes category, Hagger & Orbell identified 6
groupings. However, psychological outcomes such as depression and anxiety
were included within this category, whereas in the present review they were
examined as separate outcomes.
In the description of findings more weight was given to studies deemed to be
better designed and of higher quality (i.e., larger in sample size, prospective in
design, and data analysed controlling for factors such as disease severity or
illness duration). Studies which controlled for illness severity or duration were
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deemed to be better as they consider the fact that illness representations are
greater than the sum of the illness itself and may be more important in
determining outcomes.
2.4. Method
The present review was conducted in accordance with recommended methods,
the details of which are outlined below (Oxman, 1996; Cook et al, 1995).
Inclusion and exclusion criteria
To be included, studies had to report quantitative data on illness
representations in adults with chronic disease and their associations with
clinical, behavioural or psychosocial outcomes. Papers not including data on
these relationships (e.g. theoretical papers), or which focused solely on illness
representations of partners or carers of people with chronic disease, were
excluded. However, this literature is addressed in detail in part 2 of this
chapter.
Identificahon of papers and data extraction
Electronic searches were conducted using 'Web of Science' (1981-2002),
'Medline' (1966-2002) and 'Psychlnfo' (1887-2002) using the following
keywords: 'illness representations', 'illness perceptions', 'illness beliefs', 'self-
regulation model', 'self-regulatory model'. Reference lists of all included
studies were checked. Abstracts of recent health psychology conferences
(British Psychological Society, European Health Psychology Society), and key
journals (e.g. Psychology & Health, Journal of Health Psychology, Health
Psychology) were searched by hand for relevant material. In addition, key
authors in the field were also contacted to request further published or
unpublished studies.
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The author and an independent reviewer assessed the abstracts of retrieved
articles and judged whether they met the inclusion criteria. Discrepancies were
resolved through discussion. Articles that met these criteria were reviewed in
full; data were extracted and recorded on standardized data extraction sheets
(see Appendix 1). Information was collected on participants, design and
measures, outcomes and significant results.
2.5. Results
Search results: Assessment of illness representations
A total of 57 studies were deemed to meet the inclusion criteria after review and
discussion. The majority of the included papers were published recently; four
(0.7%) were published between 1990-1994, 16 (27.6%) between 1995-1999, and
the majority of studies 36 (62.1%) were published from 2000 onwards or remain
unpublished to date. Of the included studies, 34 employed some or all
dimensions of the original IPQ developed by Weinman et al, (1996). A further
six studies employed the revised version of the scale i.e., the IPQ-R. The
Personal Models of Illness Interview (Hampson et al, 1990) was employed in
eight studies and one study utilised the Implicit Models of Illness Questionnaire
(IMIQj Schiaffino & Cea, 1995). A further eleven studies used other measures
(e.g. non-validated measures derived from previous studies or qualitative
work) based on the self-regulatory theory. Some studies employed more than
one approach to measuring illness representations.
Study design
Forty-three of the fifty-eight studies (74%) adopted cross-sectional designs. Of
the 14 studies adopting prospective designs, follow-up periods ranged from 2
to 12 months. The primary outcome of studies was often difficult to determine
as most studies had multiple objectives and several outcome measures. Studies
that reported associations between illness perception dimensions and clinical,
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behavioural or psychological outcomes were included. Significant findings
pertaining to illness representations and outcome variables relating to the
stated aims of the review were extracted and tabulated.
Characteristics of participants
The patient groups represented in the reviewed literature represented a diverse
range of disease groups including: diabetes (n=11), heart/circulatory disease
(n=1O), rheumatoid arthritis (n=7) chronic fatigue syndrome (n=4),
inflammatory bowel disease (n=4), psoriasis (n=3), prostate cancer (n=3),
Marfan syndrome (n=2), chronic obstructive pulmonary disease (n=2), epilepsy,
MND, asthma, Huntington's disease, multiple sclerosis, HP!, osteoarthritis,
schizophrenia and reflex sympathetic dystrophy (all n1). A further study was
undertaken in patients with various, mostly chronic conditions (e.g. psoriasis,
RA, asthma) who were receiving homoeopathic treatment. Study sample sizes
also varied ranging from 17 to 2056 participants and were all mixed gender
except in three studies. Thirty-one studies (53%) included 100 participants or
fewer and 27 (47°o) studies included 101 participants or more.
2.6. Outcomes
The specific clinical, behavioural and psychological outcomes examined in this
review are listed in Table 2.1. Such outcomes were chosen due their
commonality in studies examining illness representations and outcomes in
chronic disease.
Clinical ou tconxes
Clinical outcomes are defined as both objective and subjective measures that
were presented as outcomes rather than measures of clinical severity, which
have been controlled for in analyses of other outcome data. Some measures
(e.g. the SF-20 and SF-36) are used as both outcomes and moderating disease
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severity variables, but this section reviews only those studies that have used
clinical measures as outcomes.





















Adherence to physical activity
Blood-glucose monitoring
Quality of life
Objective clinical outcomes included blood glucose levels in diabetes, blood
pressure, cholesterol and other clinical signs. Generic measures were used to
measure pain, disability, physical functioning, fatigue and illness impact and
severity. The most commonly used generic questionnaire was the Medical
Outcomes Study Short-Form Health Survey (SF-20 and SF-36; Stewart et al,
1988). Subjective disease-specific measures included Psoriasis Disability Index
(PDI; Finlay & Coles, 1995) Health Assessment Questionnaire (HAQ; Fries et al,
1980), Arthritis Impact Measurement Scale (AIMS; Meenan et al, 1984) and
Daily Activities of Life (DAL; Schrier et al, 1990).
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2.7. Objective clinical measures
Blood glucose levels in diabetes
Five studies reported data on illness representations and their relationship with
measures of glycosylated haemoglobin (HbAlc; Hampson et al, 1990; 1995;
2000, Griva et a!, 2000, Wearden et al, in submission). This clinical measure is
commonly used to determine long-term glycaemic control, higher levels of
HbAlc indicate higher blood glucose levels and hence poorer metabolic control.
First, in a small cross-sectional study of female patients with type 2 diabetes
(n46), it was demonstrated that personal model constructs failed to predict
HbAlc levels alter controlling for age and insulin status (Hampson et al, 1990).
However, they did predict adherence to diet, exercise and glucose testing which
are considered important in maintaining long-term glucose control in patients
with diabetes. In another small cross-sectional study of young adults with type
I diabetes (n=64) consequences and identiLy (and self-efficacy) accounted for 41%
of the variance in HbAlc after controlling for age and disease duration (Griva et
al, 2000). Finally, perceptions of control in recently-diagnosed patients treated
with insulin were correlated with blood glucose control but not for long-
standing non-insulin treated patients (Wearden et al, in submission).
In a prospective study with a larger mixed sample of patients with type 2
diabetes (n=78) personal model constructs prospectively explained 24% of the
variance in HbAlc alter controlling for demographic variables, disease duration
and insulin status; lower levels of HbAlc were associated with believing that
one's own behaviour caused diabetes, and that treatment was effective
(Hampson et al, 1995). In another prospective randomised trial diabetic patients
with stronger control beliefs had lower (better) glycosylated haemoglobin
accounting for 29% of the variance after controlling for age, gender and
comorbidity (Hampson et al, 2000).
52
Blood pressure
The relationship between illness representations and blood pressure in patients
with hypertension was examined in one large cross-sectional study (Scisney-
Matlock et al, 2001). The predictive utility of illness representations appeared to
be age-related once other demographic factors were controlled. For those
under 60 years of age, diastolic blood pressure was associated with fewer
perceived consequences of hypertension, less control and a shorter time-line. For
those over 60 years of age, increased perceptions of con trol were associated with
increased diastolic blood pressure. These age differences may result from the
notion that older adults act initially to self-manage symptoms of an acute, less
serious nature but are quick to seek professional treatment when a health
condition is perceived as serious or of long duration (Leventhal & Crouch,
1997). The expertise of older adults in dealing with the illness may be reflected
in this situation in which older adults are more likely to seek and adhere to
medical treatment, even in situations in which such adherence might not be
associated with the same level of results for younger adults. They suggest that
responses among the elderly are indicative of a heightened sensitivity to disease
management issues, particularly the perceived control of hypertension.
It is also necessary to mention that this study did not use an established
measure to assess illness representations but instead used the Cognitive
Representations of Hypertension Scales developed specifically for the study.
Although this measure comprised of items pertaining to the identity,
consequences, cause, control and time-line sub-scales it did not resemble the sub-
scales of the IPQ-IPQ-R, thus parity between these different scales cannot be
determined.
cholesterol
Two studies assessed the relationship between illness representations and
cholesterol and both demonstrated significant but different relationships. First,
in a large cross-sectional study Low Density Lipoprotein (LDL) cholesterol
control (i.e. patients' ability to reach LDL treatment goals) was associated with
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consequences, symptoms, and timeline beliefs of patients with
hypercholesterolaemia (Brewer et al, 2002). Specifically, participants had less
LDL cholesterol control when they believed that high cholesterol caused
symptoms such as fatigue and tiredness, and better control when they believed
that high cholesterol increased their risk of heart attack and stroke, and that
their own cholesterol levels were stable over time.
The second study benefited from a prospective design and assessed LDL
cholesterol levels in patients with diabetes: stronger beliefs in treatment
effectiveness predicted lower serum cholesterol levels three months later alter
controlling for age, gender and co-morbidity (Hampson et al, 2000).
In summary, while most studies demonstrated associations between illness
representations and clinical outcomes, there was little consistency between
studies in terms of which representations were the most predictive.
2.8. Subjective measures of disability and quality of life
Medical Outcomes Study Short-Form Health Survey (SF-20 and SF-36)
Fifteen studies employed a measure of physical functioning, physical impact,
functional activity/status or adaptive outcome. The most commonly used
measure was the Medical Outcomes Study Short-Form Health Survey (SF-20
and SF-36). This instrument assesses patient functioning and well-being along
several dimensions: physical, role and social functioning, general health
perceptions, bodily pain, mental health and vitality. These scales were used in
eleven of the included studies using both cross-sectional and prospective
designs in patients with osteoarthritis (OA), diabetes, chronic fatigue syndrome
(CFS), Addison's disease, Huntington's disease, reflex sympathetic dystrophy,
psoriasis, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis
(RA) and prostate cancer.
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Many of these studies report significant correlations between illness
representations and outcomes on the SF-20 and SF-36. However, in the six
cross- sectional studies which used regression analyses to control for
demographic and clinical factors such as age, gender, disease duration and
severity, fewer illness representations continued to be associated with SF-20
and SF-36 outcomes (Gonzalez, 2002a; 2002b, Heijmans, 1998, Helder et al,
2002a; Scharloo et a!, 1998; Hampson et al, 1994). In the studies which used the
JPQ or JPQ-R, perceived symptoms (identity) consistently explained variance in
the outcome measures. In all cases, poorer outcomes on the SF-20 and SF-36
were associated with stronger illness identity (e.g. more symptoms) associated
with the particular illness. However, there was inconsistency with regard to
which dimensions were predicted by identity. For example, in Huntington's
Disease, variance in pain, vitality, physical functioning, mental health and
general health was explained by identity (Helder et al, 2002a). Whereas in
COPD, role and social functioning, and general health perceptions were
associated with identity (Scharloo et al, 1998). Of all the SF-20 and SF-36
dimensions, physical and social functioning were most likely to be associated
with identity (as found in five and seven regression analyses respectively), and
pain was least likely to be associated with identity (found in one analysis).
Other IPQ dimensions were less likely to be associated with SF-20 and SF-36
outcomes: consequences was associated in four regression analyses, and control,
cause, emotional representations and timeline were each associated with outcomes
in one analysis.
The personal models framework also showed expected relationships between
outcomes and illness constructs. For OA patients, better role functioning and
overall perceived health correlated with fewer symptoms and believing that OA
was less serious (Hampson et al, 1994).
There were three prospective studies examining illness representations and
outcomes assessed by the SF-20 and SF-36 (Scharloo et al, 2000a; 2002b and
Hampson et al, 2000). First, in (n=69) psoriasis patients, regression analyses
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demonstrated that identity scores were negative predictors of physical and
social functioning and health perceptions, and were positive predictors of
depression and mental health at one year (Scharloo et al, 2000a). Perceptions of
identity were also significant predictors in patients with COPD (Scharloo et al,
2000b), identity scores negatively predicted social functioning and health
perceptions at one year. Finally, in a mixed sample of patients with type 1 and
type 2 diabetes the personal model construct of perceived seriousness was
predictive of physical functioning and treatment effectiveness predicted health
perceptions. Whereas stronger beliefs in seriousness was a negative predictor of
mental health. These results from the personal models framework appear to be
inconsistent with the cross-sectional data reported by Hampson et al (1994)
from work with osteoarthritis patients which questions the value of cross-
sectional analyses.
Sickness Impact Profile (Disabilthj)
The sickness impact profile (SIP; Bergner et al, 1981) is a measure of sickness-
related dysfunction (disability). Dimensions of this scale can be grouped into
physical dysfunction (ambulation, mobility and bodycare), social dysfunction
(social interaction, alertness, communication), and role dysfunction (work,
home management and recreation). In two cross-sectional studies employing
the SIP the impact of sickness was associated with illness representations. For
example, in a large cross-sectional study which conducted regression analyses,
illness representations accounted for 37% of the variance in SIP dysfunction in
CFS patients (identity and consequences) (Moss-Morris et al, 1996). In another
large cross-sectional study of MS patients illness representations explained 32%
of the variance in psychosocial dysfunction (identity, illness coherence,
consequences and psychological cause), 17% of the variance in role functioning
(consequences) and 11% of the variance in physical dysfunction (identity,
consequences and time-line) (Jopson & Moss-Morris, 2003).
56
In the only prospective study, myocardial infarction (MI) patients' total score on
the SIP was correlated with concurrent measures of identity, timeline and
consequences (Weinman et al, 1996). Overall, the findings show that illness
representations are predictive of illness-related dysfunction, however, there
was little consistency in terms of which individual components were
independent predictors but this may be an artefact of inherent differences
between a 'functional' non-organic disease such as CFS and a disease with a
known aetiology and course such as MS. It was also difficult to assess
predictive consistency of individual components of the IPQ as the MS study
reports regression for individual SIP variables while the CFS study reports
regression for SIP total dysfunction.
Fatigue
The Fatigue Severity Scale (Chalder et al, 1993) was used to measure mental and
physical fatigue in patients with MS (Jopson & Moss-Morris, 2003) and CFS
(Edwards et al, 2001). Fatigue was independently associated with a strong
illness identity in both studies, and by strong consequences in CFS and control
beliefs in MS.
Disease specific measures of disability
Several studies assessed the relationship of illness representations with scores
on disease-specific measures of disability. These scales included: the Psoriasis
Disability Index (PDI; Finlay et al, 1990, Finlay & Kelly, 1987) which assesses
psoriasis-related disruption to lifestyle; Daily Activities of Life (DAL; Kaptein et
al, 1993; Schrier et al, 1990) used to assess ability to perform physical tasks in
COPD patients; the Health Assessment Questionnaire (HAQ: Fries et al 1980)
which assesses activities of daily living (e.g. hygiene, walking) in RA; and the
Arthritis Impact Measurement Scale (AIMS; Meenan et al, 1984) which assesses
physical functioning, depression, anxiety, pain, social functioning, general
health perceptions and health status in patients with arthritis.
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Illness representations significantly explained variance in all of these disease-
specific measures with identity and consequences being associated the most with
these outcomes. For example, in cross-sectional studies identity beliefs
explained additional variance in functioning, over and above that explained by
disease duration and medical variables in patients with COPD (Scharloo et al,
1998), RA (Tomlinson, 2001) and psoriasis (Scharloo et al, 1998) as did control
beliefs in RA patients (Scharloo et al, 1998) and consequences in psoriasis patients
(Scharloo et al, 1998, Fortune et a!, 2002).
In a further cross-sectional study, patients with RA reporting more pain held
stronger beliefs in the consequences of living with the condition (Tomlinson,
2001).
In patients with OA it was found that prior to joint surgery, functional activity
was associated with patients' perceptions of the consequences of their illness
(poorer functional activity was associated with more reported consequences).
However, after patients had undergone surgery on the affected joint, functional
activity was better in those who believed they had more control over their
condition, and that it was not due to ageing (Orbell et al, 1998).
In the only prospective study utiuising the HAQ, identity beliefs explained 20%
of the variance levels in pain at 12 months while identity and perceived
consequences explained 53% of the variance in tiredness after controlling for
disease duration, and levels of pain and tiredness at baseline (Scharloo et al,
1999).
In summary, in these four studies of COPD, psoriasis, RA and OA, identity
and/or consequences appear to be the most important predictors of functioning
and disability. In RA and OA, control beliefs also play an important role.
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2.9. Coping
Leventhal et al. (1984) suggested that not only do illness representations give
personal meaning to patients' symptoms and experience of illness, but act as a
framework for guiding and evaluating their coping efforts in dealing with the
illness. Moreover, self-regulation theory posits that illness representations will
be directly related to coping and, via coping, to adaptive or maladaptive
outcome (Leventhal et al, 1984). Thus the illness representation framework has
been applied in a number of studies examining coping strategies in chronic
illness. In addition, health behaviours such as clinic attendance and adherence
to treatment regimens may be viewed as objective indicators of coping
behaviour therefore studies examining these outcomes are reviewed with the
literature concerned with coping.
Coping strategies
The notion that illness representations have a 'direct' relationship with coping
and adaptive outcome is not unequivocal. There is a body of evidence which
suggests that adaptive outcomes in chronic disease are not mediated by coping
(Scharloo et al, 1998, Heijmans, 1999, Moss-Morris et al, 1996 & Lawson et al,
2004). Indeed, some studies have found illness representations to be better
predictors of adaptive outcomes than measures of coping (Earli et al, 1993,
Heijmans, 1998, Watters, 2001, Wilby & Stewart, unpublished). However, as the
focus of this review is to consider the utility of illness representations in
predicting outcome in chronic disease the following sections examine studies
that have employed coping as an outcome, rather than to test the mediating
relationship between illness representations, coping and adaptive outcomes.
The most frequently used coping measures were the COPE (Carver et a!, 1989)
and the Utrecht Coping List (Schreurs et al, 1993).
COPE
The COPE questionnaire assesses 15 different coping mechanisms, of which 10
can theoretically be divided into two categories: Emotion-focused coping
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strategies are designed to regulate the emotional responses to the stressor and
include seeking social support, engaging in positive reinterpretation and
growth, acceptance, turning to religion and denial. In contrast, problem-
focused strategies directed at altering the stressor in some way and include
active coping, planning, suppression of competing activities, restraint and
seeking social support for instrumental reasons. The remaining scales include
mental and emotional disengagement strategies.
Five studies utilised components of the COPE as outcome measures of coping
strategies. These studies assessed the associations between illness
representations and coping in patients with lBS (Rutter, 2001, Rutter & Rutter,
2002), CFS (Moss-Morris et al, 1996), Huntington's disease (Helder et al, 2002a),
and stroke (Wilby & Stewart, unpublished).
A large cross-sectional study of predominantly female patients with CFS
employed twelve of the sub-scales most relevant to chronically ill patients
(Moss-Morris et al, 1996). Illness representations significantly correlated with 8
of the 12 coping strategies assessed. Problem-focused coping strategies were
most frequently predicted by control/cure and/or consequences; emotion-focused
strategies by consequences, and disengagement strategies were predicted by all
five IPQ dimensions.
The work of Rutter (2001) and Rutter & Rutter (2002) demonstrated that illness
representations correlated with 9 of the 15 COPE sub-scales in patients with
lBS. The IPQ dimensions control/cure, consequences and psychological cause of
lBS were the most predictive. Problem-focused strategies were associated with
control/cure and emotion-focused strategies with consequences. Path analysis
revealed that coping variables also mediated the link between illness
representations and the four main outcomes: quality of life, satisfaction, anxiety
and depression. For example, acceptance coping mediated the link between
consequences and quality of life, and behavioural disengagement mediated the
link between cure/con trol and depression. However, there was no clear pattern
as to which IPQ dimensions correlated with which COPE sub-scales.
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Helder et al. (2002a) reported that only 3 of the 15 COPE sub-scales correlated
with illness representations in a cross-sectional study of patients with
Huntington's disease). Seeking emotional support and positive reinterpretation
were associated with cure and control respectively, and mental disengagement
correlated with identity, time-line and cure. No problem-focused strategies were
predicted by IPQ dimensions. Finally, in a small cross-sectional study of
younger stroke survivors IPQ constructs correlated with 4 of 14 COPE sub-
scales. The con frol/cure dimension was the most predictive construct,
correlating positively with positive reinterpretation, seeking social support and
behavioural disengagement (Wilby & Stewart, unpublished).
Utrecht Coping List
Another widely used scale in the illness representations literature to assess
coping is the Utrecht Coping List (UCL; Schreurs et al, 1993), a generic coping
measure with well-documented reliability and validity (Schaufeli &
Dierendonck, 1992 Hopman-Rock et al, 1997). The UCL consists of 49 items
representing seven sub-scales: seeking distraction, expressing emotions, seeking
social support, behavioural-avoidant, fostering reassuring thoughts, passive
coping and problem-focused coping. Six studies employed the UCL, but it was
utilised as an outcome measure in only two (Heijmans,1998; 1999),the
remaining studies were concerned with the relative contribution of coping style
in functioning and adaptation in chronic disease (Scharloo et al, 1998; 1999;
2000a; 2000b).
Heijmans used five of the seven UCL sub-scales in cross-sectional studies of
patients with CFS (Heijmans, 1998) and in Addison's disease (Heijmans, 1999).
There was some consistency between the two studies. In CFS patients, all five
UCL sub-scales correlated with IPQ constructs. The time-line and identity
dimensions were most likely to predict coping; higher scores on these IPQ
constructs tended to correlate with more avoidance, and less adaptive (e.g.
seeking social support, venting emotions) coping. In Addison's disease, the
IPQ correlated with fewer (3 of 5) UCL sub-scales: behavioural- and cognitive-
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avoidant, and emotion venting. Again, time-line and identity were most
predictive; a stronger time-line was associated with more avoidance, and identity
was associated with more avoidance and more adaptive (emotion venting)
coping.
Other coping measures
The revised ways of coping checklist (WCCI-R; Vitaliano et al, 1985) was
employed in a cross-sectional study of patients with epilepsy (Kemp et al, 1999).
Illness representations correlated with all 4 coping sub-scales; identity (defined
by symptoms) was associated with wishful thinking and avoidance whereas
identity (defined by disease label) was negatively associated with avoidance and
positively associated with seeking social support. The appraisal and coping
questionnaire (ACQj Anderson & EkdaEl, 1992) was used in a large cross-
sectional study of patients with Reflex Sympathetic Dystrophy (Hendriks et al,
2000). It was demonstrated that emotion-focused coping correlated with more
symptoms (identity), a stronger time-line and perceived consequences whereas
problem-focused coping correlated with fewer symptoms (identity) and less
perceived consequences.
Summary
In summary, studies reporting the relationship between illness representations
and coping as an outcome variable relied mostly on correlations between beliefs
and multiple coping sub-scales. Furthermore, all the studies utilising coping as
an outcome have relied on cross-sectional designs which makes it difficult for
meaningful interpretation of the findings. Nonetheless, illness representations
were most predictive of COPE scores in CFS and lBS. and less so in
Huntington's disease and stroke patients. The dimensions control/cure and
consequences were most likely to be positively associated with emotion-focused
and problem-focused coping strategies. In contrast, studies using the UCL
found timeline to be the most positive predictor of avoidance coping in CFS and
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Addison's disease whereas identity was negative predictor of adaptive coping in
CFS and a positive predictor of adaptive coping in Addison's disease. The
identity dimension was the only consistent predictor in studies using the WCCI-
R. Studies often showed that emotion-focused and problem-focused coping
strategies were predicted by different beliefs (usually cure/control and
consequences), but there was little consistency between studies. For example,
emotion-focused coping was associated with consequences in functional
disorders such as CFS and IBS, but by control/cure in Huntington's disease and
stroke. Across the three main coping strategies causal attributions were the least
consistently associated dimension of illness representation with coping
outcomes.
2.10. Behavioural outcomes
It has been posited that illness representations are related to the decision to seek
health care (Baumann et al, 1989, Leventhal & Diefenbach, 1992, Cameron et al,
1993, Leventhal et al, 1980) and adherence with medical advice, consequently
this issue is addressed in many studies in the illness representations literature.
It is also argued that responses to health threats such as care-seeking arid
adherence to treatment regimens can also be interpreted as coping strategies;
and are thus
considered as behavioural outcomes.
Clinic attendance
With regard to seeking health care; clinic attendance and hospital visits was
examined in one cross-sectional study in patients with diabetes (Lawson et al,
2004). In this small study (n= 42) patients with type 1 diabetes the treatment
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effectiveness dimension from the PMDI and control from the IPQ was associated
with clinic attendance (Lawson et al, in press).
There were, however, three prospective studies which included clinic
attendance as an outcome. In patients with psoriasis, only control and identity
were significant predictors in psoriasis explaining 21% of the variance after
controlling for previous visits at baseline, disease duration and severity
(Scharloo et a!, 2000a). In RA, visits were prospectively predicted by
consequences of the condition after controlling for visits preceding study entry,
disease duration and severity (Scharloo et al, 1999). In patients with COPD
clinic visits were less likely if the cause of their condition was thought to be
related to stress and other people (Scharloo et al, 2000b). In patients with OA
identify was correlated with doctor visits (Hampson et al, 1994).
In summary, there was considerable evidence to suggest that illness
representations are associated with clinic and hospital attendance. However,
there was little consistency in terms of which representations were associated
with this outcome.
Cardiac rehabilitation
Three studies utilising dimensions the IPQ to predict attendance at cardiac
rehabilitation yielded contrasting results. First, in a cross-sectional study
identify was the only significant predictor such that those with fewer perceived
symptoms were less likely to attend (Whitmarsh et al, 2003).
There were two prospective studies including attendance at cardiac
rehabilitation as an outcome. First, visits to the doctor three months post MI
were positively correlated with identify and consequences (Weinman et al, 1996).
Whereas, attendance at rehabilitation clinics at six months post MI was
positively predicted by control and lifestyle cause beliefs after controlling for age
and knowledge of cholesterol concentrations (Cooper et al, 1999). One
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explanation for these inconsistent results may be due to the time-point at which
illness representations were measured - perceptions of MI may change after a
period of adjustment to the acute experience of a ML This may be particularly
pertinent if the patient has been attending rehabilitation clinics as the educative
nature of rehabilitation may alter a patients' appraisal of the condition and
subsequent representations of the condition.
Adherence to treatment recommendations
Self-reported adherence to prescribed medication was measured in cross-
sectional studies of patients with hypercholesterolaemia (Brewer et al, 2002),
hypertension (Cartwright & Lamb, unpublished), asthma (Home & Weinman,
2002), haemophilia (Liewellyn et al, 2003), chronic fatigue syndrome (Pope &
Woodcock, 2001), and acceptance of recommended treatment was examined in
patients with HIV (Home et al, 2000). Diabetes was the only condition for
which several studies of treatment adherence existed hence these studies are
discussed separately.
Medication
Of the non-diabetes studies, three cross-sectional studies reported consequences
as a significant predictor of medication adherence. Those who perceived more
consequences of their illness were more adherent to taking cholesterol lowering
medication where demographic and clinical variables were used as co-variates
(Brewer et al, 2002). In a small sample of patients with haemophilia (n= 33)
adherence to clotting agents correlated with greater consequences and weaker
identity beliefs (Liewellyn et al, 2003). In addition, analysis of variance
demonstrated that patients under-treating with clotting agents perceived less
perceived consequences. Adherence with preventive asthma medication was
negatively predicted by consequences (Home & Weinman, 2002) explaining 13%
of the variance after controlling for demographic, clinical factors and treatment
beliefs. Thus, surprisingly those perceiving greater consequences were less likely
to adhere to medication, the authors suggest that due to the cross-sectional
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design of the study, scores on this dimension may be a result rather than a
determinant of adherent behaviour.
In a small study (n=35) of patients with HIV acceptance of antiretroviral agents
was associated with a strong illness identity, and greater time-line perceptions
(Home et a!, 2000). In a large cross-sectional study regression analyses
controlling for age and the benefits and costs of treatment revealed no
significant correlations between illness representations of patients with
hypertension and adherence with medication (Cartwright & Lamb,
unpublished). In another study of patients with CFS assessing causal
attributions only, there were no associations with adherence to antidepressants
(Pope & Woodcock, 2001).
There was only one prospective study examining medication adherence, a
unique examination of patients consulting homoeopathic practitioners with
various chronic illnesses. Adherence to homoeopathic remedies at 2 months
was associated with consequences and cause beliefs (pollution and poor past care)
after controlling for demographic factors (Searle & Murphy, 2000). In addition,
non-adherence defined by the use of non-homoeopathic remedies was
predicted by identity and cause beliefs (chance, own behaviour and other
people). However, these results are tempered by a small sample size (n30)
and a short follow-up period of only two months.
Physical activity
Adherence to recommended exercise programs yielded contrasting results in
two cross-sectional studies. In patients with Marfan Syndrome (an autosomal
dominant condition of abnormal connective tissue) perceived consequences were
positively correlated with exercise modification based on their diagnosis (Peters
et al, 2001b). In a study of two patient groups (hypertension and diabetes)
perceived consequences was negatively correlated with exercise in diabetes
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patients only and failed to reach significance in regression analyses after
controlling for age and costs and benefits of engaging in exercise
Diet
None of the IPQ dimensions were predictive in a cross-sectional study of
hypertensive patients controlling for age and the costs and benefits of dietary
adherence (Cartwright & Lamb, unpublished).
In a prospective study, attributions of cause 'poor past care' and 'chance' were
positive predictors of dietary recommendations in homoeopathic patients with
various chronic illnesses (Searle & Murphy, 2000).
Summary
The studies examining the relationship between illness representations and
behavioural outcomes such as clinic attendance and cardiac rehabilitation have
not provided consistent results and are hampered by a reliance on cross-
sectional data. With regard to adherence with health behaviours it appears that
the consequences dimension was most consistently associated with medication
(Brewer et al. 2002, Liewellyn et al. 2003, Home and Weinman, 2002) and
exercise (Peters et al, 2001a).
2.11. Self-management of diabetes
Pertinent to the focus of this thesis, seven studies measured at least one of the
mainstays of diabetes treatment i.e., blood-glucose testing, diet, physical
activity, insulin and medication adherence, Of these, four studies utilised
variations of the Summary of Diabetes Self-Care Activities scale (SDSCA)
(Hampson et al, 1995; Glasgow et al, 1997; Skinner et al, 2002), all adopted
cross-sectional designs except Hampson et al (1995). The SDSCA is a self-report
measure of the frequency of adherence to different regimen activities (e.g.,
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blood glucose testing, diet, physical activity and medication) in the preceding
seven days and provides a global measure of level of diabetes self-care. Self-
care assessed by the SDSCA correlates significantly with other more objective
methods of assessment (Toobert & Glasgow, 1994, Glasgow et al, 1995). These
studies all employed the PMDI to elicit illness representations.
Blood-glucose monitoring
Blood-glucose monitoring was assessed in four cross-sectional studies
(Hampson et al, 1990, Griva et al, 2000, Glasgow et al, 1997, Skinner et al, 2002)
and was positively associated with illness representations in both type I and
type 2 patients. In three of these studies (Hampson et al, 1990, Glasgow et al,
1997, Skinner et al, 2002) glucose testing was associated with PMDI constructs
however, these constructs were defined and assessed differently making the
results difficult to compare. Overall, patients' beliefs regarding the importance
or effectiveness of self-care activities such as glucose monitoring and glycaemic
control, and seriousness/threat (e.g. consequences of diabetes on health and
lifestyle) were the most significant predictors of glucose monitoring. For
example, in Skinner et al's (2002) study of 358 type 1 patients, monitoring
correlated with treatment effectiveness (e.g. importance of glucose monitoring to
control and prevent complications). Furthermore, structural equation
modelling demonstrated that perceived threat (which was derived from IPQ
consequences and PMDI items, e.g. my diabetes is a serious threat to my
current/future health) was a predictor of monitoring (Skinner et al, 2002). In
Hampson et al's (1990) study of only 46 female patients with type 2 patients,
monitoring was predicted by treatment importance (e.g. perceived importance
of self-care activities such as glucose monitoring) after controlling for age and
insulin administration. In a much larger study of 2056 type 1 and 2 patients of
mixed gender, treatment effectiveness/importance and perceived seriousness were
significant and explained 13% of the variance after correcting for insulin
administration, age and education (Glasgow et al, 1997). Finally, monitoring
also correlated with the IPQ construct control, and self-efficacy beliefs in type 1
diabetes (Griva et a!, 2000). This study also showed that 39% of the variance in
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total adherence (to glucose monitoring, insulin, diet, and exercise) could be
explained by patients' control beliefs assessed with the IPQ.
Physical activity
Physical activity was assessed in five cross-sectional studies of patients with
diabetes. Of these, three studies showed that exercise could be predicted by
illness representations even after controlling for patient characteristics such as
age, gender and disease duration (Glasgow et al, 1997, Hampson et al, 1990,
Skinner et al, 2002). Beliefs about the importance/effectiveness of self-care and the
perceived threat or seriousness of diabetes explained the most variance in
physical activity. For example, in patients with type 1 and type 2 diabetes,
exercise was predicted by the PMDI construct treatment effectiveness (Hampson
et al, 1990, Glasgow et al, 1997, & Skinner et al, 2002) and perceived seriousness
(Glasgow et al, 1997). In Glasgow et al's (1997) study of 2056 diabetes patients
23% of the variance in physical activity could be explained by these beliefs, after
correcting for age and education. In Skinner et al's, (2002) study, exercise
participation in patients with type 1 diabetes was predicted by perceived threat
(e.g., diabetes is a serious threat to my future/current health). Finally, in a
study of patients with type 1 and 2 diabetes, exercise was negatively correlated
with perceived consequences (Cartwright & Lamb, unpublished). However, this
association did not maintain significance after controlling for age in regression
analyses.
The only prospective study to examine adherence to recommended physical
activity was a study of (n78) patients with type 2 diabetes and utiuised the
SDSCA (Hampson et al, 1995). In this study physical activity was positively
predicted by perceived treatment effectiveness and negatively by cause (own
behaviour).
Diet
Seven studies assessed the association between illness representations and diet
in patients with diabetes. Three cross-sectional studies employed the SDSCA
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which assesses eating over the last seven days (e.g., frequency of eating red
meat, full-fat dairy products and fruit and vegetables). All three studies found
the PMDI construct treatment effectiveness/importance to predict dietary intake,
after controlling for age, duration of diabetes and insulin administration
(Hampson et al, 1990; Glasgow et al, 1997, Skinner et al, 2002). Dietary choices
were also predicted by the perceived seriousness and threat of diabetes in three
cross-sectional studies (Hampson et al, 1990, Glasgow et al 1997, Skinner et al,
2002).
Again, in the only prospective study to utilise the SDSCA perceived treatment
effectiveness positively predicted concurrent diet (Hampson et al, 1995).
The remaining studies employed different measures to assess dietary
adherence. Looking at cross-sectional studies first, Griva et al (2000) assessed
intentional non-adherence using items based on the Reported Adherence to
Medicines Questionnaire (Home, 2001). Dietary adherence in type 1 diabetes
was correlated with identity and stronger control beliefs assessed by the IPQ
(Griva et al, 2000). In a large unpublished study, Cartwright and Lamb found
no significant correlations between IPQ dimensions and a measure specifically
developed for the study measuring adherence to dietary recommendations in
patients with type 1 or type 2 diabetes.
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Finally in their prospective study Hampson et al (2000) assessed eating patterns
in type 1 and type 2 diabetes patients using the Kristal Food Habits
Questionnaire (Kristal et al, 1990). High-fat eating patterns were prospectively
predicted by treatment effectiveness (e.g. importance of self-care activities) after
controlling for demographic variables and medical history. Patients with
stronger beliefs in treatment effectiveness reported fewer high-fat eating patterns
(Hampson et al, 2000).
Medication
Four cross-sectional studies assessed adherence to medication in patients with
diabetes. . Three of these studies (Griva et al, 2000, Cartwright & Lamb,
unpublished, Glasgow et al, 1997) used adapted versions of the SDCSA. The
scale includes three items on medications adherence (e.g. 'On how many of the
last seven days did you take your recommended diabetes medication'?). Two
of the three cross-sectional studies which used this scale later excluded this data
from their analyses and do not report their findings (Hampson et al, 1990;
Glasgow et al, 1997). These studies all included patients with type 2 diabetes
who may not have been prescribed medication, so some questions on this scale
may not have been applicable. In contrast, Skinner et al (2002) employed two
questions from the SDSCA scale to assess frequency and timing of insulin
injections in patients with type 1 diabetes. Results of bivariate analysis and
structural equation modelling suggest that insulin administration was
associated with perceived threat and treatment effectiveness to control diabetes.
Griva et al (2000) reported that insulin adherence correlated with IPQ control
beliefs. Thus, where data were provided, beliefs regarding control and threat
were the most significant predictors of medication adherence.
Once again, the only prospective study to measure medication adherence in
diabetes patients was that of Hampson et al (1995) using the SDCSA but did not
report any significant findings from their analyses.
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Summary
The extent of the predictive utility of the PMDJ construct of treatment
effectiveness with self-management in diabetes patients suggests that the beliefs
patients hold regarding the recommended treatment of diabetes is the most
important predictor of health behaviours. In addition, the perceived seriousness
of diabetes (defined by time-line and consequences) was also prominently
implicated in the extent of self-management of diabetes. However, in studies
employing the IPQ and IPQ-R control beliefs were the most important variables
in predicting adherence with self-management behaviours.
2.12. Psychological outcomes
Depression
Depression was one of the most ubiquitous psychological outcomes measured
in the studies reviewed. Depression was assessed in a wide variety of disease
groups including CFS, psoriasis, RA, lBS. MS, prostate cancer, diabetes and
motor neurone disease (MND). Therefore, it was deemed appropriate to
consider depression in these disease groups separately.
Many studies employed the Hospital Anxiety and Depression Scale (HADS;
Zigmond & Snaith, 1983) to assess depression. The HADS consists of two sub-
scales each with 7-items measuring depression and anxiety. Scores of 8-10 on
either sub-scale indicate mild levels of anxiety and depression. Scores of 11 or
higher on either or both of the sub-scales indicate moderate-severe
symptomatology or clinically significant disorder.
Of the studies reviewed, all but one found significant associations between
depression and illness representations. However, the extent of associations
between representations and the consistency of the most significant
components appeared to differ according to the disease studied. Cross-
sectional studies are examined first.
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There were two cross-sectional studies of patients with CFS. First, IPQ
variables explained 28% of the variance in depression scores (Edwards et al,
2001) and only time-line was not significantly associated with depression. Pope
and Woodcock's (2001) study assessed the influence of causal beliefs on
depression in CFS and found no associations between attributions of cause and
depression.
In a study of 225 patients (Fortune et al, 2002), identity and consequences
explained 43% of variance after controlling for age, gender and clinical history.
In patients with long-standing RA, depression correlated most strongly with
consequences (patients view their condition as serious) and control/cure (feel they
have little control over their illness), even when disability was controlled for
(Murphy et a!, 1999).
The two cross-sectional studies of patients with irritable bowel syndrome (IBS)
demonstrated some consistency. They found depression to be associated with
reported consequences (Holt et al, 2002, Rutter & Rutter, 2002). Holt et al (2002)
reported that 25% of the variance in depression scores could be explained by
illness representations. Another study using path analysis demonstrated that
control beliefs and perceived consequences explained 30% of the variance in
reported depression (Rutter & Rutter, 2002). Despite the large sample sizes
(>200) of these studies, the participants were predominantly female.
In a large study of patients with MS a number of IPQ variables (lack of personal
control, consequences and psychological causes) explained 26% of the variance in
depression after controlling for age and illness severity (Jopson & Moss-Morris,
2003). In a particularly small (n17) study of patients with prostate cancer a
strong illness identity explained 59% of the variance in HADS depression scores
(Watters, 2001). Finally, a small study of patients with motor neurone disease
demonstrated that a belief in more serious consequences correlated with higher
levels of depression (Earli et al, 1993).
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In the prospective studies examining the association between illness
representations and depression the findings were equally diverse. First, in
patients with psoriasis (Scharloo et al, 2000a), baseline identity explained 9% of
the variance in depression scores measured at 12 months. In recently diagnosed
patients with RA (< 2 years) depression could be prospectively predicted by
previous assessments of perceived consequences. However, although initial
levels of depression were controlled for, this study included only 22 patients
(Sharpe et al, 2001). However, in another prospective study of long-standing
RA patients (Scharloo et al, 1999), depression was predicted by symptoms
(identity), which explained 2% of the variance (after controlling for illness
duration, disease activity and baseline depression scores). Thus the results
demonstrated inconsistency with regard to which components predicted
depression. Overall, the results of these studies are tempered by small sample
sizes. In a prospective study of patients with IBS, stronger perceived
consequences correlated with higher levels of depression (Rutter et al, 2002) and
is consistent with the findings of cross-sectional studies (Rutter & Rutter, 2002,
Holt et al, 2002). However, this analysis was based on only 35 patients of which
80% were female.
Other measures of depression
In a large cross-sectional study of patients with Marfan Syndrome using the
Center for Epidemiological Studies Depression Questionnaire (CES-D; Radloff,
1977) found consequences and con frol to be associated with depression. Patients
who were more depressed perceived more consequences of the condition,
perceived less control over their symptoms and were more pessimistic
regarding a cure (Peters et al, 2001b)
Two prospective studies (Schiaffino et al, 1998, Orbell et al, 1998) used the CES-
D. Both studies found that illness representations explained significant
amounts of the variance in self-reported depression. However, the predictive
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components were inconsistent possibly because they were time- and disease-
dependent.
First, illness representations were unrelated to concurrent levels of depression
in patients with RA and MS (Schiaffino et al, 1998). However, initial beliefs in
the curability of RA as well as beliefs in one's own responsibility for the
occurrence of RA were associated with increased levels of depression over time.
For patients with MS, initial beliefs in symptom variability were associated with
a significant increase in depression over time. The predictive components of
the IPQ also changed over time in patients with OA (Orbell et al, 1998). While
pre-operative depression was associated with consequences, post operatively
10% was explained by control and consequences. Furthermore at 9 months post-
operative depression was positively predicted by cause (wear and tear) and
lower expectations of surgery, accounting for 8% of the variance in depression.
Anxiety
The most commonly used measure of anxiety was the HADS anxiety sub-scale
(described above). Associations between HADS anxiety and illness
representations were assessed in twelve studies, exploring a variety of
conditions: lBS (Holt et al, 2002, Rutter et al, 2002, Rutter & Rutter, 2002), CFS
(Edwards et al, 2001, Pope & Woodcock, 2001) psoriasis (Fortune et al, 2002,
Scharloo et al, 2000a), RA (Scharloo et al, 1999, MS (Jopson & Moss-Morris,
2003), prostate cancer (Watters, 2001) and MND (Earil et al, 1993). All but one
of these studies (Watters, 2001) found significant associations between illness
representations and anxiety, but there was less consistency in terms of which
components were associated with representations, and how much variance
could be explained by these factors once patient and illness-related variables
had been controlled. Cross-sectional studies are examined first.
There was some consistency in the two cross-sectional studies that assessed
patients' representations of lBS. Anxiety was associated with serious
consequences in both studies (Hoilt et al, 2002, Rutter & Rutter, 2002). In a large
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study consequences, identity and emotional cause explained 36% of the variance in
anxiety scores (Holt et al, 2002).. Another study using path analysis
demonstrated that, consequences and psychological cause explained 41% of the
variance in reported anxiety (Rutter & Rutter, 2002) (however, this result was
mediated by coping variables) coping variables.
A number of illness representations were associated with anxiety in patients
with CFS (Edwards et al, 2001, Pope & Woodcock, 2001). Edwards et al
reported that consequences, identity, control and a belief in an emotional cause
were significantly associated with anxiety explaining 30% of the variance in
anxiety scores. However, the authors did not control for demographic or
disease severity variables in this cross-sectional study. Pope and Woodcock
(2001) also demonstrated that a belief in depression as a cause of CFS was
associated with anxiety. In psoriasis patients Fortune et al (2002) reported that
illness representations (consequences and emotional cause) explained 32% of
pathological worrying and identity and belief in emotional causes explained 28%
of the variance in HADS anxiety alter controlling for age, gender and clinical
history.
Illness representations also explained significant proportions of the variance in
anxiety scores in both patients with MS. Illness representation variables
(particularly identity, cyclical time-line and coherence) explained 23% of the
variance in anxiety, after controlling for age and illness variables (Jopson &
Moss-Morris, 2003. Finally, significant associations were also found in motor
neurone disease (Earli et al, 1993), but not in patients a very small sample
(n=17) of patients with prostate cancer (Watters, 2001).
Looking at prospective studies, Rutter et al's (2002) study of lBS patients
demonstrated that perceived consequences was positively correlated with
anxiety and confirmed findings from cross-sectional work (Rutter & Rutter,
2002; Holt et al, 2002). However, the findings of Fortune et al's (2002) cross -
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sectional studies were not replicated prospectively in Scharloo et al's (2000a)
study of patients with psoriasis. Moreover, no relationship was found between
baseline illness representations and anxiety 12 months later. In patients with
RA, anxiety was predicted prospectively by consequences and time-line beliefs
which were measured one year previously (Scharloo et al, 1999); these
constructs explained 10% of the variance in anxiety alter controlling for illness
duration, severity, coping and previous anxiety scores.
Other measures of psychological well-being
Six further scales were employed to examine the relationship between illness
representations and psychological morbidity: the Mental Health Inventory
(MHI; Veit & Ware, 1983) in patients with epilepsy (Kemp et al, 1999); Arthritis
Impact Measurement Scale in RA (Orbell et al, 1998), health distress in MI
patients (Weinman et al, 1996); the Profile of Mood States (Shacham, 1983) and
Daily Hassles Scale (Revised, Hoim & Holroyd, 1992) were used in patients
with schizophrenia (Talley, 1998); and the Affect Balance Scale (Derogatis, 1975)
was used in prostate cancer (Gonzalez et al, 2002a,b). Scores on all of these
scales were related to illness representations and there was some consistency in
terms of the extent of associations with well-being; five of these six studies
showed that psychological well-being was predicted by identity and/or
consequences. In the remaining study (Gonzalez, 2002a), illness coherence was
associated with better mental health.
Summary
In summary, depression measured with the HADS yielded inconsistent
relationships between illness representations and depression. The associated
dimensions appeared to be disease- and time-specific. Overall however,
consequences, followed by identity and cure/control appeared most important
with regard to their associations with depression. The CES-D scale also yielded
mixed findings but demonstrated some consistency with the HADS in that
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consequences and control dimensions were most frequently associated with levels
of depression.
Studies of anxiety yielded more consistent results. Anxiety, as measured with
the HADS was most frequently associated with beliefs regarding the
consequences, followed by psychological or emotional causes and perceived
symptoms (identity) of illness. In studies employing other scales, symptoms
(identity) and consequences appeared to be the most consistently associated with
levels of anxiety.
2.13. Discussion
This systematic review examined relationships between illness representations
and a range of clinical, behavioural and psychological outcomes in adults with
chronic disease. Since the development of the IPQ (Weinman et al, 1996, Moss-
Morris et al, 2002), there has been a proliferation of research employing this and
other questionnaires to investigate the predictive utility of the self regulation
model and illness representations framework. Therefore, the aim was to
provide a comprehensive and accessible review of the literature in order to
summarise developments thus far and to guide the research that constitutes this
thesis. In summarising this data the focus is on the main findings; the quality,
design and analysis of included studies; clinical implications of this research;
and the direction of ongoing and future work in this field.
Main findings and implications
Many studies examined anxiety and depression in chronic disease and this was
particularly true for arthritic conditions (Murphy et al, 1999, Orbell et al, 1998,
Scharloo et al, 1999, Schiaffino et al, 1998, Sharpe et al, 2001, Tomlinson, 2001).
The illness representation dimensions of identity and consequences appeared to
be consistently related to psychological morbidity suggesting that it is the
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perceived impact on lifestyle and the perceived symptoms that are the most
important determinants of psychological distress.
With regard to coping scales, perceptions of control were largely associated with
problem-focused strategies and may be considered consistent with the findings
of Hagger and Orbell (2003) where control beliefs were associated with active
coping and cognitive reappraisal. There was a general trend for perceived
consequences of illness to be associated with emotion-focused strategies as were
identity and control. It is suggested that the prospect of the debilitating
consequences of disease gives rise to coping strategies that serve to ameliorate
the emotional impact of the disease in question, such as the seeking of social
support. One may also expect beliefs regarding the control of disease to
encourage strategies that serve to engage the patient in dealing with their
illness with either problem- or emotion-focused strategies. However, due to the
paucity of prospective studies it remains unclear whether control beliefs
influence the uptake of these behaviours or whether the process of dealing
effectively with an illness serves to increase control beliefs.
With regard to the prediction of behavioural outcomes, there was little
consistency across disease groups for clinic attendance and cardiac
rehabilitation. However, for medication adherence perceived consequences was
a consistent predictor in hypertensive (Brewer et al, 2002) and haemophiliac
(Llewellyn, et al, 2003) patients. Finally, of particular relevance to the empirical
research undertaken in the present thesis, a range of behaviours central to the
management of diabetes were predicted by personal models of diabetes. This
was particularly true for the treatment effectiveness dimension which, for
example, predicted glucose monitoring (Skinner et al, 2002), physical activity
and dietary recommendations (Hampson et al, 1990, Glasgow et al, 1997,
Skinner et al, 2002).
Finally, quality of life outcomes particularly assessed by the SF-20 and SF-36
consistently related to perceived symptoms across many chronic diseases. In all
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cases, a stronger illness identity (e.g. more symptoms) was associated with
poorer outcomes on the SF-20 and SF-36.
Quality of studies, design and analyses
Firstly, considering the quality of the studies and data that comprise this review
it is apparent that the large majority (65%) of the studies adopted cross-
sectional designs. Clearly, this prohibits the determination of the direction of
causality between beliefs and outcomes. Furthermore, this is often
compounded by the employment of correlational, rather than multivariate
analyses. Although there were some prospective! longitudinal studies, follow-
up periods were limited to a maximum of 12 months, which may be inadequate
in studies of chronic disease. Of these prospective studies, none addressed the
dynamic nature of illness representations by examining within-patient changes
in representations over time. In addition, few studies examined differences
between patients with new and long-standing diagnoses and the way in which
illness representations may change over time (i.e. from diagnosis on).
Included studies were further limited by the reliance on self-report measures of
adherence to treatment regimens. This approach permits over- or under-
reporting due to failure of memory, understanding, or deliberate omission of
the truth and as such may bias the results. Taking medication adherence as an
example, when validated against objective measures such as pill counts or
biochemical methods, self-report is highly variable in terms of accuracy (Francis
et al, 1969). This has been observed across a range of therapies for chronic
conditions including medications for hypertension (Rudd et al, 1989) and RA
(Dunbar-Jacob,1993). However, studies that rely solely on clinical outcome
measures (e.g., blood pressure, HbAlc) as a proxy measure of adherence may
also be unreliable as a patients' condition may improve or deteriorate for a
number of reasons, only one of which may be adherence.
Bivariate correlational analysis was the most common approach with regard to
delineating associations between illness representations and outcomes.
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However, if both correlation and regression analyses were reported in primary
studies, only the results of the regression were extracted and presented in Table
2.2. Multivariate approaches were given more weight in this review as they
aim to control for confounding factors such as age and disease duration.
Percentage of explained variance was not reported in this review due to
inconsistencies in the use of regression models (i.e., demographic and clinical
control variables entered), and methods of reporting of these results between
studies. Furthermore, it is argued that results of studies controlling for disease
severity are more robust as patients' representations of a disease may be greater
than the sum of the illness itself and subsequently may be more important in
terms of determining disease related outcomes. A further point is the difficulty
in determining the consistency of results emerging from the employment of
different measures to elicit illness representations such as dimensions of the
IPQ and PMDI. The same is also true of the measurement of some outcomes
such as depression. For example, we cannot be sure that responses to the
HADS-D are equivalent to that of the CES-D. The considerable range of chronic
diseases comprising this review adds to the generalisability of the findings, and
utility of this review. However, such diversity also restricted possible
comparisons made between the studies.
One disease in which there was a degree of consistency across studies was
diabetes; particularly studies employing the personal models approach to the
disease. However, it is emphasised that studies employing the PMDI were
authored by the members of the same research team and were often consistent
regarding the selection of study outcome measures. It is clear that treatment
beliefs and the perceived seriousness of the condition are important predictors of
a range of self-care behaviours in this disease.
Another finding of this review was that causal attributions were not
consistently operationalised across studies, and of all the illness representation
dimensions, were least likely to be significantly related to the outcomes
examined in this review. Jt is possible that the arbitrary selection of causal
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items and differing methods of aggregating causal beliefs (i.e, factor analysis,
'external' v 'internal cause) may have contributed to this observation.
Limitations of the review process
Although a thorough literature search was employed, it is possible that some
relevant material may have been missed. Although every effort was made to
contact authors for relevant papers and data, not all responded to these
requests. The included literature provided a wealth of data and it was not
feasible to include all of this in the review. Indeed, the focus was solely on
significant associations between representations and clinical, behavioural and
psychological outcomes. This strategy highlights problems of publication bias.
It is of note that many studies failed to find significant relationships between
illness representations and outcomes of interest. Compounding this bias, is the
well-documented notion that such studies are less likely to have been submitted
for publication, or indeed accepted.
The Ji ture of illness representations research
This review clearly demonstrates the wealth of data on illness representations
in chronic disease. The five 'core' dimensions feature prominently in these
studies and have been useful in predicting pertinent outcomes. The emergence
the IPQ-R has already made a contribution in expanding the illness
representations framework beyond these five dimensions. Indeed, emotional
representations, personal control, cyclical time-line and illness coherence appear to
play a role in health behaviours and outcomes in a range of disease groups such
as rheumatoid arthritis (Tomlinson, 2001), multiple sclerosis (Jopson & Moss-
Morris, 2003), HIV (Home et al, 2000), and prostate cancer (Gonzalez, 2002a,b).
Thus the application of the IPQ-R should be encouraged in further studies.
However, although the IPQ and PMDI have demonstrated efficiency and
practicality with regard to the assessment of illness representations it is
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questionable to what extent they capture the true nature of living with a chronic
disease. For example, the summing of items relating to the perceived
consequences of living with a chronic condition may be viewed as a superficial
assessment of what may be a complex experience. It is likely that the
experience of living with a disease is a dynamic process that is inter-dependent
on the extent of perceived and actual control the patient has. This experience
may not be adequately captured in the form of a questionnaire. Furthermore, it
is suggested that patients may have a more sophisticated or philosophical
understanding of what their illness means to them and to others around them.
To date there has no attempt to determine which aspects of living with a
chronic disease are the most debilitating to the patient from a psychological
perspective. It is argued that these issues may be clarified if patients were
given the opportunity to rate how important particular perceived consequences
are to them rather than suniming items within a global scale (i.e., financial
consequences may only be relevant to a patient if the illness had left them
unable to work).
The SRM proposes that emotional responses to chronic illness are processed in
parallel to illness representations which in turn give rise to problem-focused
and emotion-focused coping strategies (Leventhal et al., 1984). However,
studies examining the role of coping in relation to illness representations should
consider a distinction between coping 'style' (i.e. dispositional, trait) and
'strategies' (i.e., situational, specific). This issue concerns Leventhals' original
illness representations framework in which coping was conceptualized in a
more literal sense; i.e., patients' behaviours in adjusting to a disease. Indeed,
there is a tendency for researchers to misinterpret this definition of coping and
have duly conceptualized coping in terms of general styles rather than specific
behaviours with the application of measures which have derived from the
stress and coping literature (Lazarus & Folkman, 1984). For example, with
particular reference to the COPE, it is important to state that Carver et al (1989)
describe the assessment of both dispositional and situational coping. Whereas
the intention of the authors of the Utrecht Coping List (Schreurs et al, 1993) was
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to develop a scale that assesses coping as a (personality) style rather than more
general strategies. However, the original findings of Carver et al suggest that
both personality traits and coping dispositions play a role in situational coping
and may, therefore, be complementary in nature rather than competing. The
interpretation of coping within the illness representation framework may in
part explain why coping does not consistently mediate outcome in chronic
disease.
It is thus argued that measures that are more akin to coping 'strategies' are
more in keeping with the illness representations framework, but it may still be
more appropriate to focus on coping in terms of specific behaviours (i.e.,
adherence to medication or diet). Finally, appraisal of coping behaviours is a
neglected 'stage' of the SRM. Indeed, a patient may evaluate the efficacy of a
chosen coping strategy which, if perceived as ineffective, may serve to elicit an
alternative strategy or may result in a change of the representation of the illness.
Therefore, more consideration should be given to emotional responses and
appraisal in future research.
The results demonstrate that patients' representations can influence factors
concerned with long-term health. Such evidence endorses the need to examine
the amenability of changing illness representations to improve patients'
physical and psychological adaptation to disease. Indeed, positive changes in
illness representations following MI were demonstrated in a randomised
controlled trial (Petrie et al, 2003). Thus illness representations may represent
important and modifiable factors for intervention in patients with chronic
disease.
Of particular relevance to the present thesis is the emergence of studies which
examine the role of illness representations in significant others. For example,
studies have examined differences between patient and spouses (Heijmans et al,
1999, Figueiras & Weinman, 2003), and between mothers and adolescents
(Urquhart-Law, 2002). There is clearly a need to consider the congruence
between the beliefs of patients and their health care providers as these
discrepancies and! or similarity may prove important determinants of health
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outcomes and satisfaction. The second part of this chapter examines the small
body of literature that addresses these issues in detail.
To conclude, this systematic review has identified a growing body of literature
that has assessed the predictive utility of illness representations framework
with patients with chronic disease. The results suggest that the
operationalisation of the SRM with measures such as the IPQ and PMDI have
proved useful in predicting psychological, behavioural and clinical outcomes in
a wide variety of chronic diseases. This, and ongoing research, illustrates the
success and future potential of the self-regulatory model in understanding how
patients make sense of their illness. Finally, with regard to coping behaviours,
the SRM may be valuable in improving both adaptation and long-term
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2.14. Illness representations and significant others
The first part of this chapter systematically reviewed the literature examining
the role of illness representations with regard to clinical, behavioural and
psychological outcomes in chronic disease. However, recent developments in
the application of the self-regulatory model of illness behaviour have been
directed at exploring the relationship that significant others such as partners, or
other carers of patients with chronic disease, have on disease outcomes.
Weinman et al. (1996) suggest that it may be equally important to focus on
perceptions of the spouse and other key 'caregivers' to obtain new insights into
the role of partners or carers in the patient's recovery process. It is this small,
but growing, literature that is examined in the narrative review that follows.
Significant others and chronic disease
Little is known about how social interactions affect patients' views about
chronic disease and their corresponding health behaviours. However, research
suggests that not only the supportive interactions themselves but also the
beliefs held by people within a patients' social network may influence the
patients' illness representations and health related behaviour (Heijmans et al,
1999). Empirical support for this assumption has been provided by Croyle and
Hunt (1991), who found that individuals may even rely on a relative stranger
when attempting to evaluate the seriousness of an ambiguous health threat.
Although spouses generally appear to be the most important source of
'emotional' and 'instrumental' support for many patients with chronic disease
(Thompson and Pitts, 1992), it is obvious that patients' and spouses' ideas about
an illness may diverge. In comparing patients' and spouses' illness
representations it is possible that differences between patients' and spouses'
illness representations might go in two directions. For example, spouses may
minimise the seriousness of their partners' disease, by playing down the
complaints and consequences of the illness or by exaggerating the possibility for
cure. Conversely, spouses may exaggerate the seriousness of the disease and
become overprotective.
Accordingly, expression of maximisation or overprotective behaviour by the
spouse has been found to negatively affect patients' well-being (Thompson &
Pitts, 1992). It may also favour sick-role behaviour on the part of the patient
and leads to negative consequences for the patient such as increased
dependency, lowered competence, and depression (Nerenz & Leventhall, 1983;
Thompson & Pitts, 1992). However, the magnitude of the effects of
'minimisation' or 'maximisation' by the spouse may be moderated by factors
relating to the disease itself such as its symptoms, course and how amenable it
is to treatment in addition to the quality of the patient-partner relationship.
Dissimilarity in patients' and partners' illness representations
Heijmans et aL (1999) investigated whether differences in illness representations
expressed as either 'minimisation' or 'maximisation' of the disease by the
spouse affects the patients' coping behaviour and adaptive outcome in 52
patients with Addison's disease (AD) and 49 patients with Chronic Fatigue
Syndrome (CFS). The two diseases were selected by the authors as they share
similar symptomatology but differ in their aetiology. AD is characterised by
adrenal insufficiency resulting in symptoms of fatigue, weakness and weight
loss. However, AD can be adequately managed by medication. Chronic
Fatigue Syndrome resembles AD in its most important symptom, debilitating
fatigue. However, CFS patients have to cope with an illness for which there is
no diagnostic test or effective treatment.
In this study the authors measured patients' and spouses' beliefs using the 5
'core' dimensions of illness representations; identity, time-line, consequences,
control/cure and cause. Illness identity was measured with a 20-item symptom
list considered typical for CFS and AD, these included 12 symptoms taken from
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the original IPQ and 8 items central to the medical definitions of the respective
illnesses. Internal reliability for the identity scale was 0.75 for both diseases and
patient-partner dyads. The cause dimension was measured by 15 items related
to the possible causes of the illness. Factor analysis with varimax rotation
identified three scales referring to a belief in a 'biological' cause (virus, flu,
immune dysfunction), a 'psychological' cause (stress, personality, depression)
and an 'environmental' cause (chemicals, malnutrition, pollution). Together the
three scales explained 52% of the variance and yielded good reliability (a =
0.70). Internal reliability for the consequences (5-items) scale was also good for
both diseases and patients and spouses (a 0.70). The time-line scale (3-items)
had lower reliability for CFS patients and their spouses (a = .059 and a = 0.58)
but was satisfactory for AD patient and their spouses (a = 0.70). Finally, the
reliability of the control/cure scale (2-items) was satisfactory for CFS patients and
their spouses (a = 0.70) but less so for AD patients and their spouses (a = 0.54
and a = 0.63).
The quality of the marital relationship was measured from the perspective of
the patient with three scales assessing 'satisfaction', 'burden on the spouse', and
'social support'. Coping was assessed with the Utrecht Coping Questionnaire
(Schreurs et al., 1993) using the problem-focused, emotion-focused and
palliative coping sub-scales. Adaptive outcome was assessed with the Short-
Form Health Survey (Ware & Sherbourne, 1992) with specific reference to the
Physical and Social Functioning, Mental Health and Vitality scales.
Both the CFS patients and AD patients reported high levels of satisfaction with
their marital relationship but felt differently about the burden their illness
created for their spouses. The CFS patients believed their spouses were less
accepting of their illness and as a consequence criticized their management of
the illness. They also differed in the extent to which they felt supported by their
spouses with the CFS patients being less happy than the AD patients in this
regard.
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No significant differences were found between mean scores for the CFS patients
and their partners on the identity, control/cure, or cause dimensions. At a group
level patients with CFS and their partners appeared to agree on the identity of
the illness and possibility for cure. There was also some agreement regarding
the cause of the condition with both parties predominantly believing in a
'biological' cause. However, there were differences with regard to the
consequences and time-line dimensions. Indeed, compared with partners,
patients perceived more consequences of CFS but believed their illness would
improve in time. The AD patients were more optimistic about the course of
their illness than their partners and were more convinced that they could
control it either by treatment or their own behaviour. The partners of AD
patients rated the consequences of the illness more seriously than patients.
Scores of dissimilarity were calculated for the illness representation dimensions
for each dyad by subtracting the partner's score from the patient's score. This
procedure provided a continuous variable that describes the direction of
difference from the spouses' framework (i.e., as 'maximising' or 'minimising'
relative to the patients' ratings). In general, the dyads held similar views with
regard to the dimensions of illness identity and cause but disagreed on the time-
line, control/cure and consequences of the illness. However, the partners of CFS
and AD patients held more pessimistic views with regard to the time-line of the
illness than patients themselves. They were also shown to think differently
from the patients with regard to symptoms, consequences and possibilities for
cure of the illness. For example, the partners of patients with CFS were inclined
to 'minimise' the seriousness of the illness on these dimensions, while the
partners of patients with AD had a tendency to 'maximise' or exaggerate the
seriousness of the disease.
More specifically, for patients with AD, minimisation of the possibilities for cure
by the partner explained 26% of the variance in palliative coping. For patients
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with CFS, 'minimisation' by the partner regarding consequences, a belief in
environmental factors as a cause and a more pessimistic time-line, accounted for
32% of the variance in palliative coping. Patients' and partners' illness
representations were more predictive of adaptive outcome when dissimilarity
was high, when the partner had a more pessimistic belief about the time-line of
AD, and with patients exhibiting higher scores on the Physical and Social
functioning, Mental Health and Vitality scales. For patients with CFS,
minimisation of the symptoms of illness and the partners' attributions of
psychological and environmental factors as causal agents resulted in more
problems in psychological adjustment.
In summary, minimisation of the seriousness of the disorder by the partner was
found to have a negative impact on adaptive outcome, although this
observation varied between the dimension of the illness representation and the
type of illness.
Patients and spouses causal attributions of myocardial infarction
Weinman et al, (2000) examined attribution (perceptions) of cause in first time
MI patients and their partners to examine how such attributions related to
changes in patients' health behaviours (diet, exercise, and smoking) 6 months
later. It was postulated that the process of searching for a cause of the illness
was not limited to patients but also common in spouses and others close to the
patient (Taylor et al, 1984). Studies examining the attribution of spouses
following MI have found a similarity between the types of attributions made by
both spouses and patients (French et al., 2001). Many studies in the cardiac area
have highlighted the importance of the patient's spouse in the recovery phase
and in longer-term progress (Taylor et al., 1984). Turnquist et al., (1988)
proposed that people who make more attributions are more likely to be
distressed. Hence, Weinman and colleagues investigated the number of causal
attributions held by patients and spouses, and whether these were related to
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their perceptions of the severity of the MI and their spouses' fear of a further
MI.
Patients and their partners (n=143) were presented with a list of 24 possible
causes for their /partners' MI. Patients and their spouses also completed
subjective self-ratings of their own /their partners' health compared to a person
in excellent health, and spouses were also asked to rate how afraid they were
that there partner would have another heart attack in the next year.
The results of the study demonstrated that causal attributions are important
predictors of subsequent changes in health behaviour following MI. The
majority of MI patients made significant changes in their health behaviours.
For example, patients who believed their MI was caused by poor health habits
were more likely to make changes in their diet than those who believed their MI
to be caused by 'stress' or 'hereditary' factors. It was also demonstrated that
spouses' attributions about the MI being caused by poor health habits were the
most important factor in improvements in levels of exercise at 6- month follow-
up. Furthermore, the number of attributions varied as a function of the
perceived severity on the part of the patient and greater anxiety on the part of
the spouse regarding the occurrence of a further MI. However, objective
markers of severity (peak creatinine phosphokinase level and length of hospital
stay) were not related to the attributions made by the patient or spouse.
Partners representations and recovery from myocardial infarction
In a further examination of the role of illness representations in spouses of
patients with mycocardial infarction, Figueiras and Weinman (2003) examined
whether similar patient and spouse perceptions were predictive of recovery. A
total of 70 patient-partner dyads recruited from a Lisbon hospital completed a
Portuguese translation of IPQ at 3-months after discharge from hospital. A
reworded version of the measure was used to assess the spouses' perceptions of
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the patient's MI. The perceived identity of MI was assessed with a list of 15
general symptoms yielding alpha coefficients of 0.83 and 0.73 for patients and
partners, respectively. The internal reliability of the consequence (7-items) scale
was 0.73 and 0.73, and control/cure (8-items) with aiphas of 0.62 and 0.73 for
patients and spouses, respectively. Perceived time-line was assessed with one
item.
Recovery was assessed at intervals of 3, 6 and 12 months post MI using
standardised measures taken from the medical outcome study and using some
of the items from the Portuguese SF-36 (Ferreira, 2002, a, b) including 'physical
disability', the 5-item mental health index (Viet and Ware, 1983), the 'vitality'
scale of the MOS energy-fatigue scale (Stewart et al., 1988). In addition, scales
from the sickness impact profile assessing social activities and recreations were
completed along with a measure of eating behaviour assessing seven dietary
items (fried food, bran, salt sugar, red meat, fruit and breakfast). Finally,
marital functioning was assessed with appropriate items from the MOS
(Sherbourne and Kamberg, 1992) to assess the quality of the relationship with
their spouse during the previous 4 weeks.
A comparative patient-partner score was developed which attempted to take
account of not only the degree of similarity of their perceptions but also the
relative level (i.e., high / low) of the scores on each dimension of the IPQ.
A classification system based on the median score for each group (patient,
partner) was devised to identify the extent that an individual's illness
perception was broadly positive (e.g., above the median group score on control)
or negative (below the median). Thus patients' and partners' scores on each of
the four dimensions (identity, consequences, time-line and control) were recoded
according to the median split for each variable. Therefore, scores for patients
and partners that fell below the median for each respective group were coded
'0' and scores above the median were coded '1'. Three broad groupings were
then derived; (1) 'similar positive' perceptions (where both patient and partner
score is '0' for identity, consequences and time-line and both score '1' for control),
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(ii) 'similar negative' perceptions (where patient and partner both score '1' for
identity, consequences and time-line and both score '0' for control), finally (iii)
'conflicting' perceptions were where patients and partners had conflicting
scores (patient scores '1' partner scores '0' or vice versa).
The highest percentage of couples with similar 'positive' perceptions were
found on the identity, time-line and consequences dimensions of the IPQ whereas
a greater frequency of similar 'negative' and conflicting perceptions were found
on the control/cure dimension. Patients' recovery from MI was favoured in
dyads with similar 'positive' perceptions of identity and perceived consequences,
compared with dyads with similar 'negative' or 'conflicting' perceptions. The
patients from dyads with similar 'positive' perceptions of identity and perceived
consequences of MI reported lower levels of disability and less sexual problems,
higher vitality, less health distress, better psychological adjustment, and less
impact of MI on recreational and social activities. On the basis of these results
the author's assert that various aspects of recovery from MI are associated with
the degree of congruence between patients' and spouses' perceptions of MI.
Dissimilarity of adolescent and maternal representations of diabetes
Urquhart-Law (2002) examined dissimilarity in adolescent and maternal
representations of type 1 diabetes with regard to adolescent well-being. The
study was undertaken in the absence of explanatory models by which the
family may influence a child's or young person's adjustment to illness. Indeed,
little is known about how illness representations form and how social
interactions affect patients' beliefs and subsequent behaviours. In this context,
it was suggested that the mechanisms by which parents influence their child's
chronic illness is by influencing or shaping illness representations and health
related behaviour (Lau et al, 1990).
A sample of 30 adolescents aged between 13 and 19 years (Mean = 15.5 years)
with a diagnosis of type 1 diabetes were recruited to the study along with 26
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mothers (mean age 43 years). The IPQ-R was used to elicit illness
representations with the addition of items to three sub-scales; identity,
consequences and emotional representations scale. Wording on the maternal IPQ-R
was based on the advice of the original authors (i.e., 'my diabetes....' was
replaced with 'my son/daughter's diabetes. Psychological well-being was
assessed with a 22-item self-report measure developed specifically for diabetic
populations consisting of four sub-scales measuring depression, anxiety,
positive well-being and perceived energy (Bradley, 1994).
The adolescents perceived their diabetes to be chronic with high levels of
personal control over their illness. They also demonstrated positive beliefs
regarding illness coherence and emotional representations of diabetes. Maternal
representations were broadly similar but mothers were likely to perceive more
severe consequences and a greater emotional representations. Scores of
dissimilarity were computed for each adolescent-mother dyad by subtracting
the mother's score from the adolescents score. This procedure created a
continuous variable describing the direction of difference from the mother's
framework, (i.e., as either 'maximising' or 'minimising' relative to the
adolescent's ratings). Mothers had a tendency to maximise the seriousness of
diabetes on a number of dimensions; they reported worse consequences, less
illness coherence, greater emotional representations, and greater variability in the
course of their son/daughter's diabetes. They also perceived adolescents as
having enhanced personal control over their illness. There were no correlations
between the illness representation dissimilarity scores and adolescent well-
being.
Due the cross-sectional nature of the study it is not possible to determine the
process of mutual influence over time. This would have assisted in delineating
the dynamic interplay between the illness representations of mothers and
adolescents. In addition, it is not possible to determine whether adolescent
representations were more strongly guided by maternal beliefs or vice versa.
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Equally plausible is the option that each is influenced by some other source
such as paternal or peer representations. Finally, the small sample size limited
the power and ability to detect differences between adolescents' and mothers'
representations. Nonetheless, the study has shown how adolescents' and
mothers' representations may converge or diverge in relation to diabetes.
Illness representations in carers of stroke victims
Studying the illness representations of spousal caregivers may contribute to
understanding how spouses cope with caring for a chronically ill partner and
discovering if and how the quality of life of spouses is affected by their care-
giving responsibilities.
Illness representations were assessed in a cross-sectional investigation of the
determinants of distress in 86 primary carers of people with non-acute and non-
aphasic stroke (McClenahan and Weinman, 1998). The carers primarily
consisted of spouses. In addition, 53 patients with left hemisphere CVA with
aphasia and 33 patients with right CVA and no aphasia participated in the
study. The IPQ was adapted specifically to assess the carer's perception of the
stroke. This amended version was then factor analysed for subsequent
analyses. In addition, a range of other constructs relating to self-efficacy social
support, and coping were assessed.
Distress in carers was assessed with the General Health Questionnaire 12 (GHQ
12; Goldberg, 1992), a screening measure designed to detect psychological
distress in non-clinical populations. In order to assess whether carer distress
was related to dispositional factors including illness representations a series of
correlations were conducted between these measures. For illness
representations only the time-line dimension was related to distress scores. The
time-line variable was then entered into a regression analyses alongside other
correlated constructs such as self-efficacy and coping variables. In total the
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independent variables explained 45% of the variance in distress experienced by
carers.
Illness representations in carers of patients with Huntington's disease
In a cross-sectional study, Helder et al (2002b) examined representations of
spouses of patients with Huntington's disease (HD) with regard to their quality
of life and coping mechanisms. A total of 90 spouses (54% female) were
assessed with an adapted version of the IPQ. Spouses were asked to report
their views with regard to the patients' HD. A further amendment was made to
the control sub-scale by dividing it into two separate scales; cure and control.
The internal reliability coefficients of the scales reached 0.66 and 0.83,
respectively. The consequences and time-line sub-scales from the IPQ were
utilised in their original form with reliability coefficients of 0.63 and 0.81,
respectively. Finally, with regard to identity, spouses rated how often the
patient with HD experienced a list of 19 somatic symptoms on a 4-point scale
ranging from 1 (never) to 4 (all the time), yielding an internal reliability
coefficient of 0.86. The coping mechanisms of spouses were assessed with
COPE (Carver et al, 1989) and quality of life was assessed with the MOS SF-36
(Ware & Sherbourne, 1992).
The results showed that spouses scored highly on the identity sub-scale of the
IPQ. In addition, they perceived HD as having a long time-line, with negative
consequences without much possibility for a cure or control of the symptoms. All
spouses, with the exception of two, attributed HD to a genetic cause.
Correlational analyses showed that the more seriously the illness was perceived
by the spouse in terms of the number of symptoms (identity and time-line) the
less the spouse was inclined to use 'denial' as a coping strategy. The spouses
perceived the control that patients had over their disease was related to the
adoption of 'restraint' coping activities. Finally, the more spouses believed in a
cure for HD the less they focused on and vented their emotions as a way of
coping with the disease. However, when demographic and disease-related
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variables were controlled in regression analyses, none of the IPQ variables
explained variance in quality of life. The way in which spouses of patients with
HD perceive HD seems not to influence their own quality of life. The authors
suggest that this measure of illness representations was possibly too global as
spousal representations were not assessed with regard to the specific
consequences of living with and caring for a partner with HD.
Illness representations in carers of patients with Alzheimer's disease
Roberts and Connell (2000) utilised the illness representation framework among
first-degree relatives of people with Alzheimer's disease. Illness
representations were assessed with scales developed for the study rather than
using existing scales such as the IPQ. The scales assessed beliefs regarding
knowledge, causes, treatment, distress, and threat of Alzheimer's disease and were
refined in a pilot study of 200 individuals. Of the 203 participants, 75% were
female and 73% were married. The results demonstrated that participants were
better informed about AD than the general public. With regard to cause,
participants rated genetic factors as the most important cause of Alzheimer's
which is consistent with conventional medical wisdom. However, 34% of
participants endorsed beliefs in potential environmental factors such as
diet/lifestyle and mental inactivity as a possible cause suggesting some belief in
personal control over the onset of Alzheimer's. Further, a third of carers
believed that God's will was very important in the development of the disease.
With regard to treatment beliefs, 65% of participants believed that there would
be a cure in the next 5 years. The distress experienced through having a relative
with Alzheimer's manifested itself in the form of 'intrusive thoughts', 'intense
emotions' and 'intrusive imagery' and a quarter reported sleep difficulties. A
significant number considered that they were somewhat (40%) or very likely
(35%) to develop Alzheimer's in the next 5 years. However, only 34.5%
reported that they were more concerned about Alzheimer's than any other
medical problem. Finally, more than 75% of participants reported that both the
emotional and financial consequences of developing Alzheimer's would be at
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least very stressful, with a quarter of respondents anticipating such an outcome
would be overwhelmingly stressful for them and their families.
Illness representations in carers of patients with Schizophrenia
In a departure from the literature considering chronic physical disease
Barrowclough et al. (2001) investigated models of illness in carers of patients
with schizophrenia. The rationale for this study was to assess how the carer's
response to the patient's illness mediates illness outcome in schizophrenia.
A total of 47 carers were recruited into the study, of these 53% were parents,
28% were spouses, 11% were siblings and the remaining carers were either
children of the patient (4%) or had another relationship with the patient (4%).
Most carers were female (68%) and living with the patient.
Carers' representations of schizophrenia were assessed with a modified version
of the IPQ to accommodate the nature of schizophrenic illness and to examine
the impact of the patients' illness from the perspective of the carer. First, the
identihj sub-scale of the IPQ was replaced with the 'Family Questionnaire'
(Barrowclough & Pane, 1997). This scale lists 45 problems associated with
schizophrenic illness. The carer was asked to rate these problems on three
scales; 'frequency', 'coping' and 'concern'. The time-line dimension was
modified to capture the fluctuating or episodic nature of the illness (2 items, a=
0.60) as well as including the original IPQ version to focus on the chronicity of
the illness (3 items, c= 0.53). Additionally, to assess the consequences and
con trol/cure dimensions from the carers' perspective, two additional scales
containing 'parallel' items were included (consequences-relative (x
	
78) and
control/cure-relative (a= 0.61). For example, the parallel item for 'Their illness
has major consequences on their life' was 'Their illness has had major
consequences on my life'. Finally, as it was the carers' rather than the patients'
representations that were assessed, minor modifications were made to the
wording of all items of the sub-scales (e.g., 'my illness' became 'their illness'.
The internal reliability of the modified IPQ was considered acceptable with
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reliability coefficients of 0.68 for control/cure (6 items) and 0.71 for consequences
(7-items). Additionally, test-retest reliability at 2 weeks using a sub-sample of
16 participants demonstrated significant positive correlation's for all sub-scales
(p <.01) with consequences being the most stable dimension.
Carer functioning was assessed with the GHQ (Goldberg, 1978), the Beck
Depression Inventory (BDI; Beck 1988) and the distress sub-scale of the Social
Behaviour Assessment Schedule (SBAS; Platt, 1985). Symptom severity in
patients was assessed with the Positive and Negative Syndrome Scale (PANSS;
Kay et al, 1989) and social functioning with the Social Functioning Scale (SFS;
Birchwood et al, 1990, using the carer as the informant. Finally, general
functioning was assessed with the Global Assessment Scale (GAS; Endicott et
al, 1976).
Correlational analysis demonstrated that greater perceived negative
consequences for the patient was associated with a higher psychological
morbidity in the carer. Perceived negative consequences was also consistently
associated with adverse carer outcomes including higher psychopathology,
depression and subjective burden. Problems relating to the symptoms of
schizophrenia were associated with higher scores for carer distress. The
dimensions of con trol/cure and control/cure-relative were not associated with any
carer outcome measures. Analysis was also conducted to determine if carer
representations were associated with functioning in the patients. A different
pattern of associations emerged from that seen with carer functioning analyses.
There were no associations between patient functioning and perceived
consequences of the illness. However, the chronic time-line and the identity-
symptom scores were associated with patients' illness characteristics. For
example, a longer time-line was associated with a longer duration of patient
illness, a higher PANSS score, and lower scores on the GAS (indicating less
adaptive functioning) and the social functioning scale. Similarly, a greater
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number of symptoms were associated with a higher PANNS score and poorer
social functioning.
The findings demonstrate that links exist between illness representations and
assessments of carer and patient outcomes. While there were significant
associations between measures of the illness characteristics and carers'
perceptions of illness identity and time-line, the consequences and con trol/cure
dimensions showed no association to the measures. The well-being of carers
was mainly related to perceptions of the magnitude of the consequences of the
illness for themselves. The authors suggest that the components of illness
representation found to be important in models of physical illness cannot be
assumed to be important in mental illness-there may be other dimensions of
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The findings of the studies reviewed in the second part of this chapter suggest that
the study of illness representations of patients and significant others may be
particularly fruitful for understanding how illness beliefs develop in the social
context. In particular, the findings demonstrate how differences in the beliefs of
significant others and patients influence psychological adaptation to chronic
disease (Heijmans et al, 1999; Figueiras & Weinman, 2003, Urquhart-Law, 2002)
and behavioural outcome (Weinman et al, 2000, Figueras & Weinman, 2003). This
limited evidence suggests that the illness representations and causal attributions of
partners of chronically ill individuals are influential in adaptation to chronic
illness. In addition, there are a number of studies that have solely examined the
representations of carers, relatives arid spouses' of individual's with chronic
disease in relation to their own well-being rather than the their impact on the
patient (Helder et al, 2002b, Roberts & Connell, 2000, McClenahan & Weinman,
1998).
Approaches in measuring the representations of significant others
The studies reviewed here have, largely, adapted the original Illness Perception
Questionnaire as a means of measuring the illness representations of significant
others (Heijmans et al, 1999, Figueiras & Weinman, 2003, Helder et al, 2002b,
McClenahan & Weinman, 1998, Barrowclough et al, 2001). In general, studies
utilising this approach have used a re-worded version of the measure to elicit the
partners perceptions of the patients illness. Support for the validity of this
approach to assess the representations of significant others is provided by the
reporting of generally comparable internal reliability coefficients (Heijmans et al,
1999, Figueiras & Weinman, 2003, Barrowclough et al, 2001, Helder et al, 2002b).
To date, only one study has utilised the revised version of the IPQ in this regard
(Urquhart-Law, 2002). However, this study has shown the importance of
differences in the new scales illness coherence and emotional representations between
adolescents with type 1 diabetes and their mothers.
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A further issue arising from this review is with regard to Barrowclough et al's
(2001) study and the extent that a patient is to blame for the onset or exacerbation
of a disease is perceived by the partner. As Leventhal et al. (1984) suggest that the
importance of different aspects of the representation will vary depending on the
nature of the illness. An important omission in the IPQ in this context is beliefs
about how 'blameworthy' the patient is for failing to exert more control over
his/her symptoms. Indeed, attributions of control measured in the modified IPQ
explore general beliefs about the carers' perceptions of the amenability of the
illness to be controlled rather than specific 'patient blame'. Clearly, perceptions of
blame have implications for physical disease with aetiology relating to a patients'
lifestyle such as diabetes or CHD.
Representations of significant others and outcomes in chronic disease
The studies conducted assessing the illness representations of significant other
have generally looked at issues relating to patients' adaptation to disease such as
coping, physical and social functioning, quality of life (Heijmans et al, 1999, Helder
et al, 2002b, Figueiras & Weinman, 2003) and well-being (Urquhart-Law, 2002).
The assessment of behavioural adaptation to a diagnosis of chronic disease may be
particularly pertinent as health behaviours may be viewed as a coping response
that is influenced by the illness representations of significant others. To date only
two studies have examined the relationship between representations of significant
others and health behaviours (Weinman et al, 2000, Figueiras & Weinman, 2003).
However, these studies demonstrated that the representations of significant others
play an important role in recovery from MI and therefore may be important in
other 'lifestyle' diseases such as diabetes.
Directions forfu ture research
The findings of the reviewed studies demonstrates that the assessment of illness
representations of significant others provides a useful insight into the influence of
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a patients' social context on disease. That said, the studies examining the
representations of significant others are few and share little commonality with
regard to methodology. Therefore, there is a need for the further examination of
the interaction of dyadic representations if the phenomenon is to be more clearly
understood. This raises a number of issues that need to be addressed in future
work in this context.
First, there is no consensus as to how 'dissimilarity' in patients' and partners'
illness representations should be measured or how to utilise differences with
regard to predicting patient or disease outcomes. Second, the lack of prospective
studies examining the illness representations of significant others does little to
delineate how illness representations of dyads develop in response to a diagnosis
of disease. Therefore, longitudinal studies are required to delineate the magnitude
of the influence of the spouse or partner with regard to adaptation to a diagnosis of
chronic disease and relevant health behaviours. In addition, there is scope for
studies to be conducted with individuals at risk of disease or before a diagnosis is
given. For example the illness representations of individuals with insulin
resistance and their partners could be assessed before the onset of symptoms. In
response to some of the issues raised, the present thesis will examine the illness
representations of patients; with type 2 diabetes patients and their partners'
employing a prospective design.
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CHAPTER 3: PROJECT STUDY
3.1. Introduction
The second chapter of this thesis examined the utility of the illness representations
framework in predicting behavioural, psychological and clinical outcomes in
chronic disease. Of particular relevance to the present thesis was the focus on
adherence to treatment recommendations in chronic illness and the extent that
illness representations play in predicting such behaviour.
This chapter introduces the research project conducted for the present thesis. The
project is an investigation into the role of 'significant others' in determining the
health behaviours of patients with type 2 diabetes. The chapter will provide
information regarding ethical approval, the recruitment of participants and the
study procedure. The rationale for the selection of both explanatory and outcome
measures is also described.
3.2. Self-management and the social context
Many factors can directly and indirectly influence disease management behaviour
and metabolic control of people with diabetes. In addition to individual variables
(biological and psychological factors), it is evident from the literature reviewed in
Chapter 1 that patients' health behaviours and subsequent glucose control is
influenced by transactions within the context of the family and the broader social
and cultural community. It is the influence of the immediate social environment
on self-management behaviour, namely 'significant others' (defined as the patient's
spouse or partner), that is the focus of the project.
3.3. The role of illness representations
A substantial body of quantitative investigations support an association between
the five dimensions of illness representation described by Leventhal and a range of
psychological and behavioural and clinical outcomes (Chapter 2). For example,
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illness representations have been found to be related to coping (Heijmans, 1998,
1999; Moss-Morris et al., 1996; Scharloo et al., 1998, 2000a, b), psychological
morbidity (Fortune et al, 2000, Murphy et al, 1999), functional adaptation or
adjustment to illness (Heijmans ,1998; Heijmans et al, 1999; Petrie et al., 1996;
Scharloo et al, 1998) and also adherence to a range of medical recommendations
(Cooper et al, 1999; Weinman et al, 2000). Additional investigations using the
Personal Models of Diabetes Interview (PMDI) demonstrated the applicability and
validity of representations of diabetes. This work has shown that the illness
representations of diabetic patients were related to their self-reports of dietary
intake as well as levels of physical activity (Hampson et al, 1990, 1995, Glasgow et
al,1997).
At present, the application of the illness representations framework in chronic
disease is limited with regard to the role of 'significant others' in the health
behaviours of patients. However, it was demonstrated that the beliefs
partners! carers hold in relation to a patients' illness are important in patients'
adjustment to their illness, their well-being and subsequent health related
behaviours (Heijmans et al, 1999, Weinman et al, 2000, Figueiras & Weinman,
2003). The focus of the present thesis is to determine the role of significant others
in the health behaviours of patients with type 2 diabetes. It is, therefore, necessary
to examine how patients' beliefs and attitudes regarding the uptake and
maintenance of health behaviours are influenced by the social milieu of the patient.
It is proposed that in addition to examining the health beliefs of the patient, it may
be equally important to examine the health beliefs of the partner. It is postulated
that the extent and type of social support received by patients may be moderated
by the extent that partners' and patients' illness beliefs converge. For example, a
partner of a patient with diabetes may perceive the illness as having less severe
consequences and that the treatment was less effective for controlling diabetes than
the patient. It is argued that such representations would not favour adherent
behaviour by the patient, particularly if these representations determine the level
of support the patient receives from the partner. This endeavour will serve to
further inform the role of the social context in the management of diabetes.
Specifically, it will assist in delineating if the health beliefs of 'significant others'
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play an active role with regard to the patients' health behaviours. Whether beliefs
are shared or are different it is important to explore the magnitude such beliefs
have on patients' health behaviours.
3.4. Aims of study
The primary aims of the study were to examine the effectiveness and validity of
the illness representations framework in predicting behavioural, psychological and
clinical outcomes in patients with type 2 diabetes.
In particular, the study aims to;
• Assess the illness representations of patients with type 2 diabetes and their
spouse or partner.
. Determine if the illness representations of patients and partners differ with
regard to living with diabetes.
• Examine the extent to which the representations of the patient and partner
are associated with the patient's self-management of diabetes.
3.5. Ethical approval
Ethical approval for the study was granted by the South and West Multi-centre
Research Ethics Committee in Spring 2001. As participants were recruited from
primary care surgeries participating in the Somerset and Avon Survey of Health
(SASH) Diabetes Study it was also necessary to obtain approval from the 5 local
ethical committees representing the areas involved (United Bristol Health Care
Trust, North Bristol NHS Trust (Southmead and Frenchay), Weston and West
Somerset (Taunton).
3.6. Study design and methods
The primary research aims were addressed via quantitative methodology through
the administration of self-report questionnaires. The study adopted a prospective
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design with 2 phases of data collection, 0 months (baseline) and 12 months. All
phases of data collection were undertaken by posting the questionnaires to the
participant's home address. All measures assessing the participant's adherence
(self-management behaviour) to diet, physical activity and medication were
assessed through self-report questionnaires.
3.7. Participants
Somerset and Avon Survey of Health
The study participants were derived from a cohort of 28,080 individuals aged 35 or
over who were originally enrolled in the Somerset and Avon Survey of Health
(SASH) in 1993 to 1995. In brief, this cohort was obtained by sampling a fixed
number of patients from 40 primary care surgeries. The surgeries were taken from
a mix of rural, suburban and inner city locations. A total of 1068 patients with
either type 1 or type 2 diabetes were identified from this cohort. However, General
Practitioners were asked to exclude anyone who had a severe mental illness,
terminal illness or who had changed address or died. This procedure resulted in
789 diabetes patients that were approached to participate in the 'SASH Diabetes
Study'. A total of 586 patients consented to participate in the study giving a
response rate of 79%. A total of 19 patients were omitted from the recruitment
procedure as these individuals claimed not to have diabetes.
Recruitment of type 2 diabetes patients from SASH Diabetes Study
In order to recruit patients for the present study participants with type 2 diabetes
from the 'SASH Diabetes Study' were identified. Patients were classified as having
type 2 diabetes if they were either:
1. treated by diet only
2. treated with oral drugs (no insulin)
3. treated with insulin (age of onset> 35)
140
Of the 567 patients in the original 'SASH Diabetes Study' a total of 506 patients
were classified as having type 2 diabetes.
In order to contact these patients, the practice managers of the 40 primary care
surgeries on the SASH database were contacted by telephone and, if agreeable,
were sent details on the proposed project to be given to the relevant GP. The GPs
were requested to give their approval to contact diabetic patients under their care
that met the following inclusion criteria:
1. the patient had a diagnosis of type 2 diabetes
2. the patient was married and or living with a partner.
The GPs were also requested to verily the patients' diagnosis and notify the author
of any changes of address, physical health and whether the patient was still under
their care (either deceased or left the practice). Furthermore, any dyads in which
both patient and spouse had diabetes were excluded. Once approval from the GP
was given, eligible patients were contacted directly by the author as consent had
been given by their participation in previous studies relating to SASH.
Recruitment of patients from Bristol Primary Care Research and Development Consortium
In an attempt to increase the number of patient-partner dyads in the study the
Bristol Primary Care Research and Development Consortium (BPCRDC) were
approached. This procedure led to the identification of 12 contactable GP
surgeries. Patients attending these surgeries had no prior experience of the 'SASH
Diabetes Study', therefore for reasons of patient confidentiality and in accordance
with the recommendations of the Caldicott agreement (Caldicott Committee, 1997)
the initial approach to recruit these patients came from the relevant GP. Thus,
study invitation letters were sent to these patients printed on relevant GP surgery
letter-headings (see Appendix 2.). These invitation letters described the nature of
the study and contained a reply slip and pre-paid envelope for patients to return if
they were interested in receiving more details regarding the study.
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Participants
A total of 29 surgeries from SASH and gave consent to contact eligible patients and
6 surgeries representing the BPCRDC agreed to contact eligible patients. In
addition to this, the Diabetes Unit at Southmead Hospital, Bristol agreed to recruit
patients attending diabetes education classes. In October, 2001 a total of 225
patients meeting the study inclusion criteria (i.e., had a type 2 diagnosis and living
with partner) were sent a 'study pack' containing an invitation letter (Appendix 3.),
an information sheet (Appendix 4.), consent forms for patient (Appendix 5.) and
partner (Appendix 6.), a questionnaire booklet (for patient and partner) and a
FREEPOST envelope to return completed questionnaires. Patients were sent a
postal reminder at 3 weeks and patients who had not returned questionnaires at 6
weeks received a telephone reminder (Appendix 7).
Of the 225 patients from the SASH cohort 95 heterosexual patient-partner dyads
consented to participate (42% response rate). However, on return of study
booklets it was revealed that 12 partners of patients had either not completed the
relevant questionnaires adequately. These patients were omitted from the study
leaving n= 83 dyads.
A further 150 patients with type 2 diabetes with no previous involvement in SASH
were approached through primary care surgeries participating in SASH and from
the practices representing the Bristol Primary Care Research and Development
Consortium. In line with current research governance guidelines it was necessary
for relevant GPs to invite eligible patients to participate in the study before consent
was obtained. This procedure resulted in the recruitment of a further 89
participants (59% response rate). Of these there were 8 partners of patients who
failed to complete their questionnaires and were omitted from the study.
The combination of the two recruitment procedures yielded a final sample of
n164 dyads (50.5% response rate). Independent t-tests were conducted to
determine if the demographic (age, gender, years married, ethnicity) and clinical
(disease duration, BMI, weight, medication) characteristics of the patients recruited
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through the two procedures were significantly different. This analysis revealed
that patients who had not previously participated in the 'SASH diabetes study'
had been diagnosed with type 2 diabetes more recently (t 2.72, p <.01). Further
independent t-tests were conducted to determine if the final patient sample
(n=164) differed significantly from patients with type 2 diabetes participating in
the 'SASH Diabetes Study'. No significant differences were found for age, gender
and ethnicity and a range of co-morbid conditions with the exception of
hypertension (t = -3.43, p <.001). Thus, patients in the present sample reported less
hypertension than patients participating in the SASH Diabetes study. The
recruitment procedure is illustrated in Figure 3.1.
Follow-up
After a period of 12-14 months all patient-partner dyads were contacting again to
complete the follow-up phase of the study. The questionnaire booklets were sent
again via post (containing same scales) to patients responding in the first phase of
data collection. At three weeks, patients not returning questionnaire booklets were
sent reminder letters followed with a telephone reminder at 6 weeks. The final
sample at follow-up was n=134 dyads, giving a response rate of 82%.
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Figure 3.1 Flow diagram of recruitment procedure.
SOMERSET AND AVON SURVEY OF HEALTH
(SASH) COHORT = N=28 080. RECRUIIED FROM
40 Q SURGERIES
PATIENTS WITH DIABETES (TYPE I OR 2)
N= 1068
PATIENTS APPROACHED FOR 'SASH DIABETES
STUDY FROM 40 GP SURGERIES
N=789
PATIENTS CONSENTING TO PARTICIPATE IN
SASH DIABETES STUDY
N=567 (79% RESPONSE RATE). N 506 PATIENTS




PATIENTS WITH TYPE 2
DIABETES
95 PATIENT-PARTNER





WITH TYPE 2 DIABETES
89 PATIENT-PARTNER
DYADS GAVE CONSENT FOR
PRESENT STUDY
(59% RESPONSE RATE)
TOTAL SAMPLE OF N= 164 PATIENT
PARTNER DYADS COMPLETING Q's
(COMBINED RESPONSE RATE OF 50.5 %)
N=134 PATIENT-PARTNER DYADS
FOLLOWED UP AT 12 MONTHS
(82% RESPONSE RATE)
Socio-econornic and clinical data
A series of questions assessing the sociodemographic profile and health status of
the participants were included in the questionnaire. These items asked patients
and partners to state their ethnic background, current and former occupation (as
applicable) and educational status.
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To assess the extent of co-morbidity affecting patients they were asked to indicate
which conditions from a list of 18 they had suffered within the preceding 12
months. The patients were also asked to state if they were prescribed insulin, and
if they were prescribed any additional medicine as part of their treatment regimen
for type 2 diabetes. Finally, patients were asked to state what type of diabetes they
had (i.e., type 1 or type 2.).
Demographic data
The mean age of the participants was 67 years, the mean age for partners was also
67 years. The majority of patients (54%) were in retirement or approaching
retirement age. Patients and partners who were still in paid employment were
likely to have semi-skilled or manual occupations. The majority of patients and
partners had left school before the age of 16. The number of years married or
living together ranged from 2 to 64 years, indicating that all the participants were
in well established relationships. Finally, despite recruiting patients from primary
care practices in geographically diverse areas, only 5% of participants were from
non-European ethnic groups.
Co-morbidiiij
The incidence of co-morbidity in the study sample was common, many patients
reported suffering from other serious chronic conditions within 12 months before
study entry. The most common conditions were Hypertension (43%) and arthritis
(31 %). Other conditions included angina (12%), asthma (11%), other heart trouble












Table 3.1. Demographic data for sample population (n=164)
Ethnicity
Disease duration




(in last 12 months)
95% White European
6 months - 38 years
Mean = 8.8 (7.07) years
2 - 64 years





14 years = 28%
15 years = 32%
















14 years = 24%
15 years = 37%




The illness representations of participating patients were assessed with the Revised
Illness Perception Questionnaire (IPQ-R: Moss-Morris et al., 2002). The
development of this measure was described in detail in Chapter 2. The measure
has been psychometrically evaluated in 711 patients from 8 different illness groups
including patients with diabetes. The IPQ-R encompasses 38 items within sub-
scales reflecting the 'core 'dimensions of the illness representations framework (i.e.,
time-line, consequences, con trol, identity, and cause) and includes three new related
concepts. The new sub-scales are; (1) emotional representations (to assess emotional
responses such as fear, anxiety and anger generated by the illness), (2) illness
coherence (to assess how the illness "makes sense" to the patient) and (3) time-line
cyclical (to assess day to day variability in symptoms of the illness). Finally, the
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control dimension of the IPQ-R now assesses personal control and treatment control
with two separate sub-scales.
The IPQ-R was specifically adapted for use in the present diabetic population.
Typically, this was achieved by replacing the word 'illness' with 'diabetes' for all
applicable items. One item (item 20 of IPQ-R; 'My treatment will be effective in
curing my illness') was changed to read 'My treatment will be effective in
managing my illness) in recognition of the fact that there is no cure for diabetes.
Finally, a further item was added to the treatment control sub-scale (i.e., 'My
diabetes can be controlled by my treatment') making 6 items in total for this sub-
scale. All items were rated on a 5-point scale (1= strongly disagree to 5 strongly
agree). In order to avoid 'response set' bias in the participants, the items were
randomly presented in the diabetes-specific version of the IPQ-R. This measure
can be seen in full in Appendix 8.
Consequences
The consequences dimension is a measure of the perceived impact the illness has on
a patients' life. It is assessed with 6 items (a= 0.84) and scored on a 5-point scale;
1= strongly disagree to 5= strongly agree (e.g., 'My illness has major consequences
on my life').
Time-line
The time-line dimension is a measure of the perceived course or duration of the
illness and provides an indication of the extent that the patient perceives the illness
as an acute versus a chronic state. It is assessed with three items (a=0.89) (e.g., 'I
expect to have this illness for the rest of my life').
Time-line cyclical
The cyclical time-line sub-scale measures the extent of illness variability and
unpredictability. For example, the perceived experience of the illness may
fluctuate according to the degree of control of diabetes. The sub-scale is comprised
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of 4 items with a reliability alpha of a =0.79 (e.g., 'My symptoms come and go in
cycles')
Control
The revised control dimension now measures the patients' perceived control of
illness in two distinct sub-scales. First, treatment con frol (treatment efficacy)
measures the patients' belief that treatment is effective in controlling the illness
and is assessed with 5 items (a= 0.80) (e.g., 'My treatment will be effective in
controlling my illness'). The personal control sub-scale measures the patients'
perceived efficacy in controlling their illness and is assessed with 6 items (a= 0.81)
('There is a lot that I can do to control my illness').
Emotional representations
Items for the emotional representation sub-scale measures perceived emotional states
such as anger, fear, anxiety and depression that a patient may associate with the
illness. It is assessed with 6 items (a=0.88) (e.g., My illness makes me feel angry').
A higher score on this scale is indicative of a greater emotional impact of the
condition.
Illness coherence
The illness coherence dimension is a 5-item measure of the extent to which a
patient's illness representations are collectively helpful in providing a coherent
understanding of the illness and is described as a 'meta-cognition' (Moss-Morris et
al, 2002). A higher score on this sub-scale is indicative of an increased awareness
of the illness and the degree to which it makes sense to the patient in terms of the
perceived cause, control, consequences, and course (a= 0.87; e.g., 'I have a clear
understanding of my illness').
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Cause
Weinman et al (1996) suggest that the items of the cause sub-scale should be
modified according to the illness being investigated. Therefore, patients'
representations of the cause of their diabetes was assessed with a list of 13 possible
causes for their diabetes. Therefore 10 items were taken from the IPQ-R (i.e.,
'stress or worry', 'hereditary', 'germ or virus', 'diet or eating habits', 'chance or bad
luck', 'poor medical care in past', 'my own behaviour', 'pollution', 'smoking' and
alcohol). Three other items were added by the author (i.e., 'lack of exercise, my
weight, and other people).
The participants were asked to rate on a 5-point scale (1= strongly disagree to 5=
strongly agree) the extent to which they felt that each factor had caused their
diabetes.
Personal models of diabetes
In conjunction with items from the IPQ-R, sub-scales from the Personal Models of
Diabetes Interview were included. These scales have been shown to be important
predictors of the health behaviours of patients with diabetes (Hampson et al, 1990;
1995). First, to make the measure more diabetes-specific, a list of 10 symptoms
associated with high blood glucose and 11 symptoms associated with low blood
glucose replaced the 14 general illness symptoms included in the original IPQ-R
identity sub-scale. The participants were instructed to tick either 'Yes' or 'No' as
applicable to indicate their experience of each symptom.
In addition, the control/cure dimension of the illness representations framework
(IPQ-R) was expanded to include 13 items to assess the relative importance of
specific aspects of diabetes treatment for controlling diabetes now and for avoiding
complications in the future. For example, participants were asked to rate on a 5-
point scale (1= not important to 5 very important) how important it is to exercise
regularly, eat a diet low in fat and high in fibre and to take one's medication for
controlling diabetes now. The same questions were asked again but this time the
emphasis was on the perceived importance of these behaviours for avoiding future
complications of diabetes.
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Illness representations of the partner
A 'significant other' version of this measure was also produced to be completed by
the spouse / partner of patients with diabetes. All the items of the measure
devised for the diabetic patient were rephrased to assess the partner's
representations of the patient's diabetes. For example, the item; 'My diabetes will
improve in time' was modified to read; 'My partners' diabetes will improve in
time, and 'I have a clear understanding of my diabetes' was modified to read 'My
partner has a clear understanding of his/her diabetes'. This measure can be seen
in full in Appendix 9.
Outcome measures
As described earlier in Chapter 1, type 2 diabetes is primarily managed with diet,
regular physical activity and medication. Therefore, the extent of adherence to
these behaviours were chosen as the primary determinants of self-management in
the present study. From the literature reviewed in Chapter 2 it is evident that
many previous studies have relied on a single measure to assess self-management
behaviours in diabetes such as diet, physical activity and medication adherence,
namely the Summary of Diabetes Self-care Scale. For the present study it was
considered that an improvement could be made by employing behaviour-specific
measures to assess patients' adherence to these behaviours. Therefore relevant
scales were included to assess the three key behavioural outcomes in the study;
diet, physical activity and medication.
In addition to these behavioural outcomes, psychological morbidity was assessed
as it is proposed these 'psychological' outcomes may be 'markers' for the patients'
adaptation to diabetes. Finally, as the family environment was shown to be
particularly important in patient's management and control of diabetes in Chapter




It is likely that the responsibility for healthy eating habits lies not only with the
diabetic patient but also with their spouse or partner or others sharing the same
household. It is, therefore, suggested that it is important to examine the social
context of eating behaviour, particularly, within a shared household (i.e.,
cohabiting couples).
Previous studies examining psychological variables and adherence to a diabetic
regimen have not adequately assessed dietary adherence. For example, studies
have tended to rely on 'self-care' inventories where the respondent is asked
general questions about their dietary behaviour in addition to other aspects of the
regimen such as levels of exercise, medication adherence, glucose testing etc. It
was thus deemed necessary to assess the quality and quantity of the typical weekly
diet of the diabetic patient and this was achieved with a Food Frequency
Questionnaire
Food Frequency Questionnaire
The Food Frequency Questionnaire selected was originally developed by the
Health Education Authority (HEA 3, Little et al., 1999; 2000). This measure was
primarily developed as a simple self-report dietary assessment tool in the context
of primary care particularly for providing counselling for patients at risk of
cardiovascular disease. The measure has been shown to perform as well as more
time consuming methods and almost as well as the accepted standard reference, a
seven-day weighed record (Little et al., 2000).
Respondents were asked to indicate how often, on average, they have eaten a
range of foods over the past month. The HEA 3 categorises individual food items
into the following groups (i.e., bread/cereal/ potatoes; fruit/vegetables;
meat/alternatives; cakes/puddings; sugar; drinks; fats; milk and dairy products.
Respondents were requested to indicate their average portion size (i.e., small,
medium, large; an example of a medium serving is given) for each item on the list.
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The respondents are also asked to state how often they consume each item (i.e.,
day, week, month). This measure can be seen in Appendix 10.
Additional questions were asked to assess whether the respondents used
wholemeal bread, high-fibre breakfast cereal, wholegrain rice, low-fat dairy
products and what type of fat was used for spreading/frying etc.
Using responses to this questionnaire a computer programme was developed in
association with a Public Health nutritionist. The programme used standard
portion size data and nutritional data to calculate the energy intake for each
respondent consumed as fat, saturated fat, sucrose, fibre, carbohydrate, fruit and
vegetables and starch over a typical month.
Weight and weight management
In addition questions were asked regarding weight control (i.e., Have you been
recommended to lose weight by your GP?; 'Are you currently dieting to lose
weight?'. Participants were asked to report their current weight and height in
order to calculate their body mass index (BMI).
Physical activity
The effectiveness of exercise in the management of type 2 diabetes is well
established. Improvements in glucose homeostasis, cardiovascular risk and quality
of life have been reported alter moderate and vigorous exercise (Lehman et al,
1995; Mayer-Davis et al, 1998; Walker et al, 1998; Ligtenberg et al, 1998). However,
despite numerous studies supporting the benefits of frequent physical activity for
people with type 2 diabetes, an estimated 60-80% of this population remain
sedentary (Ford & Herman, 1995; Hays & Clark, 1999).
To assess levels of intentional physical activity (other than exercise in the course of
occupational activity), two sub-scales from the Baecke habitual physical activity
questionnaire (Baecke et al., 1982) were used (see Appendix 11). First, the 'sports
index' is concerned with the extent and intensity of a particular activity such as
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cycling, walking etc. This scale asks respondents to state their most frequently
played sport and indicate how many hours per week and how many months per
year he/ she engages in the sport. The respondent is also asked to state a second
sport and to rate it in the same way. The 'sports index' also comprises of a further
3 items concerned with the level of physical activity (e.g., 'In comparison with
others my own age, I think my physical activity during leisure time is 1=much
more, 2=more, 3=the same, 4 less, 5= much less').
The 'non-sports index' is concerned with exercise taken in going about everyday
life such as walking to shops etc and comprises of 4 items. For example,
respondents are asked to rate their extent of agreement or disagreement to
statements such as; 'During leisure time I watch TV'; 1= never, 2= seldom, 3=
sometimes, 4= often, 5= very often). The mean scores for the two scales are
summed to provide a composite measure of physical activity. The 'non-sports
index' scale has good test-retest reliability at 3 months with a Pearson correlation
of 0. 74. Overall, the measure has been shown to have high reliability and provides
an accurate assessment of both heavy intensity exercise as well as light intensity
activities which in turn has been associated with measures of aerobic fitness and
body fatness in expected directions (Richardson et al., 1995).
Medication
Many patients with type 2 diabetes are required to take oral medication in addition
to careful adherence to diet and exercise to control blood glucose. The
sulfonylurea class of drugs play a primary role in the pharmacological
management of type 2 diabetes (Florence & Yeager, 1999). Metformin is another
oral agent that is frequently prescribed to lower blood glucose and may be used in
combination with sulfonylureas and other agents. Patients with type 2 diabetes
become less responsive over time to one agent alone and frequently require
combination therapy to adequately control their disease.
The extent of the patients' adherence to such agents was assessed with the
Medication Adherence Report Scale (MARS; Home, 2001). The MARS is a
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validated 6-item scale that assesses the frequency of medication lapses in the
previous 7 days (see Appendix 12.). It has also been designed to limit under-
reporting of medication lapses by pre-empting patient's responses with a
statement indicating that medication lapses are commonplace. The respondent is
asked to rate their extent of agreement or disagreement to each statement on a 5-
point scale (e.g., 'I avoid using my medicines if I can', 1= always true, 2= often true,
3= sometimes true, 4= rarely true, 5= never true.
Psychological morbidity
Having diabetes is associated with higher levels of depression than in the non-
diabetic population. Indeed, a meta-analysis of 42 studies found that having
diabetes doubles the odds of having depression (Anderson et al, 2001). Depression
has also been implicated as a factor affecting good glucose control (Lustman et al.,
1986). High levels of anxiety are also prevalent in patients with diabetes. A
systematic review found elevated symptoms of anxiety in 40% of patients with
diabetes (Grigsby et al, 2002).
To assess psychological morbidity in both patients and partners the Hospital
Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983) was employed
(see Appendix 13). A study using the HADS examining the prevalence of
psychological morbidity in diabetes patients demonstrated that 28% of study
participants reported moderate-severe levels of depression or anxiety or both
(Lloyd, Dyert & Barnett, 2000). A greater proportion of patients (25%) reported
these levels of anxiety than depression (8%). The HADS consists of two sub-scales
each with 7-items measuring depression and anxiety. Since the HADS does not
contain any items that measure somatic symptomatology, symptoms of anxiety
and depression cannot be confounded with the physical symptoms of poorly
managed diabetes. Scores of 11 or higher on either or both of the sub-scales
indicate moderate-severe symptomatology or clinically significant disorder. Scores
of 8-10 on either sub-scale indicate mild levels of anxiety and depression. All items
are measured on a scale of 1 to 4 indicating the extent to which they feel the item
reflects how they have been feeling in the last week (e.g., 'I feel as if I am slowed
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down'; 1 =
 most of the time, 2= a lot of the time, 3 = time to time, occasionally, 4
not at all).
Dyadic adjustment
A further finding pertinent to the proposed project is the importance of marital
satisfaction or adjustment in patients' adherence to treatment regimens. Therefore,
it was felt necessary to include a measure of marital satisfaction to be completed by
both patients and their partners. The original Dyadic Adjustment Scale is a 32-item
measure of satisfaction in an intimate relationship (DAS; Spanier, 1976). It has four
sub-scales that measure marital satisfaction, cohesion, consensus, and affectional
expression. A higher score indicates better marital quality. The measure also
correlates highly with the widely used Locke-Wallace Marital Adjustment Test
(Locke & Wallace, 1957).
As the 32-item version of the DAS was considered too long, it is argued that a
shorter scale assessing dyadic adjustment would be more appropriate in the
present context due to the number of other measures used in this study. Therefore,
the 7-item version of the Dyadic Adjustment Scale (Sharpley & Rogers, 1984) was
selected for this purpose (see Appendix 14.). Investigation of the construct validity
among the short-form alternatives of the DAS by Hunsley et al (1995)
demonstrated that this scale is a valid version of the DAS.
Respondents are asked to indicate the extent of agreement or disagreement
between them and their partner for 6 items of the DAS (e.g., philosophy of life; 1=
always agree, 2= almost always agree, 3= occasionally agree, 4 frequently
disagree, 5 almost always disagree, 6= always disagree). For the remaining item
respondents are asked to circle a number on a continuum of 0-6 which most
represents the degree of happiness in their relationship (0 extremely unhappy, 1=
fairly uni-Lappy, 2= A little unhappy, 3= happy, 4= very happy, 5= extremely
happy, 6= perfect.
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Glycosylated Haenioglobin (HbA 1 c)
An amendment to the original study protocol for which ethical approval was
obtained made it possible to obtain an objective measure of blood glucose control
to coincide with the completion of the final questionnaire booklet. Metabolic
control measured by HbAlc reflects patients' mean metabolic control over the 6-12
weeks preceding measurement and is part of the routine management of patients
with diabetes and widely accepted as reliable and valid index of metabolic control
(Nathan et al., 1984, Goldstein et al, 1985). Higher values indicate higher blood
glucose levels and hence poorer metabolic control.
A letter was enclosed with the final questionnaire booklet requesting patients to
provide a blood sample specifically to determine the extent of control of their
diabetes for the study (see Appendix 15). Due to the wide geographical dispersion
of the study participants in the Somerset and Avon Survey of Health the study
sample was divided into two groups for the collection of HbAlc. Patients living in
the vicinity of the Bristol Royal Infirmary and those living in the vicinity of Weston
General Hospital attended the appropriate clinic (see Appendix 16 for consent
form). A total of 102 patients consented to give blood for the measurement of
HbAlc (62% of the original 164 patients recruited, 76% of patients at follow-up).
Independent t-tests revealed that patients providing blood samples did not differ
significantly with regard to demographic (age, gender, years married) and clinical
variables (disease duration, medication use, BMI and weight).
3.9. Plan of analysis
The first aim of the thesis is to determine and describe the illness representations of
patients and partners with type 2 diabetes. To achieve this aim it is necessary to
sum the responses to the relevant scales and calculate the mean for each sub-scale
in accordance with the directions of the authors of the IPQ-R (Moss-Morris et al,
2002). To examine the second aim of the thesis; to determine the extent of
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differences between patients' and partners' illness representations, a series of
paired t-tests will be performed. This procedure was adopted in previous studies
examining differences in the illness representations of patients and partners
(Heijmans et al, 1999); and adolescent s and mothers (Urquhart Law, 2002) and can
therefore be considered as the precedent for examining differences between the
representations of patients and significant others.
The overall aim of the study was to examine the extent that the illness
representations of partners are influential in patients' self-management
behaviours. Specifically the study is endeavouring to determine if partners'
representations of diabetes impact on patients' behaviours over and above the
influence of patients' representations. To date, there are no studies that have
specifically addressed the extent how partner representations impact on patient
outcomes which leaves analytical approaches in this regard to be determined post-
hoc. It was thus anticipated that decisions regarding analysis to determine the
influence of partners' representations would be dependent to some extent on the
distribution of scores for the outcomes of interest.
Bivariate correlational analysis will be conducted to examine inter -relationships
between the dimensions of diabetes representations and also examine their
relationships with the outcome variables. If the outcome variables do not assume a
'normal' distribution independent t-tests will be conducted to determine if
differences exist with regard to diabetes representations. Multivariate regression
approaches will be employed to determine the magnitude of the predictive utility
of the diabetes representations. This procedure will permit demographic and
disease related variables to be controlled and will allow the strength of partners'
representations in predicting patients' behaviours over and above the influence of
patients' own representations to be determined.
In Chapter 4 the analysis of the time 1 data collection is described. However, this
paragraph provides an outline of the decisions and justification for the
employment of the chosen analytical methods. On the strength that scores on the
outcome measures were not normally distributed a decision was made to split
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outcome scores at the median or clinically relevant cut-offs where appropriate. To
examine differences between diabetes representations a series of independent t-
tests were conducted. To further explore these relationships with outcome
variables, and to control for demographic and clinical variables and the relative
influence of patient and partner representations, binary logistic regression was
employed. However, there are limitations associated with split data and the
employment of logistic regression analysis that are discussed alongside alternative
strategies in the discussion (Chapter 6).
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CHAPTER 4: RESULTS-TIME 1
4.1. Introduction
This chapter summarises the descriptive data relating to the measurement of
illness representations in patients with diabetes and their partners as described in
the study procedure in chapter 3. In particular, the internal reliability of the
patients' and partners' illness representation scales are assessed and the formation
of scales assessing causal attributions through factor analysis are described. The
extent of adherence with the recommended behaviours relating to diet and weight
management, medication and physical activity is also described. The chapter
proceeds with an examination of the differences between patient' and partners
diabetes representations. The statistical methods used to examine the associations
between representations and behavioural, psychological and dyadic adjustment
outcome variables are described, as are the results. Finally, the chapter ends with
an interim summary of the results of time 1.
4.2. Descriptive data
The data from the questionnaires for the first phase of data collection were
analysed. Individual items of the sub-scales of the IPQ-R were summed in line
with the authors' recommendations (Moss-Morris et al, 2002). Where applicable
item scores were reversed. In addition, a missing data count was conducted for
individual items on the IPQ-R which identified a minimal proportion of missing
values, ranging from 0.8% to 4.2%. It is suggested that if greater than 10% of data
is missing for a respondent the measure in question should be deemed as missing
(Bryman & Cramer, 1997). As the proportion of missing data did not exceed 10% it
was considered appropriate to replace missing values for individual items with the
mean derived for the composite scales.
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Scale reliability
To determine the internal reliability of the scales Cronbach alpha coefficients were
conducted for patients with type 2 diabetes and their partners (n164). The
reliability coefficients for some of the IPQ-R sub-scales were not as satisfactory as
coefficients reported by Moss-Morris et al (2002). This was particularly true for the
time-line, time-line-cyclical, consequences, personal control, treatment control sub-scales
although for patients the alpha coefficients were all above 0.6. An attempt was
made to improve the alpha coefficients of the scales by removing weakly
correlated items. However it was not possible to improve the reliability of any
single scale (for patients and partners) by more than 0.5. Therefore all of the scales
include all of the original items. The mean scores and alpha coefficients are shown
in Table 4.1.
Table 4.1. Descriptive statistics for illness representation scales (n164 patient-partner dyads)
Mean (SD)	 Alpha
Illness Representation 	 Max	 Patient	 Partner	 Patient	 Partner
score
Timeline-acute	 30	 23.2 (4.8)	 23.7 (4.3)	 .63	 .73
Timeline-cyclical 	 15	 11.1 (2.8)	 10.8 (2.8)	 .60	 .66
Consequences	 25	 17.2 (3.8)	 17.1 (3.6)	 .61	 .58
Personal control	 30	 23.4 (3.8)	 23.1 (4.4)	 .61	 .54
Treatment control 	 30	 22.9 (4.6)	 23.5 (3.5)	 .68	 .63
Illness coherence	 25	 17.5 (4.6)	 18.4 (4.3)	 .85	 .81
Emotional representations 	 25	 12.1 (3.6)	 12.6 (3.7)	 .80	 .81
Control-now	 65	 60.3 (5.0)	 61.0 (4.3)	 .84	 .80
Control-future	 65	 60.9 (4.9)	 61.9 (3.7)	 .69	 .77
Cause- own behaviour	 30	 14.4 (4.0)	 14.2 (4.5)	 .71	 .69
Cause-external	 30	 12.7 (3.6)	 12.6 (3.5)	 .67	 .68
Cause-hereditary	 5	 3.2 (1.3)	 3.2 (1.2)	 n/a
Identity-high bg
	
10	 3.16 (2.2)	 3.25 (2.3)	 n/a
Identity-low bg	 11	 3.20 (2.3)	 3.41 (2.4)	 n/a
Importance of treatment to control diabetes 'Now' and in the 'Future'
Two scales adapted from the PMDI regarding beliefs in the importance of treatment
to control diabetes now and treatment to avoid complications in thefrture relating
to diabetes were also analysed. The Control-now scale has 13 items which were
summed yielding a mean of 60.3 (SD= 5.07) for patients and 61.04 (SD =4.31) for
partners. The reliability coefficients for the scale were .84 and .80 for patients and
partners respectively. Similarly, the scale reflecting beliefs in the treatment to
avoid complications in the future, Control-future, yielded a mean of 60.9 (SD= 4.93)
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for patients arid 61.9 (3.70) for partners. The alpha coefficients were .69 for patients
and .77 for partners. As the maximum score for these scales is 65, it is clear that
both patients and partners have strong beliefs in the importance of the treatment
regimen for controlling diabetes now and for avoiding complications in the future.
Represe.thit.tnis of cause
The frequency with which patients and partners endorsed each of the 13 items
relating to the possible cause of diabetes as either 'agree' or 'strongly agree' were
calculated (Fable 4.2). For patients the 5 most frequently endorsed causes were;
stress (50.6%) hereditary factors (41.6%), weight (31.3%), diet (29.3% and chance
241%). For partners the 5 most frequently endorsed causes were herechtaiy
factors (43.5%) weight (32%), diet (27.4%), stress (26.2% ,lack of exercise 13.1%.
Although there was a general level of agreement between patients and partners
particularly for hereditary factors, diet and weight as causes of diabetes, it would
appear that for patients perceived stress was particularly salient as a perceived
cause of diabetes. However, there was a clear disparity in patients' and parltner'
attributions of stress. It is suggested that patients more readily attribute stress as a
cause of their diabetes rather than factors related to their own behaviour.
Table 4.2. Percentage of cause items endorsed as
agree or strongly agree' for patients and partners n164









Lack exercise	 151	 131
Sniiking	 90	 131
Mabol	 7.S	 101
Other people	 66	 60
aeon /Vinis	 42	 24
Pr ,ise4gc.*l care	 41	 12
16	 6
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Factor analysis of causal attributions
The 13 items pertaining to the perceived cause of diabetes for patients and partners
were factor analysed using principal components analysis (PCA). For all analyses,
eigenvalues above 1.1 were used as selection criteria in accordance with Moss-
Morris et al (2002). Items with loadings of greater than 0.45 were interpreted as
representing a particular factor.
For patients, varimax rotation produced three factors which explained 50.9% of the
total variance (see Table 4.3). The first factor included smoking, alcohol, germ
/ virus, chance, poor medical care and pollution as causes of diabetes accounting
for 22% of the variance. The second factor included weight, own behaviour, diet
and lack of exercise as causes accounting for 18% of the variance. The third factor
included stress, other people and hereditary factors accounting for the remaining
11% of the variance.






Stress	 .283	 .134	 .611
Other people	 .489	 -0.004	 .620
Germ or virus	 .635	 -0.003	 .253
Weight	 0.060	 .749	 0.054
Alcohol	 .654	 .272	 -0.099
Smoking	 .671	 .114	 -0.033
Hereditary	 -.371	 -0.002	 .660
Own behaviour	 .129	 .774	 0.004
Diet	 0.016	 .856	 -.105
Chance	 .397	 0.043	 0.060
Poor medical care	 .686	 0.071	 0.044
Pollution	 .706	 -0.0098	 .110
Lack of exercise	 .116	 .564	 .315
Variance	 22%	 17%	 10%
explained
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	 Factor	 3	 Factor 4
Stress	 0.048	 -0.081	 .814	 -0.032
Other people	 .114	 .351	 .706	 .203
Germ or virus	 0.015	 .591	 .435	 -.111
Weight	 .705	 -0.009	 .111	 .218
Alcohol	 .645	 .168	 0.094	 -.348
Smoking	 .517	 .115	 .352	 -.367
Hereditary	 .122	 -0.082	 0.850	 .822
Own behaviour	 .792	 .129	 0.072	 -.106
Diet	 .814	 0.048	 -0.062	 .221
Chance	 -0.21	 .728	 -0.057	 -0.097
Poor medical care	 .212	 .787	 .101	 0.059
Pollution	 .228	 .849	 0.064	 -0.015
Lack of exercise	 .505	 .233	 -0.001	 .306
Variance	 22%	 19%	 12%	 9%
explained
For partners, PCA produced a four-factor structure of causal representations
explaining 62% of the total variance shown in Table 4.4. The first factor included
weight, diet, lack of exercise, own behaviour, alcohol and smoking as causal factors
accounting for 22% of the variance. This factor reflects health behaviours for
which the patient has responsibility. The second factor identified germ /virus,
chance, poor medical care and pollution as causal factors accounting for 19% of the
variance. The third factor comprised of only two items; stress and other people
accounting for 12% of the variance. Finally, hereditary factors emerged as a single
item factor accounting for 9% of the variance. To operationalise patients' and
partners' representations of the cause of diabetes an attempt was made to make
more meaningful scales that would also permit differences between patients and
their partners to be identified. Thus the construction of the scales were joinfly
informed by; 1) the results of the factor analysis and 2) to reflect a distinction
between internal and external causes as described by Weinman et a! (1996. As the
distinction between 'internal' and 'external' causes was most apparent in the
partners' causal structure and explained a large proportion of the variance, the
construction of the 'internal' and 'external' scales were based on these results.
Therefore, for the internal scale 6 items deemed to be under the volitional control of
the patient were summed (i.e., smoking, alcohol, weight, behaviour, diet and lack
of exercise). This scale was labelled 'own behaviour' with an alpha of 0.71 for
patients and 0.69 for partners. For the external scale, 7 items which could be
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described as being beyond the control of the patient (i.e., chance, germ /virus, poor
medical care, and pollution, stress other people and hereditary factors) and
labelled Cause-external yielding an alpha of 0.54 for patients and 0.56 for partners.
However, the removal of hereditary factors from this scale increased the alpha
coefficient to 0.67 for patients and 0.68 for partners. Therefore, hereditary beliefs
were utilised as a single item variable.
Inter-correlation of diabetes representations
Pearson's correlation coefficients were computed to test for inter-correlation
between the patients' representations of diabetes and also for partners'
representations. A correlation matrix was constructed (See Tables 4.5 for patients
and 4.6 for partners). For example, logical correlations were found for patients
perceiving a longer time-line (r = .247, p <.05) and a stronger illness identity (r =
.348, p <.05) with perceived consequences of diabetes. Stronger correlations were
found between perceived emotional representations and consequences (r = .489, p<.Ol)
and between emotional representations and time-line (r = .408, p <.01). Indicating that
the perceived seriousness of the diabetes was reflected in stronger emotional
discord and, interestingly, partners' correlation coefficients for these
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Clinical variables, illness representations and psychological outcomes
As the two-stage recruitment procedure yielded a wide variation in disease
duration (6 months to 38 years) it was necessary to test ãr diirences in patientsae
and partnerswillness representations in relation to how long they had' een living
with the disease- Eirst+the duration od the dia' etes diagnosis was dichotomised to
represent ewly-diagnosedcwand !hronica1lyadiagnosed patients- A diagnosis
was deemed to' e Uiewidit did not evceed two years at the time odstudy entry
(n<4/ )+a diagnosis evceeding two years was therere deemed to' e chronic
(n<113)- Thdependent t-tests revealed that there were no signidicant diàrences ãr
patientsoand partnersc&lness representations in relation to whether they had a
new or chronic diagnosis-
Additionally+a small num' er odpatients were prescri' ed insulin (n<31) as part od
their dia' etes management regime thereare it was also necessary to consider id
this aspect od the treatment indluenced the illness representations od patients and
their partners- G owever+independent t-tests only identidied diarences dr one
varia' le: patients on insulin reported a higher identity score when' lood-glucose
was low than patients not prescri' ed this treatment agent (t < -1-479-f-p <-I 1)-
Body Mass Index
One od the dietary related treatment o' jectives recommended dr patients with
dia' etes is to achieve or maintain a desira' le Body Mass thdev (BMi- The BMHis
the ratio od a personc weight to height- H is used as an indicator od o' esity and is
graded thus:
Grade 1:1/-14 (healthy weight)
Grade 1:16-3/ (overweight)
Grade 3: 31-39 (very overweight)






Std. 0ev = 5.53
Mean = 31.5
N = 151.00
A patient's BMI is calculated by dividing weight in pounds/kilograms by height in
inches/centimetres 2• The BMI was calculated for all patients reporting their
current weight and height (n =151). Current body weight ranged between 51 and
160kg (mean 91.8 kg (17.7), median = 88 kg. The mean BMI for the sample was
31.5 (5.53) and scores ranged from 16 to 48 with 90% scoring above the cut-off for
being overweight of >25. The range of scores are shown in Figure 4.1. Therefore, it
can be concluded that the present sample were predominantly overweight.
Figure 4.1. Distribution of patients' body mass index at time 1 (n=151).
16.0	 20.0	 24.0	 28.0	 32.0	 36.0	 40.0	 44.0	 48.0
18.0	 22.0	 26.0	 30.0	 34.0	 38.0	 42.0	 46.0
BMI
Weight control
Data were also collected on weight control behaviour. Despite the prevalence of
obesity within the sample, only 54% reported that they had been recommended to








Std. Dev = 3.20
Mean = 28.3
N = 129.00
entry to the study and 36% had made between 1 and 6 attempts at dieting to lose
weight in the previous 12 months.
4.3. Measures of outcome; medication, physical activity, diet, psychological
morbidity and dyadic adjustment
Medication
Figure 4.2. Distribution of scores for patients' scores on medication adherence report scale at time 1
(n129).








Std. Dev = 3.19
Mean = 6.5
N = 164.00
Of all 164 patients, 129 patients reported taking oral medication such as Mefformin
and Gliclazide to control their diabetes and 37 patients reported injecting insulin to
control their diabetes. A total of 49% of these patients were taking more than one
agent on a daily basis. The responses to the MARS (Home, 2001) were summed.
The maximum score for the scale is 30 representing optimal adherence. Scores on
the scale ranged from 9-30 with 80.1% of the sample scoring above the median
value of 29 (mean= 28.3). The distribution of scores is shown in Figure 4.2. Due to
the skewness of the distribution scores were split at the median to indicate 'sub-
optimal adherence' (>29, n =71) and 'optimal adherence' (^ 29, n = 58) and for
subsequent analyses.
Physical activity
Figure 4.3. Distribution of scores for patients on Baecke physicai activity questionnaire scores
(n164).
2.0	 4.0	 6.0	 8.0	 10.0	 12.0	 14.0	 16.0	 18.0
3.0	 5.0	 7.0	 9.0	 11.0	 13.0	 15.0	 17.0
Physical activity (Time 1)
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The extent of physical activity in the sample revealed that only 28% of the sample
engaged in activities other than walking, gardening and housework. Those
engaging in other activities typically reported low intensity activities such as bowls
and golf. The responses to the items on the two sub-scales derived from the
Baecke physical activity were calculated. First, scores on the 'sport index' were
calculated by multiplying the intensity code for the sport(s) engaged in (e.g.
cycling (1.76) x duration (3 hours per week) x proportion of year (4 months) =
21.12) spent participating in that activity. This score was then added to the
summed score of the remaining 3 items and the mean was derived. The summed
score for the 4 items comprising the 'non-sport leisure index' were summed and
the mean was derived. The mean scores for the 'sports index' and the 'non-sport
leisure index' were added together to provide a total exercise score. Total scores
(n164) ranged from 2 to 17.7, the mean was 6.5 (3.2) and the median was 6.35 as
shown in Figure 4.3. Due to the skewness of the data, the physical activity scores
were split at the median to indicate 'less exercise' (<6.35, n = 84) and 'more
exercise' (^ 6. 35, n = 80).
Dietary composition
Responses to the food frequency questionnaire were summed according to the
McCance food codes (Holland et al., 1991) to determine energy derived from the
major dietary components of fat, saturated fat, carbohydrate, sucrose, non starch
polysaccharides (fibre), starch and fruit and vegetables. Energy values were
calculated using a customised SPSS programme previously used for calculating
dietary risk factors for heart disease in the context of primary care. The program
calculates energy scores for each food group based on the following equation:
frequency x portion size x nutrient composition (based on McCance foodcodes).
The energy scores for each food group are expressed as percentage of energy per
day and/or as gram per day as appropriate and are shown in Table 4.3.
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Analysis of the responses to the food frequency questionnaire suggest that there
was a disparity between total energy intake and patients' body weight (i.e., their
reported energy intake was not adequate to sustain their reported body weight).
Thus, a basal metabolic rate (BMR) was calculated using Schofield equations
(Schofield et al., 1985) based on the age, gender and current bodyweight of
individual participants to estimate the extent that participants were
underreporting energy intake. This was achieved by calculating an acceptable
energy intake and then multiplying BMR by a factor of 1.2. The result was then
compared with the recorded energy intake in KJ. Subjects yielding energy scores
higher than the recorded energy intake were identified as having energy intakes
less than 1.2 x BMR and are thus regarded as under-reporters. This procedure
revealed that 76% of respondents were classified as 'low energy reporters'.
Table 4.7. Mean (SD) percentage and/or grams per day for food
groups derived from food frequency questionnaire (n=164)

























A number of measures of dietary intake also showed skewed distributions and for
consistency with the measures of medication and physical activity adherence were









on Health Education Authority daily intake 'target' cut-offs used in the
development of the food frequency questionnaire (HEA3, Little et al, 2000).
Fat
Figure 4.4. Distribution of scores for percentage of energy from fat per day (n= 164)
14.0 18.0 22.0 26.0 30.0 34.0 38.0 42.0 46.0
16.0 20.0 24.0 28.0 32.0 36.0 40.0 44.0 48.0
% fat per day (Time 1)
The recommended total fat intake is approximately 33% of total energy per day,
therefore the scores were split at this value; 'low fat' intake was defined as <33%











Figure 4.5. Distribution of scores for percentage of energy from saturated fat per day (n=164).
3.0	 7.0	 11.0	 15.0	 19.0	 23.0
5.0	 9.0	 13.0	 17.0	 21.0
% Saturated fat per day (Time 1)
The recommended daily intake of saturated fat is approximately 10%, therefore
scores were split at this value, scores <10% indicate low' saturated fat intake (n =
87), scores ^ 10% indicate 'high' saturated fat intake (n = 77). The distribution of
scores for percentage of saturated fat intake are shown in Figure 4.5.
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Figure 4.6. Distribution of scores for percentage of carbohydrate intake per day (n164)
% Carbohydrate per day (Time 1)
The recommended daily carbohydrate intake is approximately 50% thus the
percentage scores were split at this value; 'low' carbohydrate intake was defined as
<50% (n = 102) and 'high' carbohydrate as ^ 51% (n = 62). The distribution of










Figure 4.7. Distribution of scores for percentage of sugar intake per day (n= 164)
1.0	 3.0	 5.0	 7.0	 9.0	 11.0	 13.0	 15.0	 17.0
2.0	 4.0	 6.0	 8.0	 10.0	 12.0	 14.0	 16.0	 18.0
% Sucrose per day (Time 1)
The mean (7.0) and median (6.0) scores for simple sugars (sucrose) were below the
daily target of 10% (reflecting one aspect of dietary behaviour which may have
been underreported). However, for this variable scores were split at the
recommended value; scores < 10% indicate 'low' sugar (n = 28) and scores ^ 10%
indicate 'high' sugar (n = 136). The distribution of scores for percentage of sugar
intake per day are shown in Figure 4.7.
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Figure 4.8. Distribution of scores for grams of fruit and vegetables consumed per day (n=164).
0 0000 0
Grams fruit and vegetables per day (Time 1)
The mean score for fruit and vegetable intake reached the recommended 400 g/d
(or 5 portions a day) and scores were split at this value. Therefore, 'low' fruit and
vegetable intake was defined as <400 g/d (n = 110) and 'high' intake as ^ 400 g/d
(n = 54). The distribution of scores for grams of fruit and vegetables consumed per













Figure 4.9. Distribution of scores for grams of fibre consumed per day (n=164).
0	 0	 0	 0 -O	
•
Grams fibre per day (Time 1)
Mean fibre intake was 19 g/d and therefore equivalent to the recommended
18g/d. Therefore the scores for fibre intake were split at <18 g/d indicate 'iow-
fibre' (n = 106) and scores ^ 18 g/d indicate 'high-fibre' (n 58). The distribution
of scores for grams of fibre consumed per day are shown in Figure 4.9.
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Figure 4.10. Distribution of scores for grams of starch consumed per day (n=164).
0.0 100.0 200.0 300.0 400.0 500.0 600.0 700.0 800.0
50.0 150.0 250.0 350.0 450.0 550.0 650.0 750.0 850.0
Grams starch per day (Time 1)
Finally, the mean starch intake (141.5 g/d) was well below the recommended
325g/d ('Diabetes UK' recommend regular meals based on starchy foods to control
blood sugar). However, scores were split at the recommended value; scores <325g
defined 'low-starch' (n = 136) and 'high-starch' was defined as ^ 325 g/d (n = 28).














Figure 4.11 Distribution of scores for patients' levels of anxiety at time I (n164).
2.0	 4.0	 6.0	 8.0	 10.0	 12.0	 14.0	 16.0
Anxiety (Time 1)
Patients' responses to the anxiety sub-scale of the HADS were summed (n=164).
Scores of 8-10 on the sub-scale indicate mild levels of anxiety, scores of 11 or higher
indicate moderate to severe symptomatology equating to a clinically significant
disorder. The distribution of anxiety scores in patients ranged from 2-16 with a
mean of 11.7 (SD = 2.7, median=12). For analyses, anxiety scores were split at 11 to
distinguish patients with clinically significant disorder, thus scores < 11 indicate
low levels of anxiety (n = 42) and scores ^ 11 indicate 'high' or clinically significant















Figure 4.12 Distribution of scores for patients' levels of depression at time I (n =164).
2.0	 4.0	 6.0	 8.0	 10.0	 12.0	 14.0
Depression (Time 1)
Patients' responses to the depression sub-scale of the HADS were also summed
(n= 164). As for anxiety, scores of 8-10 indicate mild levels of depression, scores of
11 or higher indicate moderate to severe symptomatology. Scores for depression
ranged from 1-14 with a mean of 8.7 (SD = 1.86, median=9). It appears that
psychological morbidity in the present population is very high and is expressed
largely as clinically significant levels of anxiety and moderate to severe levels of
depression. For analyses, scores for depression were split at 11 to distinguish
clinically significant disorder, thus scores < 11 indicate 'low' levels of depression (n
= 126) and scores ^ 11 indicate 'high' or clinically significant levels of depression (n















Figure 4.13 Distribution of patients' dyadic adjustment scores at time 1 (n=164).
5.0	 10.0	 15.0	 20.0	 25.0	 30.0	 35.0	 40.0
Dyadic adjustment (Time 1)
The responses for the Dyadic Adjustment Scale (DAS) were summed for all
patients and partners (n=164). For patients, the distribution of scores ranged from
4 to 42 and the mean was 28.1 (SD= 5.8), median28 and are shown in Figure 4.13.
For partners, scores ranged from 13 to 42 and the mean was 28.2 (SD 5.7),
median=28. The scores on the DAS for patients and partners were highly
correlated (Pearson r. = .6, p <.01). In addition t-tests demonstrated that there were
no significant differences between patients' and partners' scores (t = -.197 (159), p
=.844). It can, therefore, be concluded that there is a high degree of agreement
between patients and partners regarding the quality of their relationships. Finally,
for analyses patients' dyadic adjustment scores were split at the median value of
28, thus scores <28 indicate 'poor' dyadic adjustment (n = 79) and scores ^ 29
indicate 'high' dyadic adjustment (n = 85).
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4.4. Representations of patients and partners
Differences between patients' and partners' representations
To test for differences between patients' representations of diabetes and those of
their partners (n164), a series of t-tests were performed for all of the dimensions
measured. This procedure revealed significant differences for only 3 of the 14
illness representation dimensions; personal control, illness coherence, and control-
ft ture, the results are shown in Table 4.8. For personal control partners scored lower
on this scale indicating that the patient believed they had more control (self-
efficacy) of their diabetes (p <.05). Partners scored higher on the illness coherence
dimension indicating that the patient had a poorer understanding of the condition
(p < .01) relative to the partner. Finally, partners perceived a stronger belief in the
importance of treatment in avoiding complications relating to diabetes in the
future (p < .01).
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Table 4.8. Results of t-tests for differences in patients and partners
illness representations (n164 patient-partner dyads)
Mean (SD)
Illness Representation	 Patient	 Partner
Timeline-acute	 23.2 (4.8)	 23.7 (4.3)
Timeline-cyclical 	 11.1 (2.8)	 10.8 (2.8)
Consequences	 17.2 (3.8)	 17.1 (3.6)
Personal control
	 23.4 (3.8)	 23.1 (4.3)
Treatment control
	 22.9 (4.6)	 23.5 (3.5)
Illness coherence	 17.5 (4.6)	 18.4 (4.3)
Emotional representations	 12.1 (3.9)	 12.6 (3.7)
Identity-high bg	 3.16 (2.2)	 3.25 (2.3)
Identity-low bg	 3.20 (2.2)	 3.41 (2.4)
Control-now	 60.9 (5.0)	 61.0 (4.3)
Control-future	 60.9 (4.9)	 61.9 (3.7)
Cause-behaviour	 14.4 (4.0)	 14.0 (4.4)
Cause-external	 12.7 (3.6)	 12.6 (3.4)
Cause-hereditary	 3.17 (1.3)	 3.11 (1.3)
















4.5. Relationship between illness representations and outcome measures:
Independent t-tests
A series of independent t-tests were conducted to determine if significant
differences existed for the representations of diabetes and their relationship with
the scores for the behavioural and psychological outcomes.
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Medication
For medication, patients with 'sub-optimal' levels of adherence held a stronger
belief in perceived consequences (M= 17.9 vs 16.5, t (127) = 2.11, p <.05) and
reported greater emotional representations (M = 12.9 vs 11.4, t (127) = 2.37, p <.05). In
addition, the importance of 'own behaviour '(M = 15.2 vs 13.5, t (127) = 2.33, p <
.05), and 'external' factors as causes of diabetes (M = 13.5 vs 12.3, t (127) = 1.94, p
<.05) were stronger in these patients. In contrast, patients reporting 'optimal'
medication adherence demonstrated a stronger belief in the importance of
treatment to control diabetes now (M = 61.8 vs 59.5, t (127) = -2.63, p < .05) and a
belief that treatment would help to avoid future complications of diabetes (M = 62
vs 60.2, t (127) = -2.01, p < .01).
A number of partners' representations of diabetes were associated with 'sub-
optimal' medication adherence. The partners held higher time-line beliefs,
believing in a longer chronicity of diabetes (M = 24.9 vs 23.1, t (127) = 2.24, p <.05),
greater perceptions of the patients' personal control (M = 23.4 vs 21.3, t (127) = 2.77,
p <. 01), and treatment control beliefs (M 24.6 vs 23, t (127) = 2.44, p < .05). Finally,
the partners of patients reporting 'optimal' adherence were more likely to endorse
a belief that the patients' 'own behaviour' (M = 15.2 vs 12.9, t (127) =2.81, p < .01)
and 'hereditary' factors were likely causes of diabetes (M = 3.4 vs 2.8, t (127) =2.37, p
<.05).
Physical activity
The scores split for low and high levels of physical activity were also analysed
using independent t-tests to determine whether significant differences exist for
representations of diabetes. It was demonstrated that only one dimension was
significant with regard to physical activity. Patients reporting higher levels of
physical activity demonstrated stronger beliefs in Personal control of diabetes (M =
24 vs 22.7t (162) = -2.01, p <.05).
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Dietary behaviour
A series of independent t-tests were conducted to examine patients' and partners'
representations of diabetes with regard to the scores split at recommended values
for patients' diet; saturated fat, total fat, carbohydrate, fibre, starch, fruit and
vegetables and sugar.
Fat
For total fat intake, patients who were eating less fat believed that diabetes has
more serious consequences (M = 17.8 vs 16.4, t (162) = 2.52, p < .05). Patients holding
stronger beliefs that their 'own behaviour' was a cause of diabetes consumed more
fat (M = 13.8 vs 15.1, t (162) = -2.19, p < .05). Partners of patients consuming less fat
held a stronger belief in the chronicity of diabetes (M = 24.3 vs 22.8, t (162) = 2.22, p
<.05).
Saturated fat
Patients who reported consuming less saturated fat had stronger beliefs regarding
the consequences of diabetes (M = 17.8 vs 16.5, t (162) -2.08, p < .05).
Fibre
Patients reporting high fibre consumption had stronger beliefs in the chronicity of
diabetes as indicated by time-line scores (M = 24.6 vs 22.5, t (162) = -2.73, p < .01).
These patients also held stronger beliefs in the serious consequences of their diabetes
(M = 18.2 vs 16.3, t (162) = -2.71, p < .01). The partners of patients reporting high
fibre consumption held higher personal control beliefs (M = 23.8 vs 22.1, t (162) -
2.86, p < .01).
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Carbohydrate
For patients' consumption of carbohydrate there were no statistically significant
representations of diabetes. However, the partners of patients reporting less than
the recommended 50% carbohydrate in their diet held beliefs in treatment control
(M = 24.1 vs 22.9, t (162) = 2.21, p < .05).
Starch
Patients reporting less consumption of starch in their diets held stronger identity
perceptions when blood glucose was low (M = 3.28 vs 1.37, t (162) 2.40, p < .01)
and high (M = 3.29 vs 1.62, t (162) = 1.97, p < .05)
Sugar
A high sugar diet was more likely to be consumed by patients reporting more
illness coherence (M = 18.0 vs 15.9, t (162) = -2.39 p <.05). Partners of patients
reporting high sugar diets expressed stronger treatment control beliefs (M = 23.9 vs
22.5, t (162) = 2.18, p <.05) and were more likely to believe the patients 'own
behaviour' was a cause of diabetes (M = 14.4 vs 12.7, t (162) = 1.98, p < .05).
Fruit and vegetables
Partners of patients consuming less fruit and vegetables had a stronger belief in the
treatment for controlling diabetes 'now' (M = 61.8 vs 59.4, t (162) = 3.290, p <.01).
Anxiety
For patients a number of diabetes representations were associated with levels of
anxiety. First, cyclical time-line beliefs (M = 12.1 vs 10.7, t (162) = 2.64, p < .01),
stronger beliefs in consequences (M = 18.4 vs 16.7, t (162) = 2.47, p < .01), and
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stronger emotional representations (M = 14.6 vs 11.3, t (162) = 5.66, p <.001) were all
associated with less anxiety. Patients' attributing the cause of diabetes to 'external'
factors were also less anxious (M = 13.7 vs 12.4, t (162) = 3.37, p <.001). Patients
reporting more symptoms when blood-glucose is high were more likely to
experience clinically significant levels of anxiety (M = 3.97 vs 2.94, t (162) = 2.20, p
<.05). Partners' representations of diabetes were not significantly associated with
anxiety.
Depression
For patients only stronger beliefs in the consequences of diabetes was associated
with clinically significant levels of depression (M = 18.5 vs 16.8, t (162) = -2.45, p <
.05). Partners with stronger beliefs in the importance of treatment for controlling
diabetes 'now' (M = 62.5 vs 60.6, t (162) = -2.341, p < .05) and for avoidingftllure
complications of diabetes (M = 63.2 vs 61.6, t (162) = -2.83, p < .01) were associated
with clinically significant depression in patients.
Dyadic adjustment
Patients' believing in a more chronic time-line (M = 24.3 vs 22.2, t (162) = -2.83, p <
.01) and perceiving more illness coherence (M = 18.3 vs 16.5, t (162) -2.43, p < .05)
exhibited higher levels of marital adjustment. Patients with partners perceiving
that the patient had more personal control also exhibited higher levels of marital
adjustment (M = 23.4 vs 22.0, t (162) = 2.08, p < .05).
4.6. Predicting health behaviours and outcomes: Logistic regression analysis
As the outcome data relating to patients' health behaviours were split at
recommended or clinical cut-offs it was necessary to use a method of analyses that
accommodates binary dependent variables.
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Thus, logistic regression analysis was employed to determine the relative
contribution that patients' and partners' representations of diabetes made to the
behavioural and psychological outcome variables. The patients' and partners'
representations of diabetes were used as explanatory variables to predict health
behaviours, psychological morbidity and dyadic adjustment after controlling for
demographic and clinical variables. To control for the influence of demographic
and clinical variables these were entered in the first block of the regression model.
This was necessary as there was a wide variation in disease duration, years
married or living together, the number of prescribed agents to control diabetes and
patients' BMI scores. To establish the importance of the patients' representations
of diabetes in relation to the study outcomes all variables were entered in the
second block. In the third and final block all the partners' representations were
entered to determine the importance of partners' representations of diabetes in
relation to outcomes. In view of the focus of the present thesis it was considered
most appropriate to enter the patients' representations before partners'
representations to establish to what extent the partners' beliefs were predictive of
management behaviours once the patients' representations were taken into
consideration. This method was considered to be the most conservative approach
and would provide a more robust test of the partners' representations in predicting
behavioural and clinical outcomes.
With regard to statistical power it is generally considered that 10 participants are
required per independent variable in the model (Tabachnick & Fidell, 1996). Each
regression model included a total of 32 independent variables and, in practical
terms, the sample size consisted of n328 (n=164x2) as partners were included in
each regression model. In addition, due to the number of potentially relevant
independent variables a forward stepwise procedure was employed. This
stepwise procedure was selected to reduce the number of independent variables
entered into each stage of the regression model. Thus at each stage only the most
pertinent variables are considered in the regression analyses (i.e variables
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	-.208	 .812	 .005	 .703-.938
	
-.527	 .590	 .000	 .457- .762
	
-.305	 .737	 .006	 .593- .916
	
.178	 1.194	 .008	 1.048 - 1.361
	
-.156	 .856	 .012	 .758-.966
	
.248	 1.281	 .018	 1.044 - 1.572
-.031	 .970	 .027	 .943-.997
.098	 1.103	 .021	 .806- .905
-.126	 .006	 .006	 .806- .965
correlated with the dependent variable at p <.05). Therefore it is clear that there
was adequate statistical power to run the regression models and also have
confidence in the results. The results are presented in Table 4.9.
Table 4.9. Results of logistic regression to examine predictive utility of demographic and
diabetes representations at time 1 on health behaviours and psychological morbidity.









Identity - high bg
Identity - low bg
Depression
Consequences





Cause - 'own behaviour' (partner)
-.187	 .829	 .035	 .697-.987
-.221	 .802	 .009	 .680-.947
.167	 1.181	 .019	 1.027-1.359
-.071	 .931	 .027	 .874-. 992
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Medication
To determine adherence to prescribed diabetes medication the medication scores of
'optimal' and 'sub-optimal' adherence were used as the dependent variable. In the
first block patients' age, gender, years married, disease duration, number of
prescribed medications, and BMI were entered. Patient representations were
entered in the second block and partner representations were entered in the third
block.
The final equation demonstrated that patients' beliefs in personal control (p <.05)
and emotional representations (p <.01) were negative predictors of medication
adherence. However, patients' beliefs in the treatment regimen to control diabetes
'now' was a positive predictor of medication adherence (p <.05). No demographic
variables or partners' representations emerged as significant predictors of
medication adherence.
Physical activity
A similar model was utilised to determine levels of physical activity. In the first
block patients' age, gender, number of years married, disease duration, weight and
BMI were entered, patient and partner representations were entered in the second
and third block respectively. The final equation of this model demonstrated that
those with a greater BMI were less likely to engage in physical activity (p <.05).
None of the patient or partner representations of diabetes were significant
predictors.
Anxiety
To determine which representations of diabetes predicted levels of psychological
morbidity the same procedure was used as for physical activity.
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The final equation demonstrated that lower levels of anxiety were predicted by
emotional representations (p <.01), identity when blood-glucose is high (p < .001) and
identity when blood-glucose is low (p <.01). None of the partners'
representations emerged as predictors of levels of anxiety.
Depression
Patients perceiving stronger perceptions of the consequences of diabetes predicted
clinically significant levels of depression (p <.01). In addition, patients believing
that the cause of their diabetes was due to their 'own behaviour' predicted lower
levels of depression (p <.05). Partners' beliefs in the importance of treatment for
controlling the patients' diabetes in the frture emerged as a predictor clinically
significant depression (p <.05).
Dyadic adjustment
Dyadic adjustment in patients was negatively predicted by the duration of the
marriage (p < .05), and positively predicted by levels of illness coherence (p < .01).
Partners with strong beliefs that the patients' 'own behaviour' was a cause of
diabetes negatively predicted dyadic adjustment (p < .01)
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Table 4.10. Logistic regression analyses to examine predictive utility of diabetes representations at
time I on dietary outcome.
B	 OR	 P	 95% CI
Starch (g/d)
Identity - high bg
	 -.618	 .539	 .033	 .305 - .902
Fibre (gld)
Disease duration	 -.077	 .917	 .034	 .863 - .994
Gender	 -.110	 .331	 .022	 .129 - 251
Consequences	 .119	 1.126	 .030	 1.012- 1.253
Personal control (partner) 	 .120	 1.127	 .035	 1.008 - 1.261
Fat (°41d)
Consequences	 -.101	 .904	 .037	 .822 - .994
Cause - own behaviour	 .106	 1.112	 .022	 1.016 - 1.217
Saturated fat (°4fd)
Age	 -.045	 .956	 .013	 .923-.990
Carbohydrate (°/qld)
Cause - Hereditary 	 .344	 1.411	 .021	 1.054 - 1.888




-.111	 .895	 .036	 .807 - .993
Fruit and vegetables &d)
Control 'now' (partner) 	 -.161	 .852	 .001	 .777 - .934
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Diet
Regression analyses were also conducted to determine which representations of
diabetes were predictors of dietary components. In the first block patients' age,
gender, years married, disease duration, weight and BMI were entered, patient and
partner representations were entered in the second and third block respectively.
(The results are summarised in Table 4.5).
Saturated Fat
Intake of saturated fat was negatively predicted by age (p <.05) such that older
participants consumed less saturated fats. None of the patients' or partners'
representations of diabetes were significant predictors of saturated fat intake.
Fat
The patients' belief in the consequences of diabetes was a significant predictor (p
<.05) of lower fat intake, whereas greater fat intake was predicted by a belief that
their 'own behaviour' was cause of diabetes (p <.05).
Fibre
Intake of dietary fibre was negatively predicted by disease duration such that
patients with a longer standing diagnosis consumed less fibre (p <. 05). Patients'
gender also predicted lower fibre intake such that females were less likely to
consume fibre (p <.05). Patients' holding stronger beliefs in the consequences of
diabetes were predictive of higher fibre intake (p <.05). Finally, patients with




Patients' holding stronger beliefs in their personal control of diabetes were less likely
to consume sugar (p < .05).
Starch
Patients perceiving greater symptoms when blood-glucose is high were less likely
to consume starchy foods (p <.05).
Carbohydrate
The consumption of carbohydrates was more likely if patients had a strong belief
in 'hereditary' factors with regard to the cause of diabetes (p <.05) and less likely if
partners had a strong belief in treatment control (p < .05).
Fruit and vegetables
Finally, patients whose partners held a strong belief in the importance of the
treatment for controlling the patients' diabetes now were less likely to consume
recommended levels of fruit and vegetables per day (p <.05).
4.6. Summary
The results have provided an indication of the relative importance of the
representations of patients with type 2 diabetes and their partners. From this first
phase of data collection two main issues emerged from the analyses. First, the data
demonstrate that patients and partners are largely in agreement with regard to
their beliefs about diabetes as significant differences were identified for only one of
the 5 'core' dimensions of illness representation, namely personal control. Second,
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the results have highlighted how patients' and partners' representations of
diabetes are associated with aspects of patients' self-management of diabetes and
psychological morbidity.
Relationship between patient and partner representations
Considering patients' and partners' representations first, significant differences
were found for only 3 of the 14 diabetes-specific dimensions, namely; personal
control, illness coherence, and control-future (efficacy of treatment to avoid future
complications). The direction of the relationships indicated that partners were less
likely to believe that patients have the ability to control their illness (self-efficacy).
Partners also believed that patients had a less clear understanding of diabetes.
More positively, partners were more open to believing that the patients' treatment
would assist in avoiding future complications arising from diabetes.
Representations as predictors of self-management
It is clear, to some extent, that partners' representations may influence how the
patient manages their disease and was explored through independent t-tests and
logistic regression analyses. Turning first to medication adherence, partners held
higher time-line, personal control, treatment control beliefs than patients. This
suggests that partners held more realistic beliefs with regard to the chronicity of
diabetes, and believed in the patients' ability to control the disease and that the
treatment was effective. Such beliefs appear to be counter-intuitive considering
these partners' beliefs were associated with patients reporting 'sub-optimal'
adherence. There was, however, consensus with regard to cause, as both partners
and patients were more likely to endorse the patient's 'own behaviour' as a cause
of diabetes. However, logistic regression analyses demonstrated that partners'
representations did not emerge as significant predictors of patients' medication
adherence after controlling for demographic and patient variables.
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In contrast to medication adherence, levels of intentional physical activity were
low and likely to be due to the age and the high incidence of co-morbidity in the
sample. Nevertheless, physical activity was positively associated with partners'
representation of the patients' personal control beliefs. Furthermore, regression
analysis demonstrated that BMI was a negative predictor of physical activity.
Therefore, patients engaging in exercise were not hindered by advancing age but
by increasing body mass. It is speculated that such low levels of reported activity
may have prevented the identification of significant predictors.
The cornerstone of the treatment regimen for type 2 diabetes is the maintenance of
a 'healthy' diet. It is this aspect of the treatment regimen which one would expect
to involve a partner the most due to social norms and the context in which meals
are consumed. For patients, stronger beliefs in the consequences of diabetes were
associated with less consumption of saturated and total fat and more fibre.
Partners' with stronger time-line beliefs were associated with less fat intake in
patients, belief in personal control was associated with higher fibre consumption
and partners' treatment control beliefs were associated with less carbohydrate
consumption. With regard to sugar consumption, patients with partners
expressing stronger treatment control beliefs consumed higher sugar diets and
partners were more likely to attribute the condition to the patients' 'own
behaviour'.
Once logistic regression analyses were conducted it was revealed that patients'
beliefs in the consequences of diabetes significantly predicted reduced fat intake and
greater fibre intake. Stronger time-line beliefs also predicted greater fibre intake. In
addition, patients' perception of the degree of personal control they had over their
diabetes predicted lower sugar intake whereas higher carbohydrate consumption
was predicted by beliefs that diabetes has a hereditary component with regard to
cause.
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It was evident that partners' representations had a degree of influence on patients'
dietary behaviour. Patients were likely to consume less than recommended levels
of carbohydrate if their partners believed they held strong treatment control beliefs
and more likely to consume carbohydrates if the cause of diabetes was believed to
be 'hereditary'. Furthermore, patients were less likely to consume fruit and
vegetables if their partners had a stronger belief in treatment to control diabetes
now. It is, however, debatable to what extent carbohydrate consumption is
detrimental to good management of diabetes. In conclusion, the results provide
evidence that patients' representations of diabetes impact on medication, physical
activity and dietary behaviour. However, more importantly it appears that
partners' representations are also predictors of the patients' management
behaviours after the influence of patients' representations of diabetes.
Representations and psychological morbidity
It is clear that high levels of anxiety were prevalent in the patients in this study and
were greater than those reported for depression. This was reflected in the number
of significant patients' representations of diabetes that were associated with
anxiety. Interestingly, emotional representations and perceived identity when blood-
glucose was low and high were associated with less anxiety.
Patients' with stronger beliefs in the consequences of diabetes were more likely to
suffer with depression but were less likely to do so if that believed the cause was
due to their 'own behaviour'. It appears that patients who have a less optimistic
view of their condition are more likely to suffer with depression but may fare
better if they take some responsibility for the onset of the disease.
Partners' representations of the importance of treatment to control diabetes future
was, however, associated with depression in patients and emerged as a positive
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predictor in the regression analysis. This is difficult to interpret but may mean that
although partners' have a strong belief in the outcome of treatment, patients' may
not share such optimism which may, in turn, contribute to greater depression.
Representations and dyadic adjustment
It is interesting to note that levels of dyadic adjustment in patients were negatively
predicted by the duration of the marriage and were greater in patients with higher
levels of illness coherence. In addition, partners with strong beliefs that the
patients' 'own behaviour' was a cause of diabetes negatively predicted dyadic
adjustment. Such results suggest that representations of diabetes have important
implications for the marital relationship. Indeed, it would appear that happier
relationships are enjoyed by patients in less established relationships, have a better
understanding of the condition with partners who do not view the onset of
diabetes as being the fault of the patient.
4.7. Conclusions
It is not clear whether or how patient and partner representations interact.
However, in the logistic regression analyses it was either patient or partner
representations that were associated with a particular outcome variable which may
be a function of the extent that patient and partner representations were correlated.
The direction of the observations are not certain as the data are cross-sectional.
Nevertheless, it is clear that partners' representations play a role in some aspects of
patient behaviour and psychological well-being. The stability of diabetes
representations and their predictive utility will be examined prospectively with the
12-month follow-up data.
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CHAPTER 5: RESULTS - TIME 2
5.1. Introduction
The analysis and findings of the time 1 data were described in Chapter 4. This
chapter will describe the patient-partner diabetes representations and patients'
behavioural and psychological outcomes assessed at time 2. In particular, this
chapter describes the stability of patient-partner diabetes representations,
differences between patients' and partners' representations, and the utility of
representations assessed at time 1 in predicting patients health behaviours
controlling for previous levels of adherence with the recommended behaviours.
As at time 1 the relationship between patient-partner representations in relation to
measures of psychological morbidity and dyadic adjustment are also assessed.
Follow-up population
All patients and partners participating at time 1 were contacted again
approximately 12 months later (12-14 months) and invited to complete follow-up
questionnaires and provide a blood sample for the study. The slight variation in
follow-up was for two logistical reasons. Firstly, patients were invited to attend a
clinic based on their geographical location (Bristol or Weston-Super-Mare) to
provide blood samples and secondly to ensure that the collection of the blood
sample coincided with the completion of the follow-up questionnaires.
The follow-up questionnaire booklet assessed representations of diabetes and self-
reported levels of diet, exercise, medication, psychological morbidity, dyadic
adjustment, BMI and was identical to that used at time 1. Of the original 164
patient-partner dyads, 134 dyads completed the time 2 questionnaire booklet thus
yielding a response rate of 81%. Of these 134 patients a total of 102 consented to
provide a blood sample for the study (a response rate of 76%).
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Independent t-tests were conducted to determine if differences existed between the
characteristics and diabetes representations of patient-partner dyads completing
questionnaires at time 1 only (n=30) compared with those completing at both time-
points (n134). No significant differences were found for age, years cohabiting,
disease duration, weight, BMI and number of prescribed medications. Significant
differences were found, however, for patients' representations of diabetes. The
degree of illness coherence for patients assessed at both time-points was less than
those assessed at time 1 only (t (162) = -2.12, p <.05). Patients assessed at both time-
points also held stronger beliefs that the cause of diabetes was hereditary (t (162)= -
2.15, p <.05). Partners assessed at both time-points exhibited stronger beliefs in the
patients' personal control of diabetes (t (162) = -2.57, p <.01). Descriptive statistics
for patient and partner representations of diabetes at both time-points are shown
in Table 5.1.
HbAlc
All assays of HbAlc (n=102) were processed using the Menarini-Arkray HA 8140
haemoglobin Aic analyser (John et al., 1997) at the Department of Clinical
Biochemistry, Bristol Royal Infirmary. The distribution of scores for HbAlc ranged
from 4.20% to 12.9% the mean was 7.4 (SD=1.26), the median was also 7.4 (see
Figure 5.1). Only 14% of scores fell within the recommended range for HbAlc
(between4% and6%). Afurther56% ofscoresfellbetween6% and8%. Thus,
overall, patients who consented to HbAlc testing were considered to be in
reasonable control of their disease. Nonetheless, 30% of the sample had elevated
HbAlc scores (i.e., > 8%). The score were split at the median value of 7.4% for








Std. Dev = 1.26
Mean = 7.4
N 102.00
Figure 5.1 Distribution of scores for HbAlc at time 2 (n102)
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5.2. Stability of diabetes representations between time 1 and time 2
A series of t-tests were conducted to examine if differences existed between
patients representations of diabetes at time 1 and time 2 (descriptive statistics are
shown in Table 5.1). It is evident that scores for a number of representations of
diabetes remained stable over the 12-14 month follow-up period (see Table 5. 2).
These stable representations were cyclical time-line, illness coherence, and cause. In
addition, the degree of perceived symptoms related to the illness when blood
glucose was low or high as measured by the identity sub-scales did not did change
between time and time 2. However, significant increases between time 1 and time
2 were evident for patients' time-line scores and emotional representations indicating
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that patients viewed their diabetes as lasting longer and having a bigger emotional
impact at time 2. A significant decrease was evident for perceived consequences,
and beliefs in personal control, treatment control, and the importance of treatment to
control diabetes now between time 1 and time 2. Thus, patients viewed their
diabetes as having fewer serious consequences and being less amenable to control
at time 2.
Stability of partners' representations from time 1 to time 2
Differences in partners' representations also emerged between time 1 and time 2.
Increased time-line beliefs reflected the chronicity of diabetes at time 2.
Additionally, personal control, treatment control and control-future beliefs also
decreased indicating that partners viewed the patients' diabetes as lasting longer
and was less controllable at time 2. Partners' beliefs that the patient's 'own
behaviour' was a cause of diabetes also increased over the follow-up period.
However, no significant changes were evident for partners' representations
regarding perceived consequences of diabetes and the importance of treatment to
control diabetes now. The results are shown in Table 5.2.
Table 5.1. Descriptive statistics for diabetes representations for patients and
partners at time 1 (n=134) and time 2 (n=134).
Time 1 (n=134)	 Time 2 (n134)
Representation	 Patient	 Partner	 Patient	 Partner
Timeline-acute	 23.4 (4.1)	 22.9 (4.0)	 24.8 (4.3)	 25.1 (3.5)
Timeline-cyclical	 11.6 (3.4)	 10.5 (4.1)	 10.8 (3.2)	 10.5 (3.0)
Consequences	 17.3 (4.0)	 17.0 (4.5)	 16.3 (4.1)	 16.5 (3.7)
Personal control	 22.6 (3.9)	 20.6 (5.1)	 21.2 (4.0)	 21.1 (3.3)
Treatment control	 22.3 (5.2)	 23.9 (3.5)	 19.8 (3.0)	 20.1 (3.2)
Illness coherence 	 16.0 (4.3)	 17.6 (4.3)	 17.7 (4.9)	 18.3 (4.3)
Emotional reps	 12.6 (3.9)	 12.6 (5.1)	 14.6 (4.7)	 15.5 (5.1)
Control-now	 60.2 (5.8)	 61.9 (3.2)	 58.4 (6.7)	 60.5 (5.4)
Control-future	 61.0 (4.9)	 62.5 (3.0)	 59.3 (6.1)	 60.1 (6.5)
Cause-behaviour	 14.7 (3.2)	 14.5 (3.7)	 14.2 (4.2)	 15.7 (4.4)
Cause-external	 13.3 (3.5)	 12.6 (3.5)	 12.1 (3.7)	 12.1 (3.9)
Cause-hereditary	 2.8 (1.2)	 3.0 (1.3)	 3.35 (1.3)	 3.28 (3.9)
Identity-high bg	 3.6 (2.3)	 3.4 (1.9)	 3.02 (2.0)	 3.33 (2.2)
Identity-low bg
	
3.5 (2.5)	 2.7 (2.3)	 3.41 (2.5)	 3.31 (2.5)
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Differences between patients' and partners' representations of diabetes from time 1 to time
2
A series of t-tests were also conducted to identify if significant differences exist
between patients' and partners' representations of diabetes at follow-up, the
results are shown in Table 5.2. It was found that partners held stronger beliefs in
the importance of treatment to control diabetes now and partners' also held a
stronger belief that the patients' 'own behaviour' was a cause of diabetes. At time 2
the differences between patient and partner representations were not consistent
with the results of time 1 which found differences between patients and partners
for three dimensions; illness coherence, personal control, and the importance of
treatment to avoidftiture complications of diabetes.
Table 5.2. Summary of t-tests comparing, patient and partner diabetes representations between
time 1 (n = 134) and time 2 (n =134) and results of t-tests for differences between patients and
partners at time 2
Patients versus
Ti to T2












Consequences	 2.510* Ii	 1.509	 -.148
Personal control	 6 .493*** J.	 4.653***	 -1.02
Treatment control 	 8.996***	 8.141***	 -1.90
Illness coherence	 .311	 931	 -3.24
Emotional representations 	
_7.384***1'	
_4 . 969*** 1'
	
-1.46
Control-now	 3.729*** +	 .985
	 3.24**
Control-future	 3039**	 2.220*	 -.415
Cause-own behaviour	
.399	 3.638*** 1'	 2.89*
Cause-external	 1.342	 .961	 -.415







p <.05, **p <.01, '4"p <.001, Time 1 df= 133, Time 2 df= 133
Note: 1' I- = Direction of change
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Dyadic adjustment
Dyadic adjustment for patients at time 2 remained stable with a mean of 27.8 (6.8)
compared with 28.1 (5.8) at time 1 (t (133) = -.72 7, p >.05). Scores for partners also
remained stable with a mean of 28.7 (6.1) compared with 28.2 (5.7) at time 1 (t (133)
.376, p >.05). As at time 1, there was no significant difference in dyadic
adjustment between patients' and partners' scores at time 2 (t (133) = -.687, p >.05).
Body Mass Index
Mean body weight at time 2 was 87. 2 kg (SD=29.6) compared with 91.8 kg (17.7) at
time 1. This weight reduction at time 2 also equated to a reduced mean BMI of 29.5
(Range = 19-47, SD=6.2) compared with 32.2 (Range 17-48, SD=5.53) at time 1. At
time 2 a total of 76.5% of the sample score above the cut-off for being overweight of
>25 compared with 90% at time 1. However this apparent weight reduction was
not statistically significant when t-tests were conducted on BMI scores (t (97)
1.42, p >.05).
5.3. Stability of outcome measures between time 1 and time 2
Diet
The descriptive data for the 7 dietary components assessed in the study are shown
in Table 5.3. A series of t-tests demonstrated that the dietary components of
percentage of fat, saturated fat, sugar and carbohydrate per day, and grams of
fruit and vegetables per day showed no significant differences between time 1 and
time 2. However, patients were consuming significantly less starch (p < .05) and
fibre (p <.05) per day in their diets when assessed at 12-14 months.
The percentage of patients underreporting energy intake at time 2 was 72.5%
compared with 76% at time 1. However, this reduction was not statistically
significant (t= -5.05, p >.05).
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Food Type	 Mean %	 Mean O,/ per Mean grams Mean grams	 t
per day	 day	 per day (gld) per day (gJd)
Total Fat
	 30.8 (7.3)	 31.4 (8.0)	 62.1 (38)	 60.7 (38)	 -1.02
Saturated Fat	 11.2 (3.7)	 11.3 (3.8)	 22.6 (14.1)	 22.1 (15.3)	 -.666
Carbohydrate	 46.7 (9.2)	 46.9 (9.9)	 229.3 (149.2)	 212.1 (132.7)	 -.047
Starch	 28.4 (7.8)	 27.9	 140.3 (105.6)	 123.4 (67)	 1.961*
Sugar	 6.96	 7.22 (3.4)	 33.5 (26.6)	 34.0 (34.3)	 -.920
Fibre	 n/a	 N/a	 19.06 (14.7)	 16.5 (8.8)	 2.217*
Fruit & Vegetables	 n/a	 N/a	 398.9 (292.6)	 359.2 (243.9)	 1.763
<.05, df =133
Table 5. 4. Descriptive data for physical activity, medication
and psychological morbidity at time 1 (n=r134) and time 2 (n'134)
Time 1	 Time 2
	 t
Variable	 Mean (SD)	 Mean (SD)
Physical Activity	 6.36 (3.28)	 7.56 (3.03)	 _5.110***
Medication	 28.3 (3.21)	 27.9 (5.0)	 .652
Anxiety	 11.6 (2.8)	 9.71 (1.97)	 7.068***
Depression	 8.65 (1.97)	 10.8 (2.02)	 _9.008***




The mean score for physical activity significantly increased (p < .001) from time 1
to time 2 (see Table 5.4).
Medication
Self-reported medication adherence remained very high and did not change
significantly between time 1 and time 2 (see Table 5.4).
Anxiety and depression
Scores for the anxiety sub-scale of the HADS decreased (p < .001) between time 1
and time 2 while scores for depression increased (p <.001), as shown in Table 5.4.
5.4. Prospective relationships between diabetes representations at time 1 and
outcome measures at time 2: Independent t-tests
As at time 1, a series of independent t-tests were conducted to examine the
prospective relationships between diabetes representations at time 1 and the
outcome variables pertaining to diet, physical activity, medication adherence and
psychological morbidity. For consistency, the scores for these outcome measures
were split as at time 1. In addition, the relationship between diabetes
representations and blood-glucose control (HbAlc) was also examined.
Medication
Patients' with stronger representations of personal control at time 1 (M = 24.0 vs
22.5,t (106) = 2.06, p <.05) and illness coherence (M = 19.0 vs 17.2, t (106) = 2.02, p
<.05) had 'sub-optimal' adherence to medication at time 2. Whereas patients
believing more strongly in the importance of treatment to control diabetes now had
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'optimal' medication adherence (M 61.8 vs 59.9, t (106) = -2.01, p <.05). No
significant relationships were found between medication adherence and partners'
representations.
Physical activity
Patients with stronger perceived time-line (M 24.1 vs 22.2, t (132) = -2.19, p <.05)
and beliefs in the importance of treatment for avoidingftLture complications of
diabetes at time 1 (M 61.7 vs 59.8, t (132) = -2.25, p <.05) engaged in higher levels
of physical activity at time 2. For patients whose partners held a greater, cyclical
time-line (M = 11.2 vs 10.1, t (132) = 2.16, p <.05) and a belief that patients' 'own
behaviour' was a cause of diabetes at time 1 engaged in less physical activity at
time 2 (M = 14.7 vs 13.1 = t (132) =1.95, p <.05).
Anxiety
Patients' perceiving greater symptoms of diabetes when blood-glucose was high (M
= 4.30 vs 2.58, t (132) = -4.65, p <.001) and low (M = 4.0 vs 2.64, t (132) = -3.28, p
<.01) at time 1 experienced clinically significant levels of anxiety at time 2. There
were no significant relationships between partners' representations of diabetes and
patients' levels of anxiety.
Depression
Patients with stronger cyclical time-line beliefs (M = 11.5 vs 10.3, t (132) = -2.55, p
<.05) and emotional representations (M = 12.6 vs 11.3, t (132) = -2.13, p <.01) at time 1
experienced clinically significant levels of depression at time 2. There were no




Patients with greater time-line beliefs at time 1 had a high consumption of fruit and
vegetables at time 2 (M = 24.8 vs 22.9, t (132) = -2.43, p <.05). Patients with
partners' with greater time-line beliefs also consumed more fruit and vegetables (M
= 25.5 vs 23.5, t (132) = -2.69, p <.05) of diabetes. However, patients with partners'
perceiving greater symptoms when blood glucose is high (M = 3.68 vs 2.46, t (132) =
2.93, p <.01) and held stronger beliefs in treatment to avoid complications in the
future (M= 62.5 vs 61.1, t (132) = 2.23,p < .01) consumed less fruit and vegetables at
time 2.
Fat
There were no differences in the initial diabetes representations between high and
low fat consumers at time 2. However, patients whose partners demonstrated
greater beliefs in treabnent control had higher fat consumption (M = 24.7 vs 23.1, t
(132) = -2.66, p <.01).
Saturated Fat
Patients with stronger identity scores when blood glucose is high at time 1
consumed more saturated fat at time 2 (M = 3.38 vs 2.63, t (132) = 2.03, p < .01).
Patients with partners holding stronger beliefs in the patients' personal control of
diabetes at time 1 consumed less saturated fat consumption at time 2 (M = 24.1 vs
22.8, t (132) =2.lO,p <.05).
Carbohydrate
There were no differences in the initial representations of diabetes between low
and high consumers of carbohydrate at time 2. Patients with partners perceiving
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stronger emotional representations of diabetes at time I consumed less carbohydrate
at time 2 (M = 12.7 vs 11.0, t (132) = -2.15, p <.05). In addition, patients with
partners' perceiving that 'own behaviour' was a cause of diabetes at time 1
consumed more carbohydrate at time 2 (M = 15.3 vs 13.2, t (132) = -2.58, p <.01).
Sugar
Patients' with greater beliefs in treatment to control diabetes now (M= 61.9 vs 59.6, t
(132) = -2.03,p < .05). and to avoidjidure complications (M= 62.8 v 60.5, t (132) = -
2.22, p < .05) at time 1 were greater consumers of sugar at time 2. Patients with
partners' reporting stronger beliefs in patients' personal control of diabetes at time 1
consumption more sugar at time 2 (M = 25.0 vs 23.0, t (132) = -2.47, p <.01).
However, patients with partners perceiving the consequences of diabetes to be more
serious at time 1 consumed less sugar at time 2 (M= 17.2 vs 15.4, t (132) = 2.8O,p <
.05). Finally, patients with partners perceiving a stronger illness identity when
blood glucose is high at time 1 consumed less sugar at time 2 (M = 3.44 vs 2.40, t
(132) = 3.07, p < .01).
Starch
There were no differences in the initial representations of diabetes for patients or
partners with regard to starch intake at time 2.
Fibre
Patients consuming higher proportions of fibre in their diet at time 2 held stronger
time-line beliefs (M = 25.1 vs 22.9, t (132) = -2.73, p <.01) and perceived consequences
at time 1 (M = 18.4 vs 16.7, t (132) = -2.41, p <.05). Patients with partners holding
stronger perceptions of the patients' belief in personal control (M = 25.1 vs 22.7, t = -
3.66, p <.001) and treatment control (M = 25.0 vs 23.2, t (132) = -2.96, p <.01) at time 1
consumed more fibre at time 2. Less fibre consumption by patients at time 2 was
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more likely if partners reported that patients' experienced stronger emotional
representations of diabetes at time 1 (M = 12.7 vs 10.7, t (132) = 2.57, p <.01).
Dyadic adjustment
Patients' with stronger emotional representations at time 1 were reported more
dyadic adjustment at time 2 (M = 12.3 vs 10.8, t (132) = 1.94, p <.05).
HbAlc
Patients' reporting more symptoms when blood glucose was high (M 3.50 vs
2.69, t (100) =2.62, p <.01) and greater beliefs in an 'external' cause of diabetes at
time 1 (M = 13.5 vs 11.5, t (100) -2.59, p <.05) had poorer control of blood-glucose
at time 2 (higher HbAlc scores). Patients with partners endorsing 'hereditary'
factors as a cause of diabetes at time 1 (M = 3.31 vs 2.76, t (100) = -2.09, p <.05) also
had poorer control of blood-glucose at time 2.
5.5. Predictive utility of diabetes representations at time 1 and outcome
measures at time 2: Logistic regression analyses
In line with the analysis of the time 1 data, to assess the predictive utility of
diabetes representations at follow-up, a series of logistic regression analyses was
conducted. A similar procedure was therefore employed as at time 1 to determine
which of the patients' and partners representations at time 1 prospectively
predicted behavioural and psychological outcomes at time 2. To control for clinical
and demographic factors relevant variables were entered in the first block in all
analyses. These were age, gender, disease duration, years married and BMI and
number of prescribed medications for medication adherence. Patients'
representations were entered in the second block. Partners' representations were
entered in the third block. Finally, past behaviour has been found to be the
strongest predictor of future behaviour when it is included in models such as the
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theory of planned behaviour (TPB; Ajzen, 1988) and is often seen to have a direct
effect on future behaviour over and above the influence of sodal-cognitive
variables (Ajzen, 1991; Oulette & Wood, 1998; Yzer, Siero, & uunk, 2001).
Therefore the regression model was modified by including past behavIour (i.e.,
exercise adherence at time 1) as an independent variable in the fourth block to
examine if it has a direct effect on adherence at time 2. A stepwise procedure was
employed to enter each block of variables in the regression model.
Finally, an additional logistic regression analysis was conducted to determine the
extent that diabetes representations predicted glucose control. The results of these
analyses are displayed in Tables 5.5. and 5.6.
Medication
Patients who believed they had a greater understanding of their illness at timel
(illness coherence) were less likely to adhere to medication at time 2 (p <.01). In
addition, by entering past behaviour in to the regression equation it is apparent
that those adhering well at time 1 were likely to continue doing so at time 2 (p
<.05).
Physical activity
Patients with higher BMI scores at time 1 were less likely to engage in physical
activity at time 2 (p <.01). In addition, a belief in the importance of treatment to
avoid fit ture complications of diabetes predicted more frequent exercise at time 2 (p
<.05). As with medication adherence patients exercising regularly at time 1 were
more likely to be doing so at time 2 (p =.001).
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Anxiety
Patients with more realistic views (i.e. chronic) regarding the duration of diabetes
at time emerged as a predictor of clinically significant levels of anxiety at time 2 (p
<.01). Patients with greater beliefs in personal control at time iwere more anxious
at time 2 (p <.01). However, patients perceiving greater levels of illness coherence
were less likely to suffer with anxiety at time 2 (p <.01).
Those experiencing more symptoms when blood glucose was high at time iwere
nearly 2.5 times more likely to have clinically significant anxiety at time 2 (p <.01),
whereas those believing that the cause of diabetes was due their 'own behaviour' at
time 1 were less anxious at time 2 (p <.01).
Depression
The level of depression at time 1 was the only significant predictor of depression at
time 2 to emerge from the logistic regression analyses (p <.05).
Dyadic adjustment
At time 1 patients with stronger emotional representations (p <.05) and partners'
cyclical time-line beliefs (p <.05) were predictive of lower levels of dyadic
adjustment at time 2.
Glucose control
A number of representations of diabetes at time 1 were predictors of levels of
HbAlc at time 2. First, patients with a strong belief in an 'external' cause of
diabetes were in poorer control of their diabetes (p <.05). Patients whose partners
endorsed a hereditary cause of diabetes were in poorer control of their diabetes (p
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patients' treatment to control diabetes now were in better control of their diabetes (p
<.05).
Table 5.5. Results of logistic regression to examine predictive utility of demographic and diabetes
representations at time i on behaviour, psychological morbidity and glucose control at time 2
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Table 5.6. Results of logistic regression to examine predictive utility of demographic and
diabetes representations at time 1 on dietary outcome at time 2.
B	 OR	 P	 95%CI
Starch (gld)
BMI	 -.235	 .790	 0.49	 .625 - .999
Fibre (gfd)
Personal control (partner) 	 .164	 1.179	 .034	 1.012 - 1.373
Emotional reps (partner) 	 -.148	 .862	 .030	 .754 - .985
Fat (°/1d)
Treatment control (partner)	 .173	 1.189	 .028	 1.019 - 1.387
Fat(timel)	 .081	 1.084	 .008	 1.022-1.151
Saturated fat (°//d)
Years cohabiting 	 .044	 1.045	 .010	 1.012 - 1.078
Control-future	 -.091	 .913	 .054	 .832 - 1.002
Carbohydrate (°A/d)
Cause-own behaviour (partner)	 .187	 1.206	 .002	 1.074 - 1.354
Carbohydrate (time 1)
	
.124	 1.091	 .000	 1.064 - 1.206
Sugar (°A/d)
Control-future	 .233	 1.662	 .029	 1.024 - 1.555
Cause - 'external' 	 -.196	 .822	 .041	 .681 - .992
Personal control (partner) 	 .261	 1.298	 .017	 1.048 - 1.608
Sugar (time 1)	 .344	 1.411	 .000	 1.165 - 1.708
Fruit and vegetables (gld)
Gender	 1.085	 2.959	 .040	 1.049 - 8.347
Time-line (partner)	 .174	 1.190	 .009	 1.044 - 1.356
Identity-high bg (partner)	 -.262	 .769	 .031	 .606 - .976
Fruit and vegetables (time 1) 	 .002	 1.002	 .040	 1.000 - 1.003
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Starch
Consumption of starch at time 2 was predicted by patients' BMI scores such that
patients with higher BMI scores were less likely to consume starchy foods (p <.05).
None of the patients or partners scores were predictors of starch intake.
Fibre
A high-fibre diet at time 2 was more likely to be consumed by patients with
partners holding a strong belief in their personal control of diabetes at time 1 (p
<.05). However, partners' beliefs that the patient experiences stronger emotional
representations regarding the condition at time 1 predicted less fibre intake at time 2
(p <.05).
Fat
Patients with partners expressing stronger treatment control beliefs were more likely
to consume a higher fat diet. In addition, those consuming more fat at time 1 were
more likely to do so at time 2 (p <.01).
Saturated fat
The number of years living with a partner increased the likelthood of consumption
of saturated fat at time 2 (p <.01). Patients holding stronger beliefs that the
treatment for their diabetes would be effective in controllingfuture complications of
diabetes predicted less fat intake (p <= .05).
Carbohydrate
Patients whose partner's believed more strongly that the cause of diabetes was due
to the patients' 'own behaviour' at time 1 were more likely to consume a high
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carbohydrate diet at time 2 (p .01). In addition, those consuming high levels of
carbohydrate at time 1 were more likely to continue to do so at time 2 (p =.001).
Sugar
Patients holding stronger beliefs in the importance of the treatment to prevent
complications of diabetes in the future at time 1 were more likely to consume sugar
in their diet at time 2 (p <.05). Patients attributing the cause of their diabetes
'external' factors were less likely to consume sugar at time 2. However, patients
with partners holding stronger personal control beliefs were more likely to consume
a high sugar diet (p <.05). Finally, patients eating higher levels of sugar at time 1
were more likely to do so at time 2 (p <.001).
Fruit and vegetables
Finally, the gender of the patient predicted the consumption of fruit and vegetables
such that females were more likely to consume these items (p <.05).
Higher consumption of fruit and vegetables at time 2 was also observed in
patients holding greater time-line beliefs at time 1 (p <.01). Finally, patients with
partner's reporting a stronger illness identity when blood glucose was high ate less
fruit and vegetables at time 2 (p <.05).
5.6. Summary
The results of diabetes representations at time 1 (Chapter 4) show that
representations of both patients and partners were associated with levels of
adherence to recommended treatment for diabetes such as medication, physical
activity and dietary behaviour. In addition, the impact of such representations on
psychological morbidity was assessed and showed that diabetes representations
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were also predictive of anxiety and depression in such patients. This chapter
examined the extent to which diabetes representations are stable over a 12-month
period and the differences between patients' and partners' representations at
follow-up. Furthermore, the extent to which these representations prospectively
predicted adherence and control of diabetes was also examined, after controlling
for previous levels of adherence. Achieving a good follow-up response rate of
over 80% has enabled comparisons of diabetes representations at both time-points
to be made with a good degree of confidence and these are examined further
below.
Stability of diabetes representations and outcome variables
By assessing diabetes representations at 12 months it has been demonstrated that,
at least in the present sample, that some dimensions are not stable over time. This
was true for both patients and partners, such that the direction of change in
partners' representations was the same as for the patient. This was true also for
most dimensions except consequences (which decreased for patients) and a belief in
'own behaviour' as a cause of diabetes (which increased for partners). In addition,
differences between patients' and partners' representations at time 2 were evident
for only two dimensions and did not replicate differences at time 1. These
differences existed for the perceived importance of treatment for diabetes for
controlling the condition now (partners had stronger beliefs) and beliefs that the
'own behaviour' of patients was a cause of diabetes (partners held stronger beliefs).
Thus, as there were few differences at both time-points it may be concluded that
patients and partners share similar representations of diabetes but that their
representations are subject to change over time. It also cannot be determined
which party of the dyad influences the other; do patients' beliefs guide the partner
or vice-versa?
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It was interesting to note that while identity scores remained stable at time 2,
dimensions pertaining to the control of diabetes changed at time 2 reflecting a less
optimistic or positive view of diabetes. In addition, patients' emotional responses
to having diabetes increased such that they perceived more fear, anxiety etc with
regard to their diabetes over the follow-up period. Such findings suggest that
beliefs regarding the control of diabetes and the emotional impact of the disease
may operate independently of the extent of symptoms experienced by patients
living with diabetes.
Both patients' and partners' representations of personal control and treatment control
significantly decreased at time 2. In addition, patients' beliefs in consequences of
diabetes and patients' belief in the importance of treatment to control diabetes now
and to avoid complications in the future decreased at time 2. However, reductions
in these beliefs did not appear to result in reduced levels of adherence to either
medication or exercise (in fact, exercise levels increased). In addition, levels of
adherence to diet remained stable for consumption of fats, sugars and fruit and
vegetables, however, there was a reduction in starch and fibre (diabetes patients
are recommended to eat a diet high in starch and fibre). Thus, this varied pattern
of adherence suggests that it is aspects of the dietary regime that patients find most
difficult to follow. It is suggested that patients may find it difficult to sustain
positive changes in their food consumption.
The predictive utilitij of illness representations
The application of logistic regression analyses to test the predictive utility of time 1
diabetes representations with behavioural and psychological outcomes at time 2
did not confirm the results from the cross-sectional analyses at time 1. The
addition of 'past behaviour' in the equations and the reduced sample size at time 2
may partly explain these results.
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Although consistency could not be found between the two time-points there are
some results worthy of mention with regard to adherence. With regard to
psychological morbidity, perceived identity when blood-glucose was high was
inversely associated with anxiety at time 1 but at time 2 the direction of the
relationship was positive suggesting that the symptoms of high blood-glucose
increase levels of anxiety over time.
At time 2 adherence to medication was less likely to be executed by patients with a
greater understanding of diabetes. It is possible that patients with a greater
understanding of the condition are more adept at controlling their glucose levels
by manipulating their diets and levels of physical activity and are thus less reliant
on taking oral agents to manage their condition.
Physical activity, however, was less likely to be undertaken by those with greater
body mass and more likely to be undertaken by patients with stronger beliefs in
the importance of treatment for avoiding complications in the future. For dietary
behaviour logistic regression analyses demonstrated a number of pertinent
findings. First, patients' belief that treatment will be effective in avoiding
complications of diabetes in the future predicted less intake of saturated fat in their
diet whereas this representation predicted greater sugar intake. However,
patients' beliefs in an 'external' cause of their diabetes predicted lower sugar intake.
At time 2 partners representations were more ubiquitous than those of patients in
predicting outcomes. First, higher fibre intake was predicted by partners'
perceived personal control of the condition. However, partners' holding greater
beliefs that the condition has an emotional impact on the patient predicted less
fibre intake. Partners' representations of diabetes also predicted intake of dietary
fat such that treatment control beliefs predicted higher fat intake in patients. In
addition, the duration of living with a partner increased the likelihood of saturated
fat intake suggesting that higher fat diets result from longer relationships. Greater
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partner beliefs in the chronicity of diabetes enhanced patients' consumption of
fruit and vegetables whereas partners perceiving that the patient experiences more
symptoms (identity) when blood glucose was high predicted less vegetable
consumption. Finally, with regard to the cause of diabetes, partners' beliefs that the
patients' 'own behaviour' was instrumental predicted greater consumption of
carbohydrates. In conclusion, it appears that partners' representations of the
patients' condition are important with regard to the role they play in patients'




The first two chapters of this thesis reviewed the literature relevant to the present
research examining the role of significant others in the health behaviours of
patients with diabetes. In Chapter 1, the importance of the social context in
managing diabetes was addressed and Chapter 2 examined the predictive utility of
the illness representations framework in a range of outcomes in patients with
chronic disease including diabetes. Particular attention was given to the
importance and validity of assessing the illness representations of significant
others and their relationship with patient's adaptation in chronic disease.
This final chapter of the thesis discusses the findings of the research in the context
of previous work and arising methodological issues. As the results of analyses
conducted at both time-points are summarised in Chapters 4 and 5 respectively
they are not revisited in detail in the following discussion. The discussion, does,
however, give consideration to the study sample, analysis of data and the findings
in the context of the primary aims of the study; the assessment of diabetes
representations of patients and partners, differences between patient and partner
representations and the predictive utility diabetes representations with regard to
the behavioural and psychological outcome variables.
The discussion then proceeds with a critique of the selected measures of diabetes
management (described in Chapter 3) and offers suggestions for improving the
measurement of these outcomes. In addition, of relevance to the literature
reviewed in Chapter 1, the relationship between dyadic adjustment and social
support in the context of patient-partner representations of diabetes is addressed.
Finally, the cumulative findings accrued from the systematic review of the illness
representations literature (Chapter 2) and the present research have implications
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for future work. Indeed, the findings are considered to be particularly pertinent in
the guidance and direction of behavioural interventions aimed at improving the
self-management of diabetes.
6.2. Study sample
First, the generalisability of the results are supported by the attainment of a good
sample size (n=164 dyads) recruited from 35 geographically diverse primary care
surgeries. Jt is also reiterated that many of the patients approached for the study
had participated extensively in the Somerset and Avon Survey of Health (SASH).
This ongoing cohort study of chronic disease was in operation for some 10 years
previous to the commencement of the present project. Therefore to attain a
response rate of 44% in a postal questionnaire survey in this context is considered
particularly good considering that consent was also sought from patients' partners.
There are, however, some limitations relating to the sample. First, the extent of
previous participation implies that the recruited sample were 'self-selected' and
such attention received in the interests of research does not make them typical
patients. Secondly, although the mean age of 67 years reflects the expected age
range for the onset of the disease such an aged sample were suffering from a
variety of co-morbid conditions that may have affected the measurement of
diabetes-specific representations and outcomes. A final point is that patients from
ethnic backgrounds may have been underrepresented. This is an important issue
considering the reported increased prevalence of diabetes in Black and Asian
populations (Abate & Chandalia, 2003; Tong & Cockram, 2003).
The implications of sampling limitations
The methodological and sampling limitations described have implications for the
generalisability and meaning of the findings for patients with type 2 diabetes in the
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general population. The fact that many of the participants were long-standing
participants in SASH demonstrates that such patients are, by character, more
interested in their illness and its management. Additionally, by receiving feedback
from involvement in previous aspects of the SASH study it is possible that these
patients have a greater awareness of the issues that go hand in hand with living
with a chronic disease. Therefore, it must be considered that these 'primed' and
motivated individuals are, to some extent, better managed patients whereas
patients demonstrating poorer management of their diabetes would be less
forthcoming to participate in research of this nature. Indeed, the findings based on
the present participants may not necessarily have commonality with results
obtained from 'naïve' research' participants.
The extent of comorbidity reported by patients makes it difficult to delineate the
extent that responses to the illness representations questionnaire provide an
accurate insight of living with diabetes. For example, rheumatoid arthritis may be
more debilitating than well-managed diabetes in terms of its impact on lifestyle
which, in turn, may be related to levels of psychological morbidity. Although, the
illness representations measures were specifically worded for diabetes patients,
outcome measures such as the HADS provide a global indication of psychological
morbidity rather than being disease specific.
Finally, despite recruiting patients from a variety of geographically diverse GP
surgeries such a procedure did not yield a fair representation of ethnic minorities.
Therefore, it is not possible to state to what extent the diabetes representations of
Black and Asian patients are similar to those of White-European patients and
whether they are similarly predictive of outcomes. However, the participation rate
of ethnic minorities in the present study was not dissimilar to recruitment rates
found in previous studies undertaken within SASH.
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Overall, the issues outlined above may prove to be more salient in the event of the
development of interventions aimed at improving the self-management
behaviours of patients with type 2 diabetes. At present, it is premature to assume
that all patients with type 2 diabetes share similar representations and engage in
health behaviours equally despite of their management, disease and ethnic status.
6.3. Analysis of data
Treatment of patient and partner data
A primary aim of this thesis was to examine the relationship between the
illness representations of patients with type 2 diabetes and their
partners to determine the extent of dissimilarity between each party. Previous
studies examining the influence of illness representations of significant others in
chronic disease have focused on the extent of dissimilarity between patients and
significant others by calculating 'difference' scores (i.e., Heijmans et al, 1999,
Figueiras & Weinman, 2003; Urquhart-Law, 2002). However, in these studies, the
differences in patients' and partners' representations have not been calculated
consistently (the methods are described in Chapter 2). At present,
therefore, there is no consensus on how to best approach this relatively
new area of enquiry in the ifiness representations literature. Furthermore, as the
focus of the present thesis was explore the relative influence of partners'
representations on patients' health behaviours, examination of the degree of
dissimilarity was not considered the most appropriate approach. This view is
supported by t-test analyses which demonstrated that patients and partners were
in considerable agreement with regard to the dimensions measured. In view of
these considerations a decision was made not to gauge the magnitude of the
difference in representations. Instead, absolute values were used to evaluate the
influence of partner representations and to determine if they make an independent
contribution to patients' self-management behaviours and psychological outcomes.
As many of the outcome variables of interest were extremely skewed, (i.e.,
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medication, physical activity, anxiety, and some dietary components), analyses
were restricted to methods accommodating binary outcomes, namely binary
logistic regression.
The partners' representations were entered after patients'
representations in the logistic regression model in order to determine
the strength of their influence on patients' self-management behaviours.
The results revealed that a number of partners' representations were
significant independent predictors of dietary outcomes, glucose control,
psychological morbidity and dyadic adjustment. The robustness of the
findings are demonstrated with the narrow 95% confidence intervals which
did not cross 1 for each significant relationship.
Entry of variables into regression model
There is no evidence from past work to suggest a logical order for the
entry of the independent variables (diabetes representations) in the
logistic regression modelling. Therefore, stepwise entry of the
independent variables was chosen in favour of hierarchical entry. This
decision was supported by the absence of strong theoretical reasoning for entry of
the diabetes representations and the exploratory research aims -
in such circumstances a stepwise procedure is considered to be justified
(Field, 2000). Additionally, the schematic nature of the illness
representations framework suggests that each dimension may play an equally
important role in predicting outcomes thus negating any priority
of entry. Therefore, the entry of diabetes representations into the model
was decided on the statistical strength of the correlation with the
outcome of interest. The stepwise procedure also served to reduce the
number of variables entered at each step increasing the statistical power
of the model.
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Justification for logistic regression analyses
It is acknowledged that logarithmic transformations could have been
performed to 'normalise' the variables assuming a skewed distribution. This
approach would have made linear regression techniques
possible to predict the outcomes of interest as continuous rather than
discrete variables. It is also acknowledged that by splitting the
outcome variables at the median (medication, physical activity, marital
satisfaction) or recommended values! cut offs (diet, psychological
morbidity) to permit the use of logistic regression analyses prohibits
the range of variance in the self-reported behaviours and other outcomes
to be accounted for in the regression equations. Indeed, to some extent,
splitting the outcome data for binary analysis limits the extent that the
selected outcome measures are informative of patients 'behaviours.
Despite these considerations, a decision was made to employ logistic
regression analyses for binary outcomes. Several theoretical and practical
considerations led to the application of logistic regression procedures.
First, the extreme skewness of the distribution of scores for medication,
exercise, anxiety and some dietary components suggested it would be
appropriate to compute binary outcomes for these variables. Indeed, in nearly all
cases recommended or clinically recognised cut-offs are available, and thus, where
possible, the outcome data were split according to these recommended/recognised
cut-offs.
Second, a further advantage of the logistic regression approach is that
it makes no restrictive assumptions about the distribution of the independent
variables and their relationships with the dependent variables; i.e., they do not
have to be normally distributed, linearly related or of equal variance within each
group (Howell, 2002). Thus, the logistic regression approach permits the inclusion
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of both categorical and continuous independent variables. For the present study
this enabled the inclusion of both categorical variables (e.g., gender) and
continuous variables (e.g., disease duration, years married etc.).
Third, with regard to ease of interpretation, the calculation of odds
ratios provides an intuitive index to assess the likelihood that an
individual will engage in a particular behaviour. This is considered to
be advantageous in comparison to interpreting the percentage of explained
variance that is the norm in the interpretation of linear regression
methods.
Justification for splitting outcome variables for binary logistic
regression
As previously reported a number of outcome variables were clearly skewed
as shown in the figures in Chapter 4. The justification for splitting the outcome
variables is described below:
In the case of medication adherence, scale scores ranged from 9
to 30 (complete adherence). however, the distribution of the data revealed that 80%
of patients scored 29 or above on this scale. The extremely skewed nature of this
distribution suggested that it would be appropriate to treat this variable as a
binary measure. indeed, this approach is not without precedent. in some other
chronic diseases, such as HIV, medication adherence is often treated as a binary
outcome e.g., patients whose adherence is at 80% or greater are considered to be
adherent, whereas all others are deemed non-adherent (Singh et al., 1996).
With regard to levels of physical activity, the data demonstrated that
72% of patients reported engaging in low intensity exercise. such low levels of
activity is consistent with previous investigations (Ford & Herman, 1995; Hays &
Clark, 1999) suggesting that this is a 'real' behavioural feature of diabetic patients
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and not due to sampling error. Thus, once again, the highly skewed nature of the
data advocated the treatment of the variable as a binary outcome.
Although there are recommendations for physical activity which are aimed at the
general population, the fact that the majority of patients in this study were not
attaining even the minimum requirement (i.e., at least 30 minutes on at least 5 days
of the week, at a moderate intensity). It was therefore deemed appropriate and
realistic to split the data according to the median of the study population.
The distribution of the dietary data also revealed that some of the outcome
measures were not normally distributed. In order to be consistent in the treatment
of all the dietary outcomes, and also to achieve consistency in the overall analytic
approach, it was decided that all the dietary measures should be treated as binary
variables. Furthermore, the dietary recommendations given to people with
diabetes are the same as those given to the wider population. Consequently, the
dietary data were split according to these recommendations and not the median
scores for the study population.
Pychological morbidity was assessed with the HADS. It was
clear that, although depression assumed a normal distribution, scores for
anxiety were skewed towards higher levels of morbidity. As clinically significant
disorders are identified by scores greater than 11 on the HADS the scores for
anxiety and depression were split at this value.
Finally, the marital satisfaction variable was also treated as a binary outcome in
order to be consistent with the analytic approach adopted for all other outcome
measures. However, as normative data for this scale do not exist for patients with
diabetes, the data were split at the median for the study population.
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6.4	 Illness representations of patients with type 2 diabetes and their partners
Plausibility of diabetes representations
Examination of the mean scores in relation to the highest attainable score for each
of the illness representation sub-scales revealed that, in general, patients and their
partners had developed representations about the illness that were generally in
accordance with conventional medical views arid understanding of type 2 diabetes.
In addition, such representations were consistent with the results of other work
(Barnes et al, in submission). For example, patients and partners who held strong
beliefs in a chronic time-line, believed the consequences to be serious, and believed
they had a high degree of illness coherence or understanding of the condition. In
addition, dyads demonstrated strong beliefs in the efficacy of the treatment for
diabetes (treatment control) and the importance of treatment to control diabetes now
and to avoid fit ture complications of diabetes. Finally, the scales derived from the
principal components analysis of causal attributions demonstrated that 'own
behaviour' was more salient than 'external' factors as a cause of diabetes. In
general, this configuration of diabetes representations demonstrates a high level of
awareness of the nature of diabetes and its treatment for patients and partners.
Such beliefs may have been formulated through living with the disease for a
number of years (mean=9 years). Finally, with regard to illness identity, patients
and partners reported relatively few symptoms as a result of either low or high
blood-glucose.
Reliability of diabetes representations
The internal reliability of both patients' and partners' diabetes representation
scales were good. However, scale reliability was not as satisfactory as those
reported by Moss-Morris et al (2002) in the development of the IPQ-R using
patients from 8 disease groups. Nonetheless, reliability coefficients above 0.60 are
considered acceptable, particularly if scales consist of less than 10 items and there
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is a good theoretical basis for the scale (Loewenthal, 1996). For patients, alpha
coefficients ranged from 0.60 to 0.84 and are favourable compared with illness
representation scales utilised in other diabetic populations (Lawson et al, 2004;
Cartwright & Lamb, in submission). The partners' scales ranged from 0.54 to 0.81
although, at present, there are no reported internal reliability data on partners'
representations of diabetes. The partners' scales did, however, compare
favourably with scales assessed in partners of non-diabetic patients (i.e, Heijmans
et al, 1999; Figueiras & Weinman, 2003; Helder et a!, 2002b, Barrowclough et al,
2001). Although small improvements could have been made (less than 0.5 in each
case) to the scales of patients and partners by removing poorly correlated items a
decision was made to keep them in their original form for reasons of consistency in
assessing the stability of the dimensions at time 2 and for comparisons with
patients' representations.
The observation that the alpha coefficients may be considered low for some
dimensions does, however, have implications for the interpretation of results and
for broader illness representations theory. For example, patients' time-line
dimensions (acute and cyclical) were not as reliable as the scales for partners
suggesting that partners have more coherent views regarding the temporal
perception of the patients' diabetes. In addition, the dimensions of consequences
and personal control yielded low alpha coefficients and this was particularly true for
partners (0.58 and 0.54 respectively). This may reflect wide variations in the
perceived seriousness of the disease and its implications for the patient and the
extent of the patients' efficacy in controlling the condition. Further work in the
context of partner representations are required to determine if the reliability of
these scales can be improved in alternative populations.
Finally, it was interesting to note that the highest alpha coefficients were found (for
patients and partners) for the additional IPQ-R dimensions illness coherence and
emotional representations and the additional control scales adapted from the PMDI.
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Such reliability provides good theoretical justification for their inclusion in further
work of this nature.
In accordance with Weinman et al (1996) and Moss-Morris et al (2002) the
individual causal items were factor analysed using principal component analyses
and the resulting factors collectively explained a large percentage of the total
variance. This procedure led to the development of two scales for both patients
and partners reflecting theoretically coherent categories. Indeed, the scales made a
distinction between 'internal' and 'external' causal beliefs and each yielded good
internal reliability. The procedure also permitted hereditary factors to be utilised
as a single item variable. No significant differences were found between patients
and partners for all three scales. The scales did, however, prove to be independent
predictors of outcome at both time-points. Finally, the scales derived for causal
factors were broadly similar to scales operationalised by Cartwright and Lamb in
patients with type 2 diabetes (in submission) thus providing further evidence for
the utilisation of such scales in the present thesis.
Inter-correlations between diabetes representations
The correlation matrix shown in Chapter 4 demonstrated that a number of diabetes
representations were significantly and positively correlated.
Due to the schematic nature of the illness representations framework it is expected
that logical relationships between representations would exist. Indeed, Heijmans
(1998) asserts that illness representations should be conceptualised as groups of
beliefs or schemata rather than single cognitions. In the present study, broadly
similar inter-correlations have been reported to that of previous studies describing
the development of the IPQ (Weinman et al, 1996) and IPQ-R (Moss-Morris et al,
2002). For example, illness coherence was strongly correlated with treatment control
and consequences was strongly correlated with emotional representations.
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Nonetheless, Field (2000) suggests that correlation coefficients exceeding 0.80 or
0.90 may be indicative of multicollinearity which may cause bias in regression
models. However, the only inter-correlation found to exceed 0.60 was between
beliefs in the importance of treatment to control diabetes now and to avoid
complications in the future (r .801, p <.01). The extent that these representations
were correlated is considered logical as individuals who believe the treatment to be
important for controlling diabetes would also be likely to believe that the treatment
would help to prevent future complications relating to diabetes.
6.5. Differences between patients and partners representations of diabetes
The results at time 1 (Chapter 4) demonstrated that patients and partners are
largely in agreement with regard to representations of diabetes. For only 3 of the
14 diabetes-specific dimensions were differences found at time 1, namely personal
control, illness coherence, and the importance of treatment to avoidfrture
complications of diabetes. Interestingly, partners held weaker beliefs than the
patient regarding the patients' personal beliefs in controlling diabetes but
exhibited stronger beliefs that the patients' treatment would be effective in
avoiding the complications associated with the disease. Partners also had a greater
perception of the degree of understanding the patient had of their condition. The
differences observed between the patients' and partners' representations were not
replicated at follow-up at time 2 where partners held stronger beliefs than patients
that treatment could control diabetes now and that the patients' 'own behaviour'
was a cause of diabetes. The differences found between patients' and partners'
representations at both time-points did not yield any consistency with the findings
of Urquhart Law (2002) examining dissimilarity between mothers and adolescents
representations of diabetes assessed with the IPQ-R. In this study differences were
only found for consequences and emotional representations, for which mothers scored
more highly. Such inconsistency regarding the dissimilarity of representations
within and between studies makes meaningful interpretation difficult. However, it
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is clear from the results of both studies that 'significant others' generally hold
similar diabetes representations to those of the patient.
Finally, it is reiterated that, in the present study, patients and partners were
requested to complete the study measures independently. However, by
conducting the project via postal survey methods it must be acknowledged that
patients and partners may not have completed their respective questionnaires
without conversing with their partners.
Minimisation and maximisation of illness representations
In relation to the mean scores derived for patients' and partners' representations of
diabetes (Table 4.6) there are implications with reference to the extent that
partners' 'minimise' or 'maximise' their views of the patients' experience of illness.
According to Thompson and Pitts (1992) (see Chapter 2), expression of
'maximisation' or overprotective behaviour by the spouse may have a negative
effect on patients' well-being. For example, partners may view the consequences of
living with diabetes as not as serious as the patients' views, which is expressed as
problem 'minimisation'. Conversely, partners may view the consequences of an
illness as far more serious than does the patient and is expressed as problem
'maximisation'. The effect of 'maximisation' may lead to overprotective behaviour
on the part of the spouse leaving the patient playing a more passive role in
adjusting to and managing their disease. The present results suggest that patients
and partners share a high level of agreement regarding their beliefs about diabetes.
However, differences were found on three dimensions of diabetes representations
at time 1 and it is feasible these discrepancies could be interpreted in this way. For
example, partners 'minimised' personal control beliefs and 'maximised'
representations of illness coherence and the extent that treatment was important for
avoiding complications of diabetes in the future.
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The expression of 'minimisation' and 'maximisation' of these variables measured
at time 1 appeared to have implications in the extent that partners' control and
treatment beliefs were predictive of aspects of patients' self-management behaviour
at time 2. Indeed, the present results suggest that some aspects of 'minimisation'
and 'maximisation' may or may not be beneficial for patients in terms of patients'
self-management behaviours. It is demonstrated that patients with partners who
'minimised' personal control beliefs at time 1 were more likely to consume a greater
percentage of sugar in their diet at time 2. Whereas, patients with partners
'maximising' the importance of treatment to avoid complications of diabetes in the
future were more likely to reduce the intake of saturated fat at time 2. Thus, in this
case, partners' 'minimisation' of personal control beliefs appear to have a negative
effect and 'maximisation' of treatment beliefs appear to have a positive effect in
terms of patients dietary intakes.
It is considered that such results may have implications for interventions aimed at
manipulating illness representations with a view to improving health behaviours.
Indeed, partners of patients 'maximising' or 'minimising' aspects of the patients'
experience of the disease could receive counselling with the aim of eliciting more
positive appraisals of the patients' illness. In turn, such appraisals may lead to
more favourable behaviours and outcomes.
Findings at follow-up
At 12 months only 18% of dyads were lost to follow-up (n=134) and the majority
(76%) of patients consented to give blood to assess their blood-glucose levels. The
diabetes representations of patient-partner dyads measured at time 1 were also
measured at time 2. No differences were found between demographic and clinical
characteristics of dyads completing questionnaires at time 1 only compared with
those assessed at both time-points. Significant differences were, however, found
regarding representations of diabetes. Patients' assessed at both time-points
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perceived lower levels of illness coherence and held stronger beliefs that the cause of
their diabetes was 'hereditary'. Partners assessed at both time-points exhibited
stronger beliefs in the extent of the patients' personal control of their diabetes.
6.6. Predictive utility of diabetes representations
Stability of illness representations
The systematic review of illness representations in Chapter 2 demonstrated a lack
of data relating to the stabiJity of illness representations in chronic disease over
time. This issue was examined in the present study by examining the extent that
diabetes representations were stable over time (i.e., representations at time 1
compared with time 2). It was apparent that mean scores for a number of
dimensions increased or decreased significantly between time 1 and time 2 and
this was as true for patients as partners. Some differences were also found
between patient and partner scores at time 2 such that partners held stronger
beliefs than patients in the importance of treatment to control diabetes now and held
stronger beliefs that the patients' 'own behaviour' was a cause of diabetes. In the
present study changes occurred for patients and partners over the study period of
12 months. It is, therefore, reiterated that, patients and partners are living with a
disease that is not only chronic but is long-standing. Participants' had been living
with the disease for many years. Thus, it may not be considered surprising that
patients were still experiencing changes in their beliefs about diabetes over time.
An explanation for the observed changes may be found in the way an individual
appraises their responses to diabetes. It is reiterated that the SRM conceptualises
health related decisions as being dynamic rather than static. Thus, a patient (or
partner) may evaluate the efficacy of a particular health behaviour - if that
behaviour is appraised as being ineffective, the patient may in turn, choose an
alternative strategy or may modify their representation of the illness. The
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appraisal of coping responses and health behaviours is a neglected 'stage' of the
SRM which may have implications for disease related behaviours and outcomes.
It is considered that the neglect of the assessment of appraisals of patients' coping
efforts is partly due to conceptual difficulties with regard to measurement and a
lack of longitudinal data. Weinman (2003), however, speculates that the addition
of the illness coherence dimension to the framework provides insight into appraisal
processes. For example, if the illness makes sense to the patient then it is likely
that coping efforts (including treatment adherence) are working accordingly the
measure of illness coherence could also be a marker for treatment efficacy.
The meaning of partners' representations in managing diabetes
A number of partners' representations were predictive of self-management
behaviours. At time 1 partners' belief in personal control of the condition
predicted a greater intake of dietary fibre and partners' beliefs in treatment control
predicted less consumption of carbohydrates. Such results indicate that partners'
representations of the control of diabetes are conmiunicated to the patient and
appear to be important with regard to the extent they influence these aspects of
dietary behaviour.
Interestingly, at time 2 the impact of partners' representations were more prevalent
in predicting outcomes than representations observed at time 1. Partners' beliefs
appeared to be most predictive of behavioural outcomes such as physical activity
and dietary choices rather than the degree of psychological morbidity and marital
satisfaction. Additionally, poor blood-glucose control was influenced by partners'
beliefs regarding 'hereditary' factors as a cause of diabetes. Thus partners' holding
stronger beliefs that diabetes is 'hereditary' with regard to cause may communicate
to the patient a belief that the onset of diabetes was inevitable and not a direct
result of the patients' lifestyle and that there was little the patient could do in terms
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of managing the condition. Therefore, such beliefs may serve to excuse the patient
from taking responsibility for his/her disease. It is suggested that this may, in
turn, be detrimental to recommended management behaviours resulting in poorer
glucose control. Conversely, better glucose control was influenced by partners'
beliefs in the importance of treatment to control diabetes now. Thus patients with
partners who communicate the belief that the recommended treatment is
important and effective for controlling the disease are more likely to engage in
management behaviours that are beneficial for attaining lower blood-glucose
levels.
Consistent with the results at time 1, it was evident that partners' beliefs in the
patients' ability to control their diabetes predicted a higher intake of fibre. Thus, it
is possible that partners may help to reinforce patients' self-efficacy beliefs (i.e.,
believing that the patient has the ability to perform this important aspect of the
dietary regime). However, partners' personal control beliefs predicted greater
sugar consumption by patients. It appears that, although the partner believes the
patient can control their diabetes, this belief has both a positive and negative
influence on dietary outcomes.
In addition, partners' beliefs in treatment control predicted greater intake of non-
saturated fats. This result could be interpreted as being a positive outcome in that
dietary advice for diabetes patients encourages the use of mono-unsaturated fats
(e.g. olive oil) and poly-unsaturated fats (e.g. sunflower oil) rather than saturated
(animal/dairy) fats (these 'healthy' fats are believed to play a role in reducing
cholesterol levels). Finally, partners' beliefs that the cause of diabetes is due to the
patients' 'own behaviour' predicted greater carbohydrate consumption and
partners with more realistic perceptions of the duration of the disease (i.e. chronic)
predicted greater fruit and vegetables consumption. These results are consistent
with the assumptions that partners' beliefs will have on patients' behaviour.
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As some findings appear to be inconsistent with regard to better management of
diabetes it is suggested that although partners' believe that the patient has the
ability control their condition effectively the patient may elect to continue with
aspects of dietary behaviour that are detrimental to good self-management. This is
an indication that patients retain a degree of autonomy or 'ownership' over their
condition and its control. Indeed, it might be an i.mrealistic expectation for
partners' representations of diabetes to consistently predict health behaviours that
will favour better blood-glucose control. However, in general, patients appear to
benefit from partners that hold favourable views that the diabetic treatment
regimen will have a positive effect on the course of the disease. It is concluded,
therefore, that partners' beliefs can have a positive impact on patients'
management of diabetes by influencing behaviour that would favour better
management of the disease and enhance glucose control. However, despite
demonstrating that partners' beliefs play an important role in behaviours and
glucose control, it cannot be determined which party of the dyad influences the
other with regard to the origins of diabetes representations. Do patients' beliefs
guide the partner or do the partners' beliefs guide the patient in their beliefs?
Differences in predictive utility of diabetes representations at time 1 and time 2
The time 1 representations were also used in logistic regression analyses to predict
health behaviours measured 12-14 months later. However, the results of these
analyses shared little commonality with the results of the time 1 analyses despite
identifying many significant predictors of behaviour. This phenomenon may be
partly explained by the addition of past behaviour in the analysis which was a
significant predictor of many outcome variables. In addition, the reduced sample
size at time 2 may have influenced the extent of behavioural outcomes.
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Not only were changes in diabetes representations evident at time 2, there were
also changes in the behavioural and psychological outcome variables that were
assessed at time 2. Thus, although the time 1 diabetes representations were used to
predict behaviour prospectively at time 2, the inconsistent findings may be due to
changes in the outcome variables of interest. Another explanation is the addition
of past behaviour in the regression model (adherence assessed at time 1) to control
for the extent that patients' adhered to the self-management behaviours in the past.
By including behaviour at time 1 as a variable in the analyses it has shown that
past behaviour does indeed have a direct effect on behaviours at time 2 in addition
to patient and partner representations (this was the case for medication, exercise,
consumption of fats, and sugars). In studies utilising Protection Motivation
Theory (PMT; Rogers 1983) past adherence behaviour has been shown to have a
direct effect on future behaviour in the prediction of a range of behaviours
including adherence with eye patching (Norman et al, 2003, Searle et al, 2002) and
breast self-examination (Hodgkins & Orbell, 1998). According to Ajzen (1988) past
behaviour influences people's beliefs about the behaviour and it is these beliefs
that determine subsequent behaviour. It has been argued that past behaviour is a
behavioural proxy for self-efficacy (belief in personal control) such that by
adequately engaging in a given behaviour, participants are reinforcing the belief
that they are capable of performing that behaviour and continue to do so (Searle et
al, 2002). A further point with regard to the purported dynamic nature of health
behaviours in the context of the SRM is the possibifity that the prediction of health
behaviours is the result of 're-appraisal' of given behaviours over the study period.
Indeed, it is likely that adherence levels fluctuate according to their perceived
efficacy at a given time.
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Usefulness of additional illness representation dimensions
The additional illness representation scales pertaining to the IPQ-R (treatment
control, cyclical-timeline, illness coherence and emotional representations) and scales
adapted from the PMDI (importance of treatment to control diabetes now and to
avoid complications in the future identity and the identity scales) were shown to be
useful with regard to their predictive utility. Indeed, at time 1 these dimensions
dominated the outcome of the logistic regression analyses whereas only the
personal control scale from the original IPQ was a predictor of medication.
However, this leaves the question to what extent the original IPQ scales could
predict outcomes if entered in the regression model alone? Indeed, the breadth of
representations measured in the study that were subsequently associated with
outcomes challenges the assertions of Leventhal and colleagues (1984) that
individuals perceive their illness in the context of 5 'core' dimensions. The
extension to the control dimension undertaken with the adaptation of the scales
derived from the PMDI (importance of treatment to control diabetes-now and to
avoidfrture complications) demonstrated high internal reliability in addition to
yielding very high mean scores. Such beliefs in the importance of treatment were
also positively associated with health behaviours. The findings relating to these
dimensions serve to validate their inclusion in the study. There is, however, no
theoretical reason restricting the number of dimensions operationalised in future
research. Indeed, it may be of more value to select dimensions in accordance to the
disease of interest and informed by the accumulated evidence of past research.
Nonetheless, the present results have demonstrated that scales taken from the JPQ,
IPQ-R, PMDI and factor analysed causal attributions were all predictors of either
behaviour or psychological outcomes in patients with type 2 diabetes.
6.7. Relevance of findings to previous research
Overall, there was little consistency with regard to the predictive utility of diabetes
representations with previous studies outlined in the review of literature in
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Chapter 2. The predictive utility of the dimensions adapted from the PMDI
measuring the importance of treatment to control diabetes now and to avoidfrture
complications were more common in terms of predicting health behaviours than
dimensions of the IPQ-R. This was true for both patients' and partners'
representations and at both time-points. First, at time 1 patients' beliefs in the
importance of treatment to control diabetes now were associated with better
medication adherence. Partners' beliefs in the importance of treatment now,
however, were associated with less fruit and vegetable consumption by patients at
time 1 (and therefore not beneficial to the patient). At time 2, patients' beliefs in
the importance of treatment to avoidftdure complications were associated with
higher levels of exercise whereas partners' scores for this dimension were
associated with greater sugar intake by patients. It appears that although patients'
perceptions of these dimensions as are predictors of positive outcomes in terms of
management behaviours, partners' perceptions do not necessarily result in positive
patient outcomes. Nonetheless, partners' beliefs in the importance of treatment to
control diabetes now was associated with lower HbAlc scores in patients. The
predictive utility of patients' perceptions of these dimensions is not surprising as
the systematic review in Chapter 2 demonstrated that the equivalent construct
(treatment effectiveness) was a consistent predictor of self-management behaviours
in diabetes patients. For example, dietary behaviour was predicted by treatment
effectiveness and seriousness (the combined variable of time-line and consequences)
in three studies (Hampson et al, 1990, Glasgow et al, 1997; Skinner et al, 2002).
Such findings suggest that patients' representations regarding the importance of
the recommended treatment for diabetes and the perceived severity of the
condition are the most important predictors of these behaviours. The consistency
of the results may be explained in part by the fact that these studies were
undertaken with the complete PMDI variables by members of the same team,
using variations of a global outcome measure, (i.e., the Summary of Diabetes Self-
Care Activities Scale; Glasgow et al, 1997; Hampson et al, 1990; 1995, Skinner et al,
2002). In contrast, studies employing the IPQ and IPQ-R showed that only control
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beliefs were predictors of self-management behaviours (Griva et al, 2000, Watkins
et al, 2000), whereas Cartwright and Lamb (in submission) found no significant
correlations between IPQ dimensions and adherence to dietary recommendations
in patients with type 1 or type 2 diabetes.
However, in the present study the operationalisation of the control dimensions of
the IPQ-R for patients and partners' was not as productive with regard to
predicting patients' behaviours. A possible explanation for this is that the control
dimensions of the IPQ-R were not rated as highly by patients and partners as the
PMDI scales and were also less reliable in terms of their internal consistency.
Differences in responses to these dimensions may be a function of the specificity of
the items to diabetes and the impact the disease has on a patient's life. Evidence to
support this contention comes from Lawson et al (in press) who examined the
comparative predictive utility of the IPQ and PMDI in the care seeking behaviour
of patients with type 1 diabetes. It was shown that the treatment effectiveness
dimension from the PMDI and the control dimension from the IPQ were the only
positive predictors of clinic attendance. In order to better understand these results
the authors examined the wording of items in each instrument. They reported that
the IPQ items relate to present and past effects of diabetes whereas the PMDI items
focus more on the current impact of diabetes. This has implications for futare
research as a diagnosis of diabetes may have had a detrimental impact on patients'
lives in the past but any difficulties arising from the illness may have been resolved
and have little effect on current lifestyle. This may be particularly pertinent in the
present sample as the majority of the patients have had the disease for many years.
6.8. Critique of behavioural outcome measures
One of the strengths of the present study is the employment of individual
behaviour-specific measures of diet, physical activity and medication. It was thus
anticipated that the selection of such measures would provide a comprehensive
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evaluation of the magnitude and nature of the relationship between diabetes
representations and measurement of these important and diverse behaviours
central to the management of the disease. Although the measures have provided a
useful insight into the extent that the participants were engaging in the relevant
health behaviours there are number of methodological issues that are addressed in
the following paragraphs.
Dietary assessment
As far as it is known this is the first study to assess the individual components of
diet in the context of their relationship with illness representations. The balance of
dietary components is particularly important in such patients and therefore to
attempt to evaluate dietary behaviour in this way is a particularly informative
approach in diabetes research. The food frequency questionnaire (HEA 3, Little et
al., 1999; 2000) was developed as an assessment tool for the evaluation of risk of MI
in the context of primary care. The measure has also been shown to perform as
well as the accepted standard reference, a seven-day weighed record (Little et al.,
2000). However, a particular concern in relation to dietary assessment in the
present study was the extent of 'low energy reporters' (73%-75%) identified in the
sample. It is clear that patients underreported or underestimated their energy
intake, this may have been due to biases of retrospective recall. Retrospective
recall may have been a particular problem with regard to the age of participants
and long-term cognitive decline has been associated with a diagnosis of type 2
diabetes (Elias et al., 1997; Scott et al., 1998). Nonetheless, patients did
demonstrate a degree of consistency in relation to energy intake as energy values
of most dietary components remained remarkably reliable at time 2. It is also
speculated that due to the high level of obesity identified by BMI scores patients
were too embarrassed to be truthful regarding energy intake. It is possible that the
responses to the measure were biased as respondents completed the measure alone
rather than sitting face to face with a practitioner (the context in which the measure
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has been applied in past assessments). Therefore, future assessment of dietary
behaviour with the measure may be more accurate if completed with the assistance
of the researcher. A further strategy would be to ask partners to complete the
measure on behalf of the patient or at least verify patients' reports.
Physical activity
Responses to the Baecke physical activity questionnaire revealed low levels of
intentional physical activity that were consistent with previous research (Ford &
Herman, 1995; Hays & Clark, 1999). It is speculated that such low levels were a
result of the degree of co-morbidity in the sample. Indeed, many patients suffered
with rheumatoid arthritis or circulatory problems. In addition, lower levels of
exercise were associated with greater body mass indicating that heavier
individuals find effective exercise difficult to perform. The combination of these
'barriers' to exercise was substantial in its impact on patients' activity levels. In
addition, there is a possibility that levels of exercise may even have been higher
than normal due to the fact that patients were being observed in a prospective
study.
It was also apparent from responses that in most cases physical activity in able
patients constituted 'gardening', 'walking' or 'housework'. This observation
highlights the need for health care professionals to emphasise the importance of
regular aerobic physical activity for health benefits in terms of managing diabetes
and cardiovascular fitness. Future assessment of physical activity in such a
population may benefit from the employment of objective assessment methods
such as accelerometers. The major advantage of this method is that it is not
influenced by self-report bias. If patients consented to wear accelerometers it
would provide accurate feedback with regard to the extent and intensity of their
daily activities. The efficacy of accelerometry has been shown in normal and
overweight individuals over a 7-day period (Cooper et al, 2000).
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Medication
It is clear from the extent that responses to the MARS were positively skewed that
patients with diabetes find the process of taking tablets to treat their diabetes to be
easier than adhering to dietary restrictions and engaging in physical activity. This
observation is consistent with previous work (Glasgow et al, 1997) and is
indicative of inherent differences regarding patients' self-efficacy with the
disparate demands of the diabetic regimen. The prescription of oral agents in the
management of diabetes often occurs once behavioural intervention relating to diet
and exercise fails to control blood-glucose levels. Therefore, it is not surprising
that patients show greater efficacy in adhering to medication. Furthermore, from
the perspective of the social context of adherence it may be easier for a patient to
take oral agents with the aid of environmental cues and reminders from concerned
partners. However, such limited variance in response to items on the MARS is
indicative of over-reporting medication adherence. When validated against
objective measures such as pifi counts or biochemical methods, self-reporting of
medication adherence is highly variable in terms of accuracy (Francis et al, 1969).
More accurate adherence with oral medication may also be measured objectively
with electronic monitoring techniques (Farmer, 1999).
6.9. Psychological morbidity
The high level of anxiety reported at time 1 yielded a positively skewed
distribution of scores, whereas depression scores revealed a distribution more akin
to 'normal'. However, scores for depression were still indicative of high levels of
'caseness'. With regard to the high prevalence of anxiety and depression assessed
with the HADS, it is a possibility that levels of well-being were partly associated
with the high level of co-morbidity in the sample. Indeed, many respondents
were elderly (mean age = 67 years) and suffering with a variety of co-morbid
conditions. For example, rheumatoid arthritis was a particularly common
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complaint (31%). It is also interesting to note that levels of anxiety had
significantly decreased at time 2 and levels of depression increased.
Although there is a high level of co-morbidity between anxiety and depression in
diabetes patients (Judd et al, 1998; Lloyd et al, 2000) these results support the view
that they should be considered as separate states. Nonetheless, it is hypothesised
that anxiety may be a pre-cursor of depression. Indeed, those scoring high on the
anxiety scale at time 1 may have gone on to develop more symptoms that are
characteristic of depression over the study period. To test this hypothesis, a partial
correlation was conducted between anxiety (time 1) and depression (time 2)
controlling for depression at time 1 which revealed a highly significant association
(p <.001). Furthermore, there was an increase in emotional representations of
diabetes at time 2 which assesses perceptions of fear, anger and depression relating
to a diagnosis of diabetes. However, representations of diabetes at time 1 did not
emerge as predictors of depression at time 2 (only previous levels of depression
predicted depression at time 2). This provides evidence that levels of depression
may not be the product of the illness representations of the patient or spouse and
thus leaves open the question as to the association between diabetes and
depression. It is possible that depression may be a function of the biochemical
changes directly due to the illness or its treatment. Possible mechanisms include
changes in the effects of catecholamine levels and serotonin concentrations on
glucose regulation (Goodnick et al., 1995).
It is, therefore, suggested that patients are reluctant to report states such as
depression and anxiety when probed in such a direct maimer (i.e., 'I get depressed
when I think about my diabetes') as opposed to assessing the symptomatology of
morbid states with the more subtle approach of the HADS.
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It is also possible that they do not associate depression and anxiety with having
diabetes. It must also be considered that patients may have experienced a
'priming' effect with regard to their reports of depressive symptomatology.
Indeed, patients may not have considered the psychological effects of living with
diabetes until entering the study and these scale items may have introduced a
concept that was not salient before participation.
At time 2 it was apparent that patients representations of diabetes at time 1 played
a significant role in predicting anxiety measures at time 2. As might be expected,
stronger beliefs that the disease is chronic predicted more anxiety whereas a
greater understanding of the condition predicted lower levels of anxiety. It is
difficult to interpret how stronger personal control beliefs lead to a greater
likeithood that the patient will suffer with clinically significant anxiety. This
finding is counter-intuitive and contradicts previous work that has shown that self-
efficacy beliefs are positively associated with a more general assessment of well-
being (Eiser et al, 2001). Additionally, in long-standing patients with type 2
diabetes weaker control beliefs were significantly associated with greater anxiety
and depression (Wearden et al, 2003). However, these previous studies adopted
cross-sectional designs making the direction of causality difficult to interpret.
A finding of particular interest is that experiencing symptoms of high blood-
glucose is almost 2.5 times more likely to result in clinically significant levels of
anxiety. This finding is a clear demonstration that the perceived identity of the
condition is directly associated with well-being and acts an unpleasant reminder of
the potential consequences of living with high blood-glucose. Finally, partners'
representations of the patients' diabetes appear to have little impact once




A measure of HbAlc was obtained from 76% of patients to coincide with
completion of measures at time 2 to assess metabolic control. As laboratory
guidelines indicate that desirable levels should fall between 4-6%, it was clear that,
generally, patients were not in reasonable control of their diabetes. The mean score
was 7.4% and although slightly less than HbAlc recordings observed in other
psychosocial studies of patients with diabetes, 30% of the sample tested had scores
of> 8% which approaches the recommended upper level of 8.4% at which the risk
of microvascular complications dramatically increases (DCCT Research Group,
1988). These levels are a further indication that although representations of
diabetes were in line with medical knowledge, such beliefs did not manifest
themselves into tight control of diabetes. Whether glucose control is maintained
through self-management behaviours is uncertain as blood-glucose levels may be
influenced factors other than adherence. For example, stress is believed to
influence hyperglycaemia, although its exact role is unclear (Surwit & Schneider,
1993). However, significant improvements in HbAlc have been found in patients
adhering to specific diet related advice in two large prospective trials (Delahanty et
al., 1993; UKPDS Group, 1990) and more recently in insulin resistant patients at
risk of developing diabetes (Diabetes Prevention Research Group, 2002,
Tuomilehto et al, 2001). In addition, a meta-analysis has shown that regular
physical activity can reduce HbAlc by 0.7% in type 2 diabetes (Boule et al., 2001).
None of the diabetes representations that predicted blood-glucose control
replicated the findings of previous studies reviewed in Chapter 1. These studies
have shown that patients' beliefs in treatment effectiveness, cause -'own-behaviour'
(Hampson et al, 1995) and control (Hampson et al, 2000) prospectively predict
lower levels of HbAlc, whereas consequences and identity dimensions were
predicted higher levels of HbAlc in a cross-sectional study (Griva et al, 2000). In
the present study patients with strong beliefs in an 'external' cause of diabetes were
in poorer control of their diabetes. It is also noteworthy that partners believing in a
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'hereditary' cause of diabetes predicted poorer control of the patients' diabetes.
Finally, partners holding strong beliefs in the importance of patients' treatment to
control diabetes predicted better control of diabetes. In general, such mixed
findings make it difficult to interpret the nature of the relationship between
representations of diabetes and glucose control. However, the present findings
suggest that patients absolve themselves from the responsibility of managing their
disease as they may perceive the cause as beyond their control. Furthermore,
patients may view the onset of diabetes as being genetic in origin and not a result
of their lifestyle. It appears that partners' representations are implicated in glucose
control, however, it should be noted that if HbAlc was measured at both time-
points it would have been possible to assess change over the study period and
perhaps provide more insight into how patients' and partners' representations are
related to changes in glucose control.
6.11. Dyadic adjustment and social support
There was a high level of marital satisfaction among dyads assessed with the DAS
and satisfaction remained stable over the study period. Furthermore, the duration
of living with a partner approached 36 years suggesting that most dyads were
enjoying long relationships. The mean score on the DAS of 28.1 at time 1
compared very favourably with a mean of 25.6 attained in a healthy sample of 196
participants (Hunsley et al, 1995). It is interesting to note that levels of dyadic
adjustment in patients were negatively predicted by the duration of the marriage
and were greater in patients reporting higher levels of illness coherence. In addition,
partners with strong beliefs that the patients' 'own behaviour' was a cause of
diabetes negatively predicted dyadic adjustment. Such results suggest that
representations of diabetes have important implications for the marital
relationship. Indeed, it would appear that happier relationships are enjoyed by
patients in less established relationships who have a better understanding of the
condition with partners who do not view the onset of diabetes as being the fault of
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the patient. At time 2 patients with stronger emotional representations and cyclical
time-line beliefs were predictive of lower levels of dyadic adjustment. The inverse
relationship between emotional representations and dyadic adjustment at time 2,
however, suggests that patients' relationships suffer as a result of the distress
resulting from living with diabetes.
A number of studies have demonstrated a general trend showing that the
provision of social support results in favourable outcomes in diabetes management
(Glasgow & Toobert, 1988; Garay-Sevilla et al. 1995, MacLean & Lo, 1998; Lo, 1999;
Toljamo &t Hentinen, 2001; Williams & Bond, 2002). The consistency of this
relationship may assist in explaining the extent that partners' representations
displayed considerable similarity with those of patients and also impacted on the
management of diabetes. The extent that patients and partners were in agreement
with regard to their representations of diabetes may be a function of the degree of
marital satisfaction in the study sample. It is proposed that patient-partner
representations of diabetes are more likely to be shared as a result of the level of
communication enjoyed in the marital relationship, which, in turn manifests in
higher levels of support and vice-versa. However, in accordance with 'family
functioning' theory (Epstein et al., 1978) the course of a chronic disease such as
diabetes may impose an excessive load on the capability for the family to adapt
and may threaten family stability. Indeed, Garay-Sevila et al. (1995) demonstrated
that adherence to diabetes medication was lower in patients from families
exhibiting more rigid patterns of functioning than those with a more flexible
outlook. With regard to glucose control, Trief et al, (2001) found marital
satisfaction assessed with the DAS predicted less diabetes-specific emotional
problems and showed a positive trend in the prediction of HbAlc.
The incidence of psychological morbidity measured in the present patient sample
suggests that emotional problems were present (although may not have been
directly related to the illness). Therefore, it is possible that dyadic adjustment acts
as a buffer against the demands of living with type 2 diabetes and is reflected in
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the extent that partners' diabetes representations were associated with patients'
management behaviours and glucose control. However, it is unclear whether a
poor relationship leads to poor illness adaptation and glucose control or that poor
control/adaptation leads to more emotional problems arising from living with the
disease. A further issue is that psychological morbidity in partners was not
assessed in this study. It is considered, therefore, that the measurement of anxiety
and depression in partners may offer insight into the emotional impact that living
with a patient with diabetes has on a partner and how partners' representations
are associated with adverse outcomes.
A further unresolved issue is the effect of gender in relation to social support,
illness representations and self-management behaviours. The findings of Doherty
et al. (1983) showed that wives who believed more strongly in the benefits of the
therapeutic regimen for hypertension offered greater support to their husbands. In
contrast, it has been shown that males fare less well in terms of controlling their
diabetes in the presence of satisfactory support (Heitzman & Kaplan, 1984, Kaplan
& Hartwell, 1987). It is reiterated that the effects of gender were controlled for in
the present study. Although, it was shown that gender was only a significant
predictor of higher sugar consumption in male patients (which has implications for
metabolic control) it is difficult to make any further comments regarding the
influence of gender in the control of diabetes.
It has been shown is that self-efficacy beliefs (one's belief in personal control) are
associated with social support and positive diet-related family interactions
(Williams & Bond, 2002). In this study the authors claimed support for Bandura's
(1977) assertion that social support is a source of efficacy information but does not
affect behaviour directly and suggests that social support could be an important
source of efficacy information among diabetes patients. Although self-efficacy was
not specifically measured in the present study it is argued that the personal control
dimension of the IPQ-R taps into this construct. It is suggested, therefore, that the
252
patients' high levels of personal control in the present study were a function of the
degree of social support they received. It may be that patients demonstrating
stronger personal control beliefs (as perceived by their partners) receive more
support from those partners which in turn reinforce the patients' own control
beliefs.
Finally, the forgoing appraisal of marital satisfaction and social support provides
support for the findings of previous work such that the execution of good self-
management and control of diabetes is most likely to take place within well-
functioning relationships (Glasgow & Toobert, 1988; Garay-Sevifia, 1995; MacLean
& Lo, 1998; Lo, 1999; Toijamo & Hentinen, 2001; Williams & Bond, 2002).
6.12. Implications for the self-regulatory model
The present research and the findings of previous research examining the illness
representations of significant others (reviewed in Chapter 2) has highlighted a
number of implications for the self-regulatory model. The first of these concerns
coping behaviours and their relationship with illness representations. Much
previous research has assessed coping strategies through the employment of
questionnaire based tools (i.e., Rutter & Rutter, 2002, Moss-Morris et al, 1996,
Helder et al, 2002a, Heijmans, 1998;1999). However, in the present context, it may
be more meaningful to conceptualise coping by assessing what patients actually do
with regard to their adaptation to a chronic illness. Indeed, it is argued that
Leventhal and colleagues refer to coping as the behaviours a patient adopts in
response to dealing with a health threat in their original description of the self-
regulatory model (1980, 1984). It is, therefore, argued that the extent of adherence
to the health behaviours outcomes (diet, activity and medication) in the present
study may be viewed as indices of coping behaviour.
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A related point concerns the appraisal of coping efforts, which have been largely
ignored in previous research with the self-regulatory model. Thus, if adherence
behaviours are viewed as being indicative of coping it is also pertinent to examine
the appraisal of such behaviours and their relationship with illness
representations.
Of particular relevance to the present research is that the appraisal of the efficacy
of a chosen behaviour is pertinent to both patients and their partners. In support
of this assertion, it was shown that partners' beliefs (in addition to patients' beliefs)
were predictive of adherence with different health behaviours at time 1 and time 2
suggesting that partners also 'appraise' the effectiveness of the patients' health
behaviours. Furthermore, the representations for which patients and partners
demonstrated differences were not repeated when assessed at time 2. Thus, if
partners perceived a particular aspect of the patients' treatment as ineffective such
beliefs may be conveyed to the patient. In turn, these beliefs may serve to elicit an
alternative behaviour or may result in a change of the representation of the
patients' illness. With further reference to the original description of the self-
regulatory model, it is proposed that the appraisal processes of patients (and
significant others) are processed in parallel, such that the appraisal of health
behaviours feedback to influence emotional responses to the illness and future
coping efforts. An illustration of how partners' representations may be integrated
into the SRM can be seen in Figure 6.1. It is suggested that such a framework may
be useful in guiding future research with the emphasis on emotional responses and
appraisal of the efficacy of health behaviours.
A third point is that there may be scope for the development of a further illness
representation dimension to assess the extent that the patient is to blame for the
onset or mis-management of their illness. This may be particularly relevant in the
context of assessing the impact of 'lifestyle' diseases such as type 2 diabetes or
coronary heart disease. Support for the development of this dimension comes
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partly from the extent that causal attributions relating to the patients' 'own
behaviour' (i.e., diet, weight, lack of exercise) were endorsed by patients and
partners alike. Moreover, such a scale may be particularly pertinent in studies
assessing the representations of significant others in relation to managing illness.
In addition, it is also considered that the illness representations framework could
benefit from further development in the context of diabetes by merging the most
salient dimensions measured by the IPQ-R and those pertaining to the PMDI.
First, with regard to the IPQ-R, the personal control and emotional representation sub-
scales were the most ubiquitous predictors whereas the time-line sub-scales (acute
and cyclical) were the least predictive of patient outcomes. In addition, the
dimensions of identity and the importance of treatment now and future adapted from
the PMDI appeared to augment the control scales of the IPQ-R. Overall, in terms
of predictive utility, the findings of previous and present findings discussed earlier
indicate that control beliefs are the most salient representations. It is suggested,
therefore, that there is support for the control dimensions of the IPQ-R and the
PMDI to be operationalised in combination as a multi-dimensional measure of
control in chronic disease. In so doing, a more comprehensive assessment of how
control beliefs operate with regard to personal and treatment efficacy may be
delineated. Specifically, the evidence suggests that not only should a distinction be
made between personal and treatment control but should also distinguish the extent
that treatment for a condition is perceived to be important from a temporal
perspective (i.e., 'now' and 'future').
With further reference to treatment beliefs and illness representations, Home and
Weinman (2002) have investigated patients' beliefs regarding preventer treatment
for asthma beliefs alongside the illness representations of such patients. This work
empirically tested an extended self-regulatory model that includes specific
treatment beliefs as well as illness representations with the aim of predicting non-
adherence. Hierarchical regression analyses showed that non-adherent behaviours
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were associated with doubts about the necessity of treatment and concerns about its
potential adverse effects and with more negative perceived consequences of illness.
The analysis also permitted the relative contribution of illness representations and
treatment beliefs in adherence to medication. The authors assert that the relations
between illness representations and treatment beliefs provide support for an
extended self-regulatory theory that includes treatment beliefs as well as illness
representations. By including additional scales to assess the multi-dimensionality
of treatment beliefs these findings and those of the present study provide a clear
direction for the development of self-regulatory theory in the context of adherence
in chronic conditions such as diabetes and asthma.
Finally, there are some points to raise with regard to the inclusion of the measure
of emotional representations in the IPQ-R. First, it is proposed that the emotional
impact of a disease may precede the patients' cognitions regarding its consequences,
control and cause and identity. Indeed, it is not known to what extent patients'
illness representations are a function of emotional impact of disease or whether the
severity of representations induces an emotional response. It is possible that there
is a dynamic interplay between emotional responses and illness cognitions that are
a feature of fluctuations in the challenges of living with a disease.
It is also not clear to what extent a disease 'label' triggers emotional representations
or whether it is the impact on lifestyle and challenges of managing the condition
that trigger such emotions. The present sub-scale is therefore considered
rudimentary in its conception and application and is worthy of further exploration.
Indeed, to assist in delineating these issues a more comprehensive approach is
required in which the application of qualitative methods may prove fruitful.
There are two more general issues to raise with regard to illness representations.
The first of these concerns the assessment of causal attributions in patients with
chronic disease. Although, patients and partners in the present study endorsed
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coherent ideas as to the possible causes of diabetes, they were not consistent
predictors of patients' self-management behaviours. Indeed, the relative lack of
predictive utility in the operationalisation of the cause dimension in the present and
previous research is indicative of a need for re-evaluating the importance of causal
beliefs in the self-regulatory model. It may be argued that this observation, may be
a function of differences in how causal attributions are aggregated into
'meaningful' sub-scales using factor analytic techniques (i.e., 'external' and
'internal' causes). Nonetheless, there is a need for disease-specific consistency with
regard to the aggregation of causal attributions in future research.
Finally, the present research demonstrated the extent that representations of
diabetes are important in predicting self-management behaviours and
psychological outcomes. However, although all the dimensions of the IPQ-R were
predictive of a range of outcomes in diabetes patients the relationships were often
difficult to interpret in the context of the self-regulatory model. This observation
emphasises the need for consistency in the operationalisation of disease-specific
dimensions of the framework in future research in order to assist in delineating
their usefulness. In summary, these findings provide further evidence that refutes
the notion that patients conceptualise their illness around the 5 'core 'dimensions




6.13. Directions for future work
The findings of the literature review in Chapter 1 and the present study may
serve to inform and direct future research on illness representations and chronic
disease. Self-regulatory theory essentially describes an individuals' internal
schemata and their subsequent relationship with the challenges of coping with
and managing a given disease. Thus, it is suggested that individuals'
representations provide a schemata or 'profile' that can be utilised to help
identify those vulnerable to poor self-management of diabetes and may also be
used to inform the development of behavioural interventions. Similarly, an
illness representations 'profile' for significant others may also be constructed
based on the extent that their representations of a patient's disease are
considered to promote adaptive self-care health behaviours. This
individualised approach in utilising illness representations has been shown to
be beneficial for patients recovering from MI (Petrie et al, 2003). Furthermore,
evidence in Chapter 1 demonstrated that patients' representations can influence
clinical outcomes (i.e., HbAlc, blood pressure and cholesterol) and subsequent
long-term health. It is argued, therefore, that there is a need to examine the
amenability of illness representations to change in order to promote patients'
physical and psychological adaptation to disease. In Petrie et al's study,
patients were randomly assigned to receive either standard care which involved
a cardiac rehabilitation nurse and hospital visits and standard MI educational
material or three 30-40 minute intervention sessions conducted by a
psychologist in addition to the routine educational material. The intervention
was individualised based on patients' responses to the IPQ and the findings of
previous work by the authors. The earlier work showed that patients'
perceptions had important effects on their recovery. Specifically, patients who
believed their MI would have more serious long-lasting consequences were
found to have greater levels of illness related disability and were slower in
returning to work (Petrie et al, 1996). In addition, patients who had weaker
beliefs in the control of their condition were less likely to attend cardiac
rehabilitation (Petrie et al, 1996, Cooper et al, 1999). Thus in the delivery of the
intervention the authors specifically explored and challenged patients' beliefs
regarding the control, consequences and time-line of MI. The intervention
significantly altered patients' beliefs about their illness particularly relating to
the targeted representations of the condition. Prior to leaving hospital, patients
who received the intervention had significantly modified their perceptions with
regard to how long their illness would last and the personal consequences of
the MI on their life, compared to the control group. The intervention, group
was also more optimistic than the control group that their illness could be
controlled. The intervention had a positive effect on patients' understanding of
their MI and their preparedness to leave hospital, the speed that patients
returned to work and intentions to attend a rehabilitation programme.
It is proposed that a similar model to that developed by Petrie et al may be used
as the foundation of an intervention applied in the context of diabetes
management. The scope for such an intervention is supported by the
accumulated evidence suggesting that representations of diabetes and its
treatment are particularly pertinent in predicting relevant health behaviours in
diabetes. For example, by targeting patients' exhibiting beliefs that would not,
based on the present evidence, favour adherence to the recommended
treatment regimen. Moreover, the findings of the present research have
demonstrated that partners' representations of diabetes may be of equal
importance in determining self-management behaviours and subsequent
glucose-control. Finally, the 12-month follow-up period demonstrated a degree
of instability with regard to patients and partners illness representations. This
observation supports the view that representations are subject to change
throughout the trajectory of the disease suggesting that interventions to
manipulate representations should be possible regardless of how long patients
have lived with the condition.
Thus illness representations may be important and modifiable factors for
intervention in patients with chronic disease who do not demonstrate adequate
adherence. Such an approach to the individualisation of interventions in health
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promotion may also serve to empower patients in terms of controlling their
disease.
It also follows that assessing the representations of partners' of patients with
chronic disease may prove fruitful in developing interventions aimed at
improving adjustment and self-management of a condition such as diabetes.
Indeed, partners may 'minimise' or 'maximise' certain representations which in
turn may not favour adherent behaviour in patients (described in detail earlier).
Therefore, such 'undesirable' representations could be manipulated with the
aid of counselling to elicit representations that would complement and support
the patient in managing their disease.
It is speculated that such an intervention will follow the following steps.
Dyads in which the partner is experiencing difficulties in the management of
the condition (as determined by HbAlc) will be targeted for the intervention.
Both parties will be required to attend intervention sessions with a health
practitioner with skills in couple counselling. The aim of the sessions will be to
address three main issues relating to the delivery of the intervention. First, to
identify deficiencies in diabetes knowledge regarding effective management.
Second, to challenge the extent that partners or patients 'minimise' or
'maximise' representations which serve as potential barriers to effective self-
management. Third, to use a shared-decision making approach to work with
dyads to identify ways of improving diet and exercise behaviours. The latter
would serve to 1) identify problems experienced in adopting health behaviours;
2) establishing realistic goals for behaviour change and 3) elicit workable
strategies to implement the behaviours.
However, it is possible that the efficacy of the described intervention may be
limited with regard to the sampling limitations outlined at the start of this
chapter. Indeed, it cannot be assumed that all patients with type 2 diabetes will
accrue the potential benefits from an intervention of this nature. However, it is
asserted that the emphasis on the individualisation of the intervention based on
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the illness representations of both parties of the dyad will serve to empower
participants which may in turn ease any potential limitations.
It is also speculated that the representations of newly diagnosed patients and
partners may fluctuate in the early stages of adjustment to the disease. Indeed,
psychological adjustment to the diagnosis may be dependent on how such a
diagnosis is communicated to the patient in the context of primary care.
Therefore studies are needed to assist in determining patients' adjustment to a
new diagnosis and the dynamic nature of illness representations over time.
Additionally, there has been little research examining the extent that
representations of patients are in agreement with the representations of the
health care provider. This proposal may also be extended to examine the extent
that representations of partners of patients are in agreement with those of
health care provider. This may be another informative area of research relating
to the assessment of illness representations in chronic disease such as diabetes.
Finally, qualitative approaches in the examination of dyadic representations
may provide further insights into how partners' representations of diabetes
influence patient behaviours and outcomes with regard to the degree of support
provided by partners.
6.14. Final conclusions
The focus of this thesis was to provide an exploratory examination of the role of
'significant others' in the health behaviours of patients with type 2 diabetes.
The study was undertaken in the context of the self-regulatory model of illness
behaviour and utilised the illness representation framework with the
employment of theoretically derived questionnaires. In the process of this
prospective study it was demonstrated that, in general, patient-partner dyads
share representations of type 2 diabetes and its management. Furthermore, it
was shown that some of the diabetes representations of partners were
important predictors of the patients' health behaviours over and above the
patients' representations of the condition. The findings have made a positive
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contribution to the limited literature examining the representations of
significant others. This was achieved by validating the usefulness of the
assessment of partners' representations in the context of adjustment in chronic
disease. In addition, the findings may be useful in informing the development
of interventions to improve self-management behaviours in chronic disease.
The study has also highlighted some neglected theoretical considerations
concerning the operationalisation of the illness representations framework and
appraisal processes. Finally, partners' beliefs may impact on patients'
management of diabetes by influencing behaviour that would favour better
control of the condition.
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APPENDiCES
Appendix 1: Data extraction sheet for systematic review of illness representations literature
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I would like to tell you about a new study that is being conducted by the University of Bristol
as part of the Somerset and Avon Survey of Health (SASH). The SASH Diabetes Study, as it
is called, aims to investigate how important people in your life, such as your spouse or
partner, influence your diabetes and how you cope with it. The researchers would like to ask
both you and your partner questions about your diabetes. This would involve you completing
a few questionnaires which will be sent you by post and will include reply-paid envelopes.
If you would like to fmd out more about this study please send the reply slip below in the pre-
paid envelope provided. Please take the time to discuss this study with your partner before
making a decision. If you would prefer not to be contacted by the researchers please ignore




Reply slip (please return in the pre-paid envelope provided)
I would like to receive further information on the SASH diabetes study
Signature:______________________ Date:___________________
PrintName:	 Title:________________
Address : 	 _____________ ____________
Post code:	 Tel Number:
Dr Simon Bradley	 Dr Gillian Lewis	 Dr Douglas Redpath
Dr Gillian Elstow	 Dr Christopher Yerbury
Dr Jean Stevenson	 Dr Patricia O'Neill
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Appendix 3: Study invitation letter for patients and partners
University of Bristol
SASH Diabetes Study
Dept of Social Medicine
Canynge Hall
Whiteladies RoadSASH DIABETES STUDY
Bristol
SOIIERSETA1D AVON SURVEY OF HEALTh	 BS8 2PR
RESEARCH INTO THE ROLE OF THE PARTNER IN THE HEALTH BEHAVIOURS OF
PATIENTS WITH TYPE 2 DIABETES
RESEARCHER: Mr Aldari Searle. Tel: 01179287351	 PROJECT SUPERVISOR: Dr Kay Vedhara. Tel: 0117928 7243
Dear Mrs Walls, 	 14 March 2002
The University of Bristol is carrying out research into diabetes and how people important to you, such as your husband or
wife influence your illness. The aim of the study is to examine how you and your partner view your illness and how these
views are related to following your doctors' advice in controlling your illness.
The researcher, Mr Aidan Searie, is inviting you and your partner to participate in the study. We have enclosed an
information sheet for both you and your partner to read so that you can decide whether or not to participate in the study. All
information that you and your partner give will be completely confidential and will be used only for the purposes of the
study. If you do both decide to participate we uld be very grateful if could both complete the consent forms and
questionnaire booklets enclosed. You will also be asked to complete similar questionnaire booklets on two further
occasions; at 6 months and 12 months time.
It is necessary for both you and your partner to com plete separate consent forms and questionnaires. The consent forms
and questionnaires are marked accordin g ly and separate FREEPOST envelopes will be provided for you to return them to
us. Please return the questionnaires even if there are some questions you are unable to complete.
If you have any queries about the questionnaire or the study please phone Mr Aidan Searle on 0117 928 7351.








Appendix 4: Patient information sheet
SASH Diabetes Study
University of Bristol
Dept of Social Medicine
SASH DIABETES Canynge HallWhiteladies Road
Bristol
SOMERSTAND AVON $URVY OF HEALTh	 STU DY
	 BS8 2PR
INFORMATION SHEET
RESEARCHER: MR AIDAN SEARLE. TEL; 0117 928 7351
PROJECT SUPEVISOR: DR KAVVEDHARA. TEL: 0117 928 7243
RESEARCH INTO ThE ROLE OF THE PARTNER IN THE HEALTH BEHAVIOURS OF
PATIENTS WITH TYPE 2 DIABETES.
You and your partner are being Invited to take part In a research study. Before you decide to participate It Is
important for you to understand why the research Is being done and what it will involve. Please take time to
read the following information carefully and discuss It with your partner. Please ask us if there Is anythIng that
Is not clear or If you would like more Information.
What is the purpose of the study?
Many patients with diabetes find it difficult to follow doctor's recommendations for controlling their illness such as dietary
advice or taking prescribpd medication. Therefore, we are Interested in the views of you and your partner towards
diabetes so that doctors and other health care workers can better understand the impact of the illness on family life.
Why have we been chosen?
You have been chosen because your GP has Informed us that you have a diagnosis of type 2 diabetes and are manied
or cohabiting with a partner.
Do we have to take part?
It is up to you and your partner to decide whether or not to take part - it is entirely voluntary. If you do both decide to
take part you will both be asked to sign a consent form. However, you are both still free to withdraw from the study at
any time and without gMng a reason. This will in no way affect the treatment you receive as a patient
What will happen to us if we take part?
If you and your partner decide to take part you will be sent a detailed questionnaire asking questions about your
thoughts and attitudes towards diabetes and control of the illness. You and your partner will be asked to complete
separate questionnaire booklets; the questionnaire for the diabetic patient will take approximately 45 minutes to
complete, the questionnaire for the patienrs partner will take approximately 10 minutes to com plete. You will both be
sent the same questionnaire on two further occasions; 6 months and 12 months after the first time.
Will our taking part in this study be kept confidential?
Your medical records will be examined by members of the research team and all the information you give us will treated
with stiict confidentiality, it will only be seen by the members of the research team.
Pabentinfo/version4/ 2113/01
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Appendix 5: Study consent form for patient
SASH DIABETES STUDY	 ID




	 I I I
Centre Number:
Study Number:
PaUent ldenficadon Number: 	 SASH DIABETES STUDY
University of Bristol
Dept of Social Medicine
Canynge Hall, Whiteladles Road.
Bristol, BS8 2PR.
RESEARCH INTO THE ROLE OF THE PARThER IN THE HEALTH BEHAVIOURS OF
PATIENTS WITH TYPE 2 DIABETES,
RESEARCHER: Mr Aidan Searle Tel: 0117 928 7351
PROJECT SUPERVISOR: Dr Kay Vedhara Tel: 0117 928 7243
Please Initial box
1. I confirm that I have read and understand the Information sheet dated....................
	 U
(version..........) for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw at any time,
	 0
without giving any reason, without my medical care or legal lights being affected.
3. I understand that sections of any of my medical notes may be looked at by responsible indMduals
from my GP practice where it is relevant to my taking part in research. I give permission for these
Individuals to have access to my records.
U







1 for patent; 1 for researcher; Ito be kept with GP notes
Patientconsentiversion3/7/1 1/00.
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Appendix 6: Study consent form for partner
SASH DIABETES STUDY	 ID
CONSENT FORM For PARTNER	 DATE
I	 I	 I	 I	 I	 I	 I
Centre Number:
Study Number:
Paent Idenficaon Number:	 SASH DIABETES STUDY
University ot Bristol
Dept of Social Medicine
Canynge Hall, Whiteladles Road
Bristol, BSS 2PR.
RESEARCH INTO THE ROLE OF THE PARTNER IN THE HEALTH BEHAVIOURS OF
PATIENTS WITH TYPE 2 DIABETES.
RESEARCHER: Mr Aldan Searle Tel: 0117 928 7351
PROJECT SUPERVISOR: Dr Kay Vedhara Tel: 0117 928 7243
Please initial box
1. I confirm that I have read and understand the information sheet dated....................
(version..........) for the above study and have had the opportunity to ask questions.
2. I understand that my participation is voluntary and that I am free to withdraw at any time,	 [I]
without gMng any reason, without my medical care or legal rights being affected.
3. I agree to take part in the above study
	 U


















SOMERSET AND AVON SURVEY Of HEALTh
Appendix 7: Reminder letter for participants
RESEARCH INTO THE ROLE OF THE PARTNER IN THE HEALTH BEHAVIOURS OF
PATIENTS WITH TYPE 2 DIABETES
RESEARCHER: MrAidan Searle. Tel: 0117 928 7351
REMINDER





You should have recently received in the post some information and questionnaires for
you and your partner regarding the above study. We appreciate that you will need to
find the time to complete the questionnaires. We would, however, be grateful if you
could do this at your earlIest convenience. It Is Important that as many people as
possible complete the questionnaires so that we can be sure that the results we obtain
accurately reflect the experiences of people with diabetes.
If you already have returned the questionnaires, please ignore this letter and accept our
apologies for having troubled you further. If, however, you would like some assistance
in completing some or all of the questionnaires, please do not hesitate to contact us on
the number above. We would be pleased to assist In any way we can.
Many thanks for considering this request - your help Is greatly appreciated. We hope
that you will be able to help us with this research and look forward to receiving your





Appendix 8: Illness representations measure - patients
Your thoughts about your Diabetes
Listed below are a number of symptoms that you may or may not experience in relation to your diabetes.
Please indicate by circling ) or , whether you experience any of these symptoms































Please indicate by circling	 or , whether you experience any of these symptoms when your















7. Irritable I Moody	 Yes	 No
8. Nauseous
	 Yes	 No







We are interested in your personal views of how you see your diabetes today.
Please indicate how much you agree or disagree with the following statements about your diabetes.
NEITHER''
STRONGLY DISAGREE AGREE OR AGREE STRONGL
_____________________________________ DISAGREE _________ DISAGREE _______ V AGREE
IMy treatment can control my diabetes 	 _____________ ___________ ___________ ________ __________
2	 My diabetes is a mystery to me
	 _____________ ___________ ___________ ________ __________
3	 My diabetes will pass quickly	 _____________ ___________ ___________ ________ __________
4	 I expect to have diabetes for the rest of my life 	 _____________ ____________ ____________ ________ __________
5 My diabetes is a serious condition 	 _____________ ___________ ___________ ________ __________
6	 My diabetes makes me feel angry 	 _____________ ___________ ___________ ________ __________
7	 My diabetes does not have much effect on my life 	 ____________ ___________ ___________ ________ __________
8	 My diabetes strongly affects the way others see me 	 ____________ ___________ ___________ ________ __________
9	 My diabetes has serious financial consequences 	 _____________ ____________ ____________ ________ __________
10 There is a lot which I can do to control my symptoms ____________ ___________ ___________ ________ __________
11 My symptoms come and go in cycles	 ____________ ___________ ___________ ________ __________
12 Nothing I do will affect my diabetes	 ____________ ___________ ___________ ________ __________
13 I have the power to influence my diabetes	 ____________ ___________ ___________ ________ __________
14 My diabetes will improve in time	 ____________ ___________ ___________ ________ __________
15 The symptoms of my diabetes are puzzling to me
	 ____________ ___________ ___________ ________ __________
16 My diabetes will last for a long time	 ____________ ___________ ___________ ________ __________
17 There is nothing which can help my diabetes 	 ____________ ___________ ___________ ________ __________
18 When I think about my diabetes I get upset 	 ____________ ___________ ___________ ________ __________
19 My diabetes will last a short time 	 ____________ ___________ ___________ ________ __________
20 My diabetes doesn't make any sense to me	 ____________ ___________ ___________ ________ __________
21 I have a clear understanding of my diabetes	 _____________ ____________ ____________ _________ __________
22 The course of my diabetes depends on me	 ____________ ___________ ___________ ________ __________
23 Having diabetes makes me feel anxious	 ____________ ___________ ___________ ________ __________
24 I get depressed when I think about my diabetes 	 ____________ ___________ ___________ ________ __________
25 My diabetes has major consequences on my life 	 ____________ ___________ ___________ ________ __________
26 I don't understand my diabetes	 ____________ ___________ ___________ ________ __________
27 My diabetes does not worry me 	 ___________ ___________
28 My diabetes is very unpredictable 	 _____________ ___________ ___________ ________ __________
29 My diabetes makes me feel afraid 	 _____________ ____________ ____________ _________ __________
30 My diabetes can be controlled by my treatment 	 ____________ ___________ ___________ ________ __________
31 What I do determines whether my diabetes gets
better or worse
32 The symptoms of my diabetes change a great deal
fromdayto day	 __________ _________ _________ _______ ________
33 My actions will have no effect on the outcome of my
diabetes_____________ ___________ ___________ ________ __________
34 There is very little that can be done to improve my
diabetes_____________ ___________ ___________ ________ __________
35 My diabetes is likely to be permanent rather than
temporary_____________ ___________ ___________ ________ __________
36 My treatment will be effective in managing my
diabetes_____________ ____________ ____________ ________ __________
37 The negative effects of my diabetes can be prevented
bymy treatment	 _____________ ___________ ___________ ________ __________
38 My diabetes causes difficulties for those who are
closeto me	 _____________ ___________ ___________ ________ __________
39 I go through cycles in which my diabetes gets better
orworse	 ____________ ___________ ___________ ________ __________
273
Control of your diabetes
Please indicate the extent to which you feel that the following treatment recommendations are important for
controlling your diabetes.
HOW IMPORTANT ARE THE FOLLOWING	 "NOT	 NOT	 VERY
FOR CONTROLLING YOUR DIABETES	 IMPORTANT	 SURE	 IMPORTANT
_______________ 1
	
2	 3	 4	 5
IExercising regularly	 _____________ ____________ ____________ ____________ _____________
2 Testing blood glucose regularly 	 _____________ ____________ ____________ ____________ _____________
3	 Having your cholesterol checked regularly 	 _____________ ____________ ____________ ____________ _____________
4	 Having your blood sugar checked regularly _____________ ___________ ___________ ___________ ____________
5 Having regular eye tests 	 ____________ ___________ ___________ ___________ ____________
6 Checking your feet regularly 	 ___________ ___________ ___________ ___________ ____________
7	 Eating a diet low in fat and high in fibre 	 ____________ ___________ ___________ ___________ ____________
8 Not eating too many sweet foods	 _____________ ___________ ___________ ___________ ____________
9 Drinking little or no alcohol 	 _____________ ___________ ___________ ___________ ____________
10 My diabetes medication 	 _____________ ___________ ___________ ___________ ____________
11 Not smoking
12 Taking diabetes medication as prescribed
I_byyourGP	 _________ ________ ________ ________ _________
Please indicate the extent to which you feel that the following treatment recommendations are important for
avoiding future complications relating to your diabetes.
HOWIMPORTANTARETHEFOLLOWING 	 NOT	 NOT	 VERY'
FOR AVOIDING FUTURE COMPLICATIONS	 IMPORTANT	 SURE	 IMPORTANT
RELATING TO YOUR DIABETES	 1	 2	 3	 4	 5
13	 Exercising regularly 	 _____________ __________ _____________ __________ _____________
14	 Testing blood glucose regularly	 _____________ __________ _____________ _________ ____________
15	 Having your cholesterol checked regularly	 _____________ __________ _____________ _________ ____________
16	 Having your blood sugar checked regularly	 ____________ __________ _____________ _________ ____________
17	 Having regular eye tests	 _____________ __________ _____________ _________ ____________
18	 Checking your feet regularly	 _____________ __________ _____________ __________ _____________
19	 Eatingadietlowinfatandhighinfibre	 ___________ ________ ___________ ________
20	 Not eating too many sweet foods	 _____________ __________ _____________ __________ ____________
21	 Drinking little or no alcohol 	 _____________ __________ _____________ __________ _____________
22	 My diabetes treatment 	 _____________ __________ _____________ __________ _____________
23	 Not smoking	 _____________ __________ _____________ __________ ____________
24	 Taking diabetes medication as prescribed by
yourGP__________ ________ __________ ________ __________
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Causes of your diabetes
We are interested in what y consider may have contributed to causing your diabetes. As people are very different, there is
no correct answer for this question. We are interested in your own views about the factors rather than what others including
doctors
or family have suggested to you. Below is a list of possible causes for your illness. Please indicate how much you agree or




STRONGLY DISAGREE	 AGREE OR	 AGREE	 STRONGLY
- ____________________________ DISAGREE __________ DISAGREE _________ AGREE
IStress or worry caused my diabetes	 _____________ _____________ _____________ ___________ ____________
2 Other people caused my diabetes	 _____________ _____________ _____________ ___________ ____________
3 A germ or virus caused my diabetes	 ___________ _____________ _____________ ___________ ____________
4 My weight caused my diabetes	 ___________ _____________ _____________ ___________ ____________
5 Alcohol caused my diabetes	 _____________ _____________ _____________ ___________ ____________
6 Smoking caused my diabetes	 _____________ _____________ _____________ ___________ ____________
7	 Hereditary factors (in the family)
- caused my diabetes
	 _____________ _____________ _____________ ___________ ____________
8	 My own behaviour caused my diabetes _____________ _____________ _____________ ___________ _____________
9	 Diet or eating habits caused my
diabetes_____________ _____________ _____________ ___________ _____________
10 Chance or bad luck caused my
diabetes_____________ _____________ _____________ ___________ _____________
11 Poor medical care in my past caused
- my diabetes	 __________ __________ __________ _________ __________
12 Pollution in the environment caused
- my diabetes	 _____________ _____________ _____________ ____________ _____________
13 A lack of exercise caused my diabetes	 _____________ _____________ ___________ _____________
Think about what may have caused your diabetes. What do you think were the three most important factors in causing your
diabetes? You may use any of the items from the box above, or you may have additional ideas of your own.
The three most important causes were:
2nd
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Appendix 9: Illness representations measure - partners
Your thoughts about your partner's diabetes
Listed below are a number of symptoms that your partner may or may not experience in relation to
his! her diabetes. Please indicate by circling ) or , whether your partner experiences any of
















6. Irritable I Moody
	 Yes	 No
Do they....
7. Urinate frequently	 Yes	 No
8.Have blurred vision	 Yes	 No
9. Have increased thirst 	 Yes	 No
10.Other	 Yes	 No
Please indicate by circling 	 or	 whether your partner experiences any of these















7. Irritable! Moody	 Yes	 No
8. Nauseous	 Yes	 No




We are interested in your personal views of how you see your partner's diabetes today.
Please indicate how much you agree or disagree with the following statements about your partner's diabetes.	 ___________
NEITHER
STRONGLY. DISAGREE 'AGREE OR AGREE STRONGL
______________________________ DISAGREE _______ DISAGREE _____ YAGREE
1	 Treatment can control my partner's diabetes	 ____________ ____________ ____________ ________ ___________
2	 My partner's diabetes is a mystery to him I her	 ___________ ___________ ___________ ________ __________
3	 My partner's diabetes will pass quickly 	 ___________ ___________ ___________ ________ __________
4	 I expect my partner to have diabetes for the rest of his!
herlife	 __________ __________ __________ _______ _________
5	 My partner's diabetes is a serious condition 	 ____________ ____________ ____________ ________ ___________
6	 My partner's diabetes makes him I her feel angry	 ___________ ___________ ___________ ________ __________
7	 My partner's diabetes does not have much effect on
his! her life	 __________ ___________ __________ ________ __________
8	 My partner's diabetes strongly affects the way others
seehim I her	 ___________ ___________ ___________ ________ __________
9	 My partner's diabetes has serious financial
consequences____________ ____________ ____________ ________ ___________
10 There is a lot which my partner can do to control his!
hersymptoms	 __________ ___________ ___________ ________ __________
11 My partner's symptoms come and go in cycles	 ___________ ___________ ___________ ________ __________
12 Nothing my partner does will affect his! her diabetes 	 ___________ ___________ ___________ ________ __________
13 My partner has the power to influence his! her
diabetes____________ ____________ ____________ ________ ___________
14 My partner's diabetes will improve in time	 ___________ ___________ ___________ ________ __________
15 The symptoms of my partner's diabetes are puzzling
tohim ! her	 _________ __________ __________ _______ _________
16 My partner's diabetes will last for a long time 	 ___________ ___________ ___________ ________ __________
17 There is nothing which can help my partner's diabetes ___________ ___________ ___________ ________ __________
18 When my partner thinks about his I her diabetes
he!shegetsupset	 _________ _________ _________ _______ _________
19 My partner's diabetes will last a short time 	 ___________ ___________ ___________ ________ __________
20 My partner's diabetes doesn't make any sense to him!
her___________ ___________ ___________ ________ __________
21 My partner has a clear understanding of his ! her
diabetes___________ ___________ ___________ ________ __________
22 The course of my partner's diabetes depends on him I
her___________ ___________ ___________ ________ __________
23 My partner's diabetes makes him! her feel anxious 	 ___________ ___________ ___________ ________ __________
24 My partner gets depressed when he! she thinks about
theirdiabetes	 ____________ ____________ ____________ ________ ___________
25 My partner's diabetes has major consequences on his!
her life	 _________ __________ _________ _______ _________
26 My partner does not understand his Iher diabetes
	 ___________ ___________ ___________ ________ __________
27 My partner's diabetes does not worry him I her	 ___________ ___________ ___________ ________ __________
28 My partner's diabetes is very unpredictable	 ___________ ___________ ___________ ________ __________
29 My partner's diabetes makes him I her feel afraid	 ____________ ____________ _________ 	 ________ ___________
30 My partner's diabetes can be controlled by treatment 	 ___________ ___________ ___________ ________ __________
31 What my partner does determines whether his! her
diabetesgets better or worse	 __________ ___________ __________ _______ __________
32 The symptoms of my partner's diabetes change a great
dealfrom day to day	 ___________	 ________ ___________ ________ __________
33 My partner's actions will have no effect on the
outcomeof his! her diabetes	 ____________ ____________ ____________ ________ ___________
34 There is very little that can be done to improve my
partner' s diabetes	 ____________ ____________ ____________ ________ ___________




37 The negative effects of my partner's diabetes can be
- prevented by his I her treatment	 ___________ ___________ ___________ ________ __________
38 My partner's diabetes causes difficulties for those who
- are close to him! her	 __________ __________ __________ ________ __________
39 My partner goes through cycles in which his! her
diabetesgets better or worse	 ,	 ,.	 ___________ ___________ ________ __________
Control of your partner's diabetes
Please indicate the extent to which you feel that the following treatment recommendations are important for
controlling your partner's diabetes.
HOW IMPORTANT ARE THE FOLLOWING	 NOT'	 OT	 VERY'
FOR CONTROLLING YOUR PARTNER'S DIABETES IMPORTANT	 SURE	 lMPORT-
1	 2	 3	 4	 ANT
___________________________________________________ _______________ ___________ __________ ___________ 	 5
IExercising regularly	 ______________ __________ __________ __________ __________
2	 Testing blood glucose regularly 	 _____________ __________ _________ __________ __________
3	 Having his I her cholesterol checked regularly 	 ______________ __________ __________ __________ __________
4	 Having his I her blood sugar checked regularly	 _____________ __________ __________ __________ __________
5	 Having regular eye tests	 _____________ __________ _________ __________ __________
6	 Checking his I her feet regularly	 ______________ __________ __________ __________ __________
7	 Eatingadietlowinfatandhighinfibre	 ____________ ________ ________ ________ ________
8	 Not eating too many sweet foods 	 _____________ __________ _________ __________ __________
9	 Drinking little or no alcohol 	 _____________ __________ _________ __________ __________
10	 My partner's diabetes medication	 _____________ __________ _________ __________ __________
11	 Not smoking	 _____________ _________ _________ _________ _________
12	 Taking diabetes medication as prescribed by his I
her GP
Please indicate the extent to which you feel that the following treatment recommendations are important for
avoiding future complications relating to your partner's diabetes.
	
HOW IMPORTANT ARE THE FOLLOWING FOR 	 NOT	 '	 NOT	 VERY
	
AVOIDING FUTURE COMPLICATIONS RELATING 	 IMPORTANT	 SURE	 IMPORT-
TO YOUR PARTNER'S DIABETES 	 1	 2	 3	 4	 ANT
______________________________________________________ ________________ ___________ ___________ ___________ 	 5
13	 Exercising regularly	 _______________ __________ __________ __________ __________
14	 Testing blood glucose regularly 	 ______________ __________ _________ _________ __________
15	 Having his I her cholesterol checked regularly	 _______________ __________ __________ __________ __________
16	 Having his I her blood sugar checked regularly 	 ______________ __________ _________ _________ __________
17	 Having regular eye tests	 _______________ __________ __________ __________ __________
18	 Checking his I her feet regularly	 _______________ __________ __________ __________ __________
19	 Eatingadiet low in fat and high in fibre	 ___________ ________ ________ ________ ________
20	 Not eating too many sweet foods 	 ______________ __________ _________ __________ __________
21	 Drinking little or no alcohol 	 _______________ __________ __________ __________ __________
22	 My partner's diabetes treatment 	 _______________ __________ __________ __________ __________
23	 Not smoking	 _______________ __________ __________ __________ ___________
24	 Taking diabetes medication as prescribed by his!
herGP_____________ _________ ________ _________ _________
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Causes of your partner's diabetes
We are interested in what yQ! consider may have contributed in causing your partner's diabetes. As people are very different,
there is no correct answer for this question. We are most interested in your own views about the factors rather than what
others including doctors or family have suggested to you. Below is a list of possible causes for your partner's illness. Please
indicate how much you agree or disagree that they caused your partner's diabetes by ticking the appropriate box.
POSSIBLECAUSES	 NEITHER
STRONGLY DISAGREE AGREE OR AGREE STRONGL
__________________________________ DISAGREE _________ DISAGREE _______ YAGREE
IStress or worry caused my partner's diabetes	 _____________ ___________ _____________ _________ __________
2	 Other people caused my partner's diabetes	 _____________ ___________ _____________ _________ __________
3 A germ or virus caused my partner's diabetes 	 ____________ ___________ _____________ _________ __________
4	 My partners' weight caused his I her diabetes	 ____________ ___________ _____________ _________ __________
5 Alcohol caused my partner's diabetes 	 ____________ ___________ _____________ _________ __________
6 Smoking caused my partner's diabetes 	 ____________ ___________ ____________ _________ __________
7	 Hereditary factors (in the family) caused my
partner's diabetes	 ____________ ___________ _____________ _________ __________
8	 My partner's own behaviour caused his I her
diabetes_____________ ____________ _____________ __________ ___________
9	 Diet or eating habits caused my partner's
diabetes_____________ ____________ _____________ __________ ___________
10 Chance or bad luck caused my partner's diabetes _____________ ___________ _____________ _________ __________
11 Poor medical care in my past caused my
- partner's diabetes	 _____________ ___________ _____________ _________ __________
12 Pollution in the environment caused my partner's
diabetes_____________ ___________ _____________ _________ __________
13 A lack of exercise caused my partner's diabetes 	 ____________ ___________ ____________ _________ __________
Think about what may have caused your partner's diabetes. What do you think were the three most important factors in
causing your partner's diabetes? You may use any of the items from the box above, or you may have additional ideas of your
own.




Appendix 10: Food Frequency Questionnaire (HEA3)
We are interested in how often you eat certain foods. Please mark your 'average' serving portion size (small, medium or large)
for the different foods below, and how often you eat them. If you do not normally eat the food please put a zero (0) in the month
column. There is an example shown at the top of the table: This person eats a medium sized portion of 2 slices of bread per
day and a large bowl of cereal four times a week.
Food	 Typical Medium Serving	 Serving Size	 How Often
________________________ ____________________ S M
	
L	 Day	 Week	 Month
-
Example: Bread	 2 medium slices	 -	 -	 I	 ________ ______
Example: Cereal




44#Qd	 S4 fl	 11a....r _S..S....	 _1!J $ -	 W4	 44
	
- -.q	 -ar	 ct *- r ---- ,,	 ,,r	 *n r-s	 -tt'	 '**	 r	 wrr
Bread) Cereal / Potatoes 	 _____________________	 - ________ ________ _________
Bread I Toast	 2 medium slices	 ________ ________ __________
Breakfast cereal	 Average bowl /3
_________________________ tablespoons	 -	 - ________ ________ _________
Crackers I Crispbread	 3 crackers! slices
_________________________ crisp bread 	 -	 - ________ ________ _________
Bun!roll	 I Bun Iroll	 _______ _______ ________
Pitta I chapati	 I small piece (not
_________________________ 'mini')
	 ________ ________ _________
Rice! pasta! noodles	 Average serving (=6
_________________________ tablespoons)
	 -	 - ________ ________ _________
Plantains I green bananas! I plantain or green
sweet potatoes	 banana 12 sweet
_________________________ potatoes	 - - - ________ ________ _________
Potatoes (not chips)	 3 egg.sized potatoes	 ___	 ________ ________ _________
-	 - ________ ________ ________
Fruit! Vegetables	 _____________________ - - - - ________ ________ _________
Vegetables (fresh I frozen! Medium serving
tinned)
_________________________ (2 tablespoons)
	 - -	 ________ ________ _________
Salad	 Medium serving
__________________________ (3 tablespoons) - 	 -	 - ________ ________ __________
Stewed or tinned fruit	 Medium serving
_________________________ (3 tablespoon)	 -	 - ________ ________ _________
Fresh fruit	 I apple, orange, or
banana I small bunch
________________________ grapes! slice lemon - --
	 - ________ ________ _________
Fruit juice	 Average glass
	
--	
- (160 ml)	 - _______ _______ ________
Meat! Alternatives 	 _____________________	 - ________ ________ _________
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All other meat (e.g. beef,
chops etc with visible fat,
chicken with skin, bacon
etc.
Sausage rolls! meat pie
Eggs
Beans! lentils / dhal
Nuts I peanut butter
Cakes, Puddings,Snacks
Donut, cake













4 ozI4 fish fingers (
small pack of playing
cards)
3 small sausages, 2
burgers, 2 slices of
luncheon meat






I small bag I table
spoon
I piece
average bowl ! I piece
3 small biscuits
Small bar
I scoop, I choc—ice, I
king cone
I small bag (25g)
1 teaspoon
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474)	 '4&,74.44444/I4/,^,/8,*fl7444,,74 ,', 44/7444%h44fl4, 7	 ,)*,	 -	 *4	 , 	 74
Fried or oily food e.g., medium portion
chips (3/4 cup), 2 fried
eggs, 2 rashers fried
bacon
Margarine or butter	 I pat
Low fat spread	 I pat
Cooking oil I fat! ghee	 I level tablespoon
Mayonnaise / oily salad	 I level tablespoon
dressing
::*2*^:4*4*,	 4'414*4('	 44	 /">	 't4*'*fl'7*74' 7
	 A	 '	 -	 '*"74	 '7	 / 44	 '4'7'*"A	 4
Milk and Dairy
Full fat milk	 1/3 pint (200m1)
Semi-skimmed milk	 1/3 pint (200m1)
Skimmed milk	 1/3 pint (200m1)
Cheese	 Small matchbox
Yoghurt! cottage cheese!	 Small pot
fromage frais
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Additional questions: Please answer the following questions by circling Yes or No.
1) Do you usually use wholemeal I high fibre! granary bread?	 Yes	 No
If yes, please specify type
2) Do you use a high fibre breakfast cereal?
Eg. Alpen, muesli, allbran, Jordan's crunchy, shredded wheat,
weetabix, porridge oats, shreddies, fruit n' fibre 	 Yes	 No
If yes, please specify type:
3a)Do you usually eat Wholegrain rice?	 Yes	 No
3b) Do you usually eat Wholewheat pasta? 	 Yes	 No
3c) Do you usually eat Potatoes with skin? 	 Yes	 No
4 a) Do you use low fat spread, low fat cheese or low fat yoghurt? 	 Yes	 No
b) If yes, please circle whichever you normally eat! use:
Specify type
I) Low fat hard cheese	 Yes	 No
II) Low fat soft cheese	 Yes	 No
III) Low fat yoghurt	 Yes	 No
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TV) Low fat spread Yes	 No	 __________________
V) Very low fat spread	 Yes	 No	 __________________
5) What sort of oil I fat do you usually use for frying? ( p lease circle one only)
I) Lard I dripping I butter or ghee	 Yes
II) Blended vegetable oil 	 Yes
Ill) Polyunsaturated oil (e.g., Sunflower oil) 	 Yes
IV) Monounsaturated oil (e.g., Olive, nut oil) 	 Yes
6) What kind of spreading fat do you usually use? (please circle one only)
I) Butter	 Yes
II) Ordinary margarine	 Yes
Ill) Polyunsaturated margarine (e.g., Sunflower) 	 Yes
IV) Monounsaturated margarine (e.g., Olive, rapeseed) 	 Yes
V) Low fat spread (e.g., Gold, Delight) 	 Yes
IV) Very low fat spread (e.g., Gold lowest)	 Yes
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Appendix 11: Scales from Baecke physical activity questionnaire
I Exercise Questionnaire
I 1) Do you play sport or engage in a particular exercise?	 Yes! No
I If yes:
Which sport ! exercise do you do most frequently?
How many hours a week?
I less than I	 I - 2	 2 - 3	 3 - 4	 more than 4
How many months a year?
I less than 1	 1 —3	 4— 6	 7-9	 more than 9
I Do you play any other sport or exercise? 	 Yes! No
If yes:
Pleasename the sport! exercise_____________________________
How many hours a week?
less than I	 I - 2	 2 - 3	 3 - 4	 more than 4
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How many months a year?
less than 1	 1 —3	 4-6	 7-9	 more than 9
2) In comparison with others my own age I think my physical activity during leisure time is;
much more	 more	 the sameless	 much less
3) During leisure time I sweat;
very often	 often	 sometimes	 seldom	 never
4) During leisure time I play sport;
never	 seldom	 sometimes	 often	 very often
5) During leisure time I watch television;
never	 seldom	 sometimes	 often
6) During leisure time I walk
never	 seldom	 sometimes	 often
7) During leisure time I cycle;




8) How many minutes do you walk and I or cycle per day to and from work, shops, visiting friend's etc.
less than 5	 5-15	 15-30	 30.45	 more than 45
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Appendix 12: Medication adherence scale (MARS)
Your diabetes medicines
We would like to ask you a few questions about how you use your diabetes medicines.
Many people find a way of using their medicines which suits them. This may differ from the instructions
on the label or from what their doctor has said.
Here are some ways in which people have said that they use their medicines for each of the statements,
please tick the box which best applies to you.
Always	 Often true	 Sometimes	 Rarely	 Never true
true	 true	 True
I	 I avoid using my medicines if I
can
2 I forget to take my medicines
3 I alter the dose of my medicines
4 I stop taking my medicines for a
while
5 I decide to miss out a dose
6	 I take less than instructed
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Appendix 13: Hospital Anxiety and Depression Scale
Your Emotions
We are aware that emotions play an important part in maintaining health. This questionnaire is designed
to help us know how you feel. Read each item and place a tick opposite the reply which comes closest to
how you have been feeling in the past week.
Don't take too long over your replies: your immediate reaction to each item will probably be more
accurate than a long thought-out response.
1. I feel tense or 'wound up'S.......	 Most of the time
A lot of the time
Time to time, occasionally
Not at all




3. I still enjoy the things I used to enjoyS.....
4. I get a sort of frightened feeling like
butterflies in the stomachS......
Definitely as much







5. I get a sort of frightened feeling as if
something awful is going to happen S
	Very definitely and quite badly
Yes, but not too badly
A little, but it doesn't worry me
Notatall
6. I have lost interest in my appearance . .......
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Definitely
I don't take so much care as I should
I may not take as quite as much care
I take just as much care as ever
7. I can laugh and see the funny side of things .......As much as I always could
Not quite so much now
Definitely not so much now
Not at all




9. Worrying thoughts go through my mind 	 A great deal of the time
A lot of the time
From time to time, not to often
Only occasionally
10. I look forward with enjoyment to things	 As much as I ever did
Ratherlessthanlusedto
Definitely less than I used to
Hardly at all
11. I feel cheerful ...... 	 Not at all
Not often
Sometimes
Most of the time













Appendix 14: Dyadic Adjustment Scale
Your Relationship
Most people have disagreements in their relationships. Please indicate below the approximate extent of
agreement or disagreement between you and your partner for each item on the following list.
Always	 Almost	 Occasionally	 Frequently	 Almost	 Always
agree	 always agree	 disagree	 disagree	 always	 disagree
_____________________________ _________ _____________ ______________ ____________ disagree __________
Philosophyof life	 _________ ______________ ______________ _____________ ___________ ___________
Aims, goals and things
considered to be important	 __________ _____________ ______________ _____________ ___________ ___________
Amountof time spent together	 __________ _____________ ______________ _____________ ___________ ___________
Never	 Less than	 Once or twice a	 Once or	 Once a day More often
______________________________ __________ once a month 	 month	 twice a week ___________ ___________
Have a stimulating change of
ideas__________ ______________ _______________ _____________ ____________ ____________
Calmlydiscuss something	 __________ ______________ _______________ _____________ ____________ ____________
Worktogether on a project	 __________ _____________ ______________ _____________ ___________ ___________
The numbers on the line below represent different degrees of happiness in your relationship. The middle point, 'Happy' (3),
represents the degree of happiness of most relationships.
Please circle the number which best describes the degree of happiness, all things considered, of your relationship.
0	 1	 2	 3	 4	 5	 6
Extremely	 Fairly	 A little	 Happy	 Very	 Extremely	 Perfect
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Appendix 15: Letter to patients at follow-up and request for blood sample
RESEARCH INTO THE ROLE OF THE PARTNER IN THE HEALTH BEHAVIOURS OF PATIENTS
WITH TYPE 2 DIABETES
RESEARCHER: Mr Aldan Searle. Tel: 0117 928 7351
PROJECT SUPERVISOR: Dr Kay
 Vedhara. Tel: 0117 928 7243
Dear
I am pleased to be able to tell you that we have now entered the final phase of this research project. We
have greatiy appreciated your cooperation with our work so far.
For this final stage we would like you to help us with two things:
1. As before, we enclose questionnaires for you and your partner to complete. These ask about
your beliefs about your diabetes and some of the behaviours you may have been asked to
change, or have considered changing since you were diagnosed.
2. We would also like to determine how well you are managing your diabetes at this time. To do
this we simply need to take one small blood sample from you. This blood sample will give us
an Indication of how well patients manage their diabetes and will help us to develop ways of
assisting patients with blood glucose control.
If you agree to having this blood sample taken, we will ask you to attend our clinic at Weston General
Hospital. The blood sample will be taken by an experienced nurse. It is emphasised that the risks
associated with taking blood samples am minimal (I.e., some individuals may expenence bruising and
discomfort). We will also be able to provide travelling expenses or provide transnort if necessary for you
to attend this appointment.
I would be very grateful If you could consider whether you would be willing to provide us with a blood
sample for the last stage of the study. I shall call you within the next few days to discuss the blood test
with you and, If you are willing, arrange a time for you to visa the centre to give this blood sample. In the
meantime if you have any queries please contact me on 0117 928 7351. (I can call you back).






Appendix 16: Consent form for blood sample (HbAlc)
SASH DIABETES STUDY	 ID








RESEARCH INTO THE ROLE OF THE PARTNER IN ThE HEALTh BEHAVIOURS OF PATIENTS
WITH TYPE 2 DIABETES.
RESEARCHER: MrAldan Searle Tel: 0117 928 7351
PROJECT SUPERVISOR Dr Ka y Vedhara Tel: 0117 928 7243
I agree to have a blood sample taken for analysis of Hbalc to measure my blood
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